id	sid	tid	token	lemma	pos
bam-9579	1	1	ordinary	ordinary	ADJ
bam-9579	1	2	and	and	CCONJ
bam-9579	1	3	severe	severe	ADJ
bam-9579	1	4	cases	case	NOUN
bam-9579	1	5	of	of	ADP
bam-9579	1	6	covid-19	covid-19	PROPN
bam-9579	1	7	in	in	ADP
bam-9579	1	8	iran	iran	PROPN
bam-9579	1	9	eur	eur	PROPN
bam-9579	1	10	j	j	PROPN
bam-9579	1	11	transl	transl	PROPN
bam-9579	1	12	myol	myol	ADV
bam-9579	1	13	31	31	NUM
bam-9579	1	14	(	(	PUNCT
bam-9579	1	15	3	3	NUM
bam-9579	1	16	):	):	PUNCT
bam-9579	1	17	9579	9579	NUM
bam-9579	1	18	,	,	PUNCT
bam-9579	1	19	2021	2021	NUM
bam-9579	1	20	doi	doi	NOUN
bam-9579	1	21	:	:	PUNCT
bam-9579	1	22	10.4081	10.4081	NUM
bam-9579	1	23	/	/	SYM
bam-9579	1	24	ejtm.2021.9579	ejtm.2021.9579	NUM
bam-9579	1	25	1	1	NUM
bam-9579	1	26	analysis	analysis	NOUN
bam-9579	1	27	of	of	ADP
bam-9579	1	28	239	239	NUM
bam-9579	1	29	ordinary	ordinary	ADJ
bam-9579	1	30	and	and	CCONJ
bam-9579	1	31	severe	severe	ADJ
bam-9579	1	32	cases	case	NOUN
bam-9579	1	33	of	of	ADP
bam-9579	1	34	covid-19	covid-19	PROPN
bam-9579	1	35	:	:	PUNCT
bam-9579	1	36	clinical	clinical	ADJ
bam-9579	1	37	features	feature	NOUN
bam-9579	1	38	and	and	CCONJ
bam-9579	1	39	treatment	treatment	NOUN
bam-9579	1	40	susan	susan	PROPN
bam-9579	1	41	azizmohammadi	azizmohammadi	PROPN
bam-9579	1	42	(	(	PUNCT
bam-9579	1	43	1	1	NUM
bam-9579	1	44	)	)	PUNCT
bam-9579	1	45	,	,	PUNCT
bam-9579	1	46	sima	sima	PROPN
bam-9579	1	47	azizmohammadi	azizmohammadi	NOUN
bam-9579	1	48	(	(	PUNCT
bam-9579	1	49	2	2	NUM
bam-9579	1	50	)	)	PUNCT
bam-9579	1	51	,	,	PUNCT
bam-9579	1	52	sarah	sarah	PROPN
bam-9579	1	53	dahmardeh	dahmardeh	PROPN
bam-9579	1	54	(	(	PUNCT
bam-9579	1	55	3	3	NUM
bam-9579	1	56	)	)	PUNCT
bam-9579	1	57	,	,	PUNCT
bam-9579	1	58	hossein	hossein	PROPN
bam-9579	1	59	azargashb	azargashb	PROPN
bam-9579	1	60	(	(	PUNCT
bam-9579	1	61	1	1	NUM
bam-9579	1	62	)	)	PUNCT
bam-9579	1	63	,	,	PUNCT
bam-9579	1	64	seyyed	seyye	VERB
bam-9579	1	65	javad	javad	PROPN
bam-9579	1	66	hosseini	hosseini	PROPN
bam-9579	1	67	shokouh	shokouh	PROPN
bam-9579	1	68	(	(	PUNCT
bam-9579	1	69	1	1	NUM
bam-9579	1	70	)	)	PUNCT
bam-9579	1	71	,	,	PUNCT
bam-9579	1	72	mojgan	mojgan	ADJ
bam-9579	1	73	mohajeri	mohajeri	ADJ
bam-9579	1	74	-	-	PUNCT
bam-9579	1	75	iravani	iravani	NOUN
bam-9579	1	76	(	(	PUNCT
bam-9579	1	77	4	4	NUM
bam-9579	1	78	)	)	PUNCT
bam-9579	1	79	,	,	PUNCT
bam-9579	1	80	maziar	maziar	VERB
bam-9579	1	81	mobasher	mobasher	NOUN
bam-9579	1	82	(	(	PUNCT
bam-9579	1	83	1	1	NUM
bam-9579	1	84	)	)	PUNCT
bam-9579	1	85	,	,	PUNCT
bam-9579	1	86	saeed	saeed	PROPN
bam-9579	1	87	soleiman	soleiman	PROPN
bam-9579	1	88	-	-	PUNCT
bam-9579	1	89	meigooni	meigooni	NOUN
bam-9579	1	90	(	(	PUNCT
bam-9579	1	91	1	1	NUM
bam-9579	1	92	)	)	PUNCT
bam-9579	1	93	,	,	PUNCT
bam-9579	1	94	mahdi	mahdi	PROPN
bam-9579	1	95	zabihi	zabihi	PROPN
bam-9579	1	96	(	(	PUNCT
bam-9579	1	97	1	1	NUM
bam-9579	1	98	)	)	PUNCT
bam-9579	1	99	(	(	PUNCT
bam-9579	1	100	1	1	X
bam-9579	1	101	)	)	PUNCT
bam-9579	1	102	hajar	hajar	PROPN
bam-9579	1	103	hospital	hospital	PROPN
bam-9579	1	104	,	,	PUNCT
bam-9579	1	105	aja	aja	PROPN
bam-9579	1	106	university	university	PROPN
bam-9579	1	107	of	of	ADP
bam-9579	1	108	medical	medical	ADJ
bam-9579	1	109	science	science	NOUN
bam-9579	1	110	,	,	PUNCT
bam-9579	1	111	tehran	tehran	PROPN
bam-9579	1	112	,	,	PUNCT
bam-9579	1	113	iran	iran	PROPN
bam-9579	1	114	;	;	PUNCT
bam-9579	1	115	(	(	PUNCT
bam-9579	1	116	2	2	X
bam-9579	1	117	)	)	PUNCT
bam-9579	1	118	department	department	NOUN
bam-9579	1	119	of	of	ADP
bam-9579	1	120	gynecology	gynecology	NOUN
bam-9579	1	121	,	,	PUNCT
bam-9579	1	122	hajar	hajar	PROPN
bam-9579	1	123	hospital	hospital	PROPN
bam-9579	1	124	,	,	PUNCT
bam-9579	1	125	aja	aja	PROPN
bam-9579	1	126	university	university	PROPN
bam-9579	1	127	of	of	ADP
bam-9579	1	128	medical	medical	ADJ
bam-9579	1	129	sciences	sciences	PROPN
bam-9579	1	130	,	,	PUNCT
bam-9579	1	131	tehran	tehran	PROPN
bam-9579	1	132	,	,	PUNCT
bam-9579	1	133	iran	iran	PROPN
bam-9579	1	134	;	;	PUNCT
bam-9579	1	135	(	(	PUNCT
bam-9579	1	136	3	3	X
bam-9579	1	137	)	)	PUNCT
bam-9579	1	138	medical	medical	ADJ
bam-9579	1	139	doctor	doctor	NOUN
bam-9579	1	140	,	,	PUNCT
bam-9579	1	141	tehran	tehran	PROPN
bam-9579	1	142	,	,	PUNCT
bam-9579	1	143	iran	iran	PROPN
bam-9579	1	144	;	;	PUNCT
bam-9579	1	145	(	(	PUNCT
bam-9579	1	146	4	4	X
bam-9579	1	147	)	)	PUNCT
bam-9579	1	148	department	department	NOUN
bam-9579	1	149	of	of	ADP
bam-9579	1	150	anesthesiology	anesthesiology	NOUN
bam-9579	1	151	,	,	PUNCT
bam-9579	1	152	paramedical	paramedical	ADJ
bam-9579	1	153	faculty	faculty	NOUN
bam-9579	1	154	,	,	PUNCT
bam-9579	1	155	hajar	hajar	PROPN
bam-9579	1	156	hospital	hospital	PROPN
bam-9579	1	157	,	,	PUNCT
bam-9579	1	158	aja	aja	PROPN
bam-9579	1	159	university	university	PROPN
bam-9579	1	160	of	of	ADP
bam-9579	1	161	medical	medical	ADJ
bam-9579	1	162	sciences	sciences	PROPN
bam-9579	1	163	,	,	PUNCT
bam-9579	1	164	tehran	tehran	PROPN
bam-9579	1	165	,	,	PUNCT
bam-9579	1	166	iran	iran	PROPN
bam-9579	1	167	.	.	PUNCT
bam-9579	2	1	this	this	DET
bam-9579	2	2	article	article	NOUN
bam-9579	2	3	is	be	AUX
bam-9579	2	4	distributed	distribute	VERB
bam-9579	2	5	under	under	ADP
bam-9579	2	6	the	the	DET
bam-9579	2	7	terms	term	NOUN
bam-9579	2	8	of	of	ADP
bam-9579	2	9	the	the	DET
bam-9579	2	10	creative	creative	ADJ
bam-9579	2	11	commons	common	NOUN
bam-9579	2	12	attribution	attribution	NOUN
bam-9579	2	13	noncommercial	noncommercial	ADJ
bam-9579	2	14	license	license	NOUN
bam-9579	2	15	(	(	PUNCT
bam-9579	2	16	cc	cc	NOUN
bam-9579	2	17	by	by	ADP
bam-9579	2	18	-	-	PUNCT
bam-9579	2	19	nc	nc	PROPN
bam-9579	2	20	4.0	4.0	NUM
bam-9579	2	21	)	)	PUNCT
bam-9579	2	22	which	which	PRON
bam-9579	2	23	permits	permit	VERB
bam-9579	2	24	any	any	DET
bam-9579	2	25	noncommercial	noncommercial	ADJ
bam-9579	2	26	use	use	NOUN
bam-9579	2	27	,	,	PUNCT
bam-9579	2	28	distribution	distribution	NOUN
bam-9579	2	29	,	,	PUNCT
bam-9579	2	30	and	and	CCONJ
bam-9579	2	31	reproduction	reproduction	NOUN
bam-9579	2	32	in	in	ADP
bam-9579	2	33	any	any	DET
bam-9579	2	34	medium	medium	NOUN
bam-9579	2	35	,	,	PUNCT
bam-9579	2	36	provided	provide	VERB
bam-9579	2	37	the	the	DET
bam-9579	2	38	original	original	ADJ
bam-9579	2	39	author(s	author(s	NOUN
bam-9579	2	40	)	)	PUNCT
bam-9579	2	41	and	and	CCONJ
bam-9579	2	42	source	source	NOUN
bam-9579	2	43	are	be	AUX
bam-9579	2	44	credited	credit	VERB
bam-9579	2	45	.	.	PUNCT
bam-9579	3	1	abstract	abstract	ADJ
bam-9579	3	2	this	this	DET
bam-9579	3	3	study	study	NOUN
bam-9579	3	4	retrospectively	retrospectively	ADV
bam-9579	3	5	analyzed	analyze	VERB
bam-9579	3	6	the	the	DET
bam-9579	3	7	clinical	clinical	ADJ
bam-9579	3	8	characteristics	characteristic	NOUN
bam-9579	3	9	of	of	ADP
bam-9579	3	10	patients	patient	NOUN
bam-9579	3	11	with	with	ADP
bam-9579	3	12	new	new	ADJ
bam-9579	3	13	coronavirus	coronavirus	NOUN
bam-9579	3	14	infection	infection	NOUN
bam-9579	3	15	(	(	PUNCT
bam-9579	3	16	covid-19	covid-19	PROPN
bam-9579	3	17	)	)	PUNCT
bam-9579	3	18	and	and	CCONJ
bam-9579	3	19	summarizes	summarize	VERB
bam-9579	3	20	the	the	DET
bam-9579	3	21	treatment	treatment	NOUN
bam-9579	3	22	experience	experience	NOUN
bam-9579	3	23	.	.	PUNCT
bam-9579	4	1	a	a	DET
bam-9579	4	2	total	total	NOUN
bam-9579	4	3	of	of	ADP
bam-9579	4	4	239	239	NUM
bam-9579	4	5	covid-19	covid-19	PROPN
bam-9579	4	6	patients	patient	NOUN
bam-9579	4	7	admitted	admit	VERB
bam-9579	4	8	to	to	ADP
bam-9579	4	9	the	the	DET
bam-9579	4	10	hajar	hajar	PROPN
bam-9579	4	11	hospital	hospital	PROPN
bam-9579	4	12	,	,	PUNCT
bam-9579	4	13	aja	aja	PROPN
bam-9579	4	14	university	university	PROPN
bam-9579	4	15	of	of	ADP
bam-9579	4	16	medical	medical	ADJ
bam-9579	4	17	science	science	NOUN
bam-9579	4	18	,	,	PUNCT
bam-9579	4	19	tehran	tehran	PROPN
bam-9579	4	20	,	,	PUNCT
bam-9579	4	21	iran	iran	PROPN
bam-9579	4	22	from	from	ADP
bam-9579	4	23	march	march	PROPN
bam-9579	4	24	22	22	NUM
bam-9579	4	25	,	,	PUNCT
bam-9579	4	26	2020	2020	NUM
bam-9579	4	27	to	to	ADP
bam-9579	4	28	may	may	PROPN
bam-9579	4	29	18	18	NUM
bam-9579	4	30	,	,	PUNCT
bam-9579	4	31	2020	2020	NUM
bam-9579	4	32	were	be	AUX
bam-9579	4	33	selected	select	VERB
bam-9579	4	34	,	,	PUNCT
bam-9579	4	35	including	include	VERB
bam-9579	4	36	176	176	NUM
bam-9579	4	37	cases	case	NOUN
bam-9579	4	38	in	in	ADP
bam-9579	4	39	the	the	DET
bam-9579	4	40	ordinary	ordinary	ADJ
bam-9579	4	41	group	group	NOUN
bam-9579	4	42	and	and	CCONJ
bam-9579	4	43	63	63	NUM
bam-9579	4	44	cases	case	NOUN
bam-9579	4	45	in	in	ADP
bam-9579	4	46	the	the	DET
bam-9579	4	47	severe	severe	ADJ
bam-9579	4	48	/	/	SYM
bam-9579	4	49	critical	critical	ADJ
bam-9579	4	50	group	group	NOUN
bam-9579	4	51	.	.	PUNCT
bam-9579	5	1	we	we	PRON
bam-9579	5	2	collected	collect	VERB
bam-9579	5	3	and	and	CCONJ
bam-9579	5	4	compared	compare	VERB
bam-9579	5	5	the	the	DET
bam-9579	5	6	clinical	clinical	ADJ
bam-9579	5	7	data	datum	NOUN
bam-9579	5	8	of	of	ADP
bam-9579	5	9	the	the	DET
bam-9579	5	10	two	two	NUM
bam-9579	5	11	groups	group	NOUN
bam-9579	5	12	of	of	ADP
bam-9579	5	13	patients	patient	NOUN
bam-9579	5	14	,	,	PUNCT
bam-9579	5	15	including	include	VERB
bam-9579	5	16	general	general	ADJ
bam-9579	5	17	conditions	condition	NOUN
bam-9579	5	18	,	,	PUNCT
bam-9579	5	19	clinical	clinical	ADJ
bam-9579	5	20	symptoms	symptom	NOUN
bam-9579	5	21	,	,	PUNCT
bam-9579	5	22	signs	sign	NOUN
bam-9579	5	23	,	,	PUNCT
bam-9579	5	24	laboratory	laboratory	NOUN
bam-9579	5	25	tests	test	NOUN
bam-9579	5	26	,	,	PUNCT
bam-9579	5	27	lung	lung	NOUN
bam-9579	5	28	ct	ct	PROPN
bam-9579	5	29	imaging	imaging	NOUN
bam-9579	5	30	and	and	CCONJ
bam-9579	5	31	prognosis	prognosis	NOUN
bam-9579	5	32	,	,	PUNCT
bam-9579	5	33	and	and	CCONJ
bam-9579	5	34	analyzed	analyze	VERB
bam-9579	5	35	the	the	DET
bam-9579	5	36	treatment	treatment	NOUN
bam-9579	5	37	plans	plan	NOUN
bam-9579	5	38	of	of	ADP
bam-9579	5	39	the	the	DET
bam-9579	5	40	two	two	NUM
bam-9579	5	41	groups	group	NOUN
bam-9579	5	42	.	.	PUNCT
bam-9579	6	1	the	the	DET
bam-9579	6	2	mean	mean	ADJ
bam-9579	6	3	age	age	NOUN
bam-9579	6	4	of	of	ADP
bam-9579	6	5	239	239	NUM
bam-9579	6	6	covid-19	covid-19	PROPN
bam-9579	6	7	patients	patient	NOUN
bam-9579	6	8	was	be	AUX
bam-9579	6	9	48.1±17.6	48.1±17.6	NUM
bam-9579	6	10	years	year	NOUN
bam-9579	6	11	,	,	PUNCT
bam-9579	6	12	including	include	VERB
bam-9579	6	13	132	132	NUM
bam-9579	6	14	males	male	NOUN
bam-9579	6	15	.	.	PUNCT
bam-9579	7	1	patients	patient	NOUN
bam-9579	7	2	in	in	ADP
bam-9579	7	3	the	the	DET
bam-9579	7	4	severe	severe	ADJ
bam-9579	7	5	and	and	CCONJ
bam-9579	7	6	critically	critically	ADV
bam-9579	7	7	ill	ill	ADJ
bam-9579	7	8	groups	group	NOUN
bam-9579	7	9	were	be	AUX
bam-9579	7	10	older	old	ADJ
bam-9579	7	11	than	than	ADP
bam-9579	7	12	the	the	DET
bam-9579	7	13	normal	normal	ADJ
bam-9579	7	14	group	group	NOUN
bam-9579	7	15	,	,	PUNCT
bam-9579	7	16	with	with	ADP
bam-9579	7	17	more	more	ADJ
bam-9579	7	18	males	male	NOUN
bam-9579	7	19	and	and	CCONJ
bam-9579	7	20	more	more	ADV
bam-9579	7	21	underlying	underlying	ADJ
bam-9579	7	22	diseases	disease	NOUN
bam-9579	7	23	.	.	PUNCT
bam-9579	8	1	the	the	DET
bam-9579	8	2	difference	difference	NOUN
bam-9579	8	3	was	be	AUX
bam-9579	8	4	statistically	statistically	ADV
bam-9579	8	5	significant	significant	ADJ
bam-9579	8	6	(	(	PUNCT
bam-9579	8	7	p	p	X
bam-9579	8	8	<	<	X
bam-9579	8	9	0.05	0.05	NUM
bam-9579	8	10	)	)	PUNCT
bam-9579	8	11	.	.	PUNCT
bam-9579	9	1	the	the	DET
bam-9579	9	2	lymphocyte	lymphocyte	NOUN
bam-9579	9	3	(	(	PUNCT
bam-9579	9	4	lym	lym	PROPN
bam-9579	9	5	)	)	PUNCT
bam-9579	9	6	counts	count	NOUN
bam-9579	9	7	and	and	CCONJ
bam-9579	9	8	albumin	albumin	NOUN
bam-9579	9	9	(	(	PUNCT
bam-9579	9	10	alb	alb	NOUN
bam-9579	9	11	)	)	PUNCT
bam-9579	9	12	counts	count	NOUN
bam-9579	9	13	of	of	ADP
bam-9579	9	14	the	the	DET
bam-9579	9	15	severe	severe	ADJ
bam-9579	9	16	and	and	CCONJ
bam-9579	9	17	critically	critically	ADV
bam-9579	9	18	ill	ill	ADJ
bam-9579	9	19	groups	group	NOUN
bam-9579	9	20	were	be	AUX
bam-9579	9	21	more	more	ADV
bam-9579	9	22	significantly	significantly	ADV
bam-9579	9	23	lower	low	ADJ
bam-9579	9	24	than	than	ADP
bam-9579	9	25	those	those	PRON
bam-9579	9	26	of	of	ADP
bam-9579	9	27	the	the	DET
bam-9579	9	28	normal	normal	ADJ
bam-9579	9	29	group	group	NOUN
bam-9579	9	30	;	;	PUNCT
bam-9579	9	31	while	while	SCONJ
bam-9579	9	32	the	the	DET
bam-9579	9	33	percentage	percentage	NOUN
bam-9579	9	34	of	of	ADP
bam-9579	9	35	neutrophils	neutrophil	NOUN
bam-9579	9	36	(	(	PUNCT
bam-9579	9	37	neu	neu	NOUN
bam-9579	9	38	)	)	PUNCT
bam-9579	9	39	,	,	PUNCT
bam-9579	9	40	c	c	NOUN
bam-9579	9	41	-	-	PUNCT
bam-9579	9	42	reactive	reactive	ADJ
bam-9579	9	43	protein	protein	NOUN
bam-9579	9	44	(	(	PUNCT
bam-9579	9	45	crp	crp	PROPN
bam-9579	9	46	)	)	PUNCT
bam-9579	9	47	,	,	PUNCT
bam-9579	9	48	d	d	X
bam-9579	9	49	-	-	PUNCT
bam-9579	9	50	dimer	dimer	ADJ
bam-9579	9	51	,	,	PUNCT
bam-9579	9	52	and	and	CCONJ
bam-9579	9	53	lactate	lactate	VERB
bam-9579	9	54	the	the	DET
bam-9579	9	55	increase	increase	NOUN
bam-9579	9	56	of	of	ADP
bam-9579	9	57	lactate	lactate	NOUN
bam-9579	9	58	dehydrogenase	dehydrogenase	NOUN
bam-9579	9	59	(	(	PUNCT
bam-9579	9	60	ldh	ldh	NOUN
bam-9579	9	61	)	)	PUNCT
bam-9579	9	62	and	and	CCONJ
bam-9579	9	63	urea	urea	PROPN
bam-9579	9	64	nitrogen	nitrogen	PROPN
bam-9579	9	65	(	(	PUNCT
bam-9579	9	66	bun	bun	PROPN
bam-9579	9	67	)	)	PUNCT
bam-9579	9	68	was	be	AUX
bam-9579	9	69	more	more	ADV
bam-9579	9	70	significant	significant	ADJ
bam-9579	9	71	,	,	PUNCT
bam-9579	9	72	and	and	CCONJ
bam-9579	9	73	the	the	DET
bam-9579	9	74	difference	difference	NOUN
bam-9579	9	75	was	be	AUX
bam-9579	9	76	statistically	statistically	ADV
bam-9579	9	77	significant	significant	ADJ
bam-9579	9	78	(	(	PUNCT
bam-9579	9	79	p	p	X
bam-9579	9	80	<	<	X
bam-9579	9	81	0.05	0.05	NUM
bam-9579	9	82	)	)	PUNCT
bam-9579	9	83	.	.	PUNCT
bam-9579	10	1	patients	patient	NOUN
bam-9579	10	2	in	in	ADP
bam-9579	10	3	the	the	DET
bam-9579	10	4	severe	severe	ADJ
bam-9579	10	5	and	and	CCONJ
bam-9579	10	6	critically	critically	ADV
bam-9579	10	7	ill	ill	ADJ
bam-9579	10	8	groups	group	NOUN
bam-9579	10	9	received	receive	VERB
bam-9579	10	10	more	more	ADJ
bam-9579	10	11	antiviral	antiviral	ADJ
bam-9579	10	12	drugs	drug	NOUN
bam-9579	10	13	,	,	PUNCT
bam-9579	10	14	glucocorticoids	glucocorticoid	NOUN
bam-9579	10	15	,	,	PUNCT
bam-9579	10	16	and	and	CCONJ
bam-9579	10	17	nasal	nasal	ADJ
bam-9579	10	18	catheters	catheter	NOUN
bam-9579	10	19	than	than	ADP
bam-9579	10	20	those	those	PRON
bam-9579	10	21	in	in	ADP
bam-9579	10	22	the	the	DET
bam-9579	10	23	normal	normal	ADJ
bam-9579	10	24	group	group	NOUN
bam-9579	10	25	,	,	PUNCT
bam-9579	10	26	and	and	CCONJ
bam-9579	10	27	the	the	DET
bam-9579	10	28	difference	difference	NOUN
bam-9579	10	29	was	be	AUX
bam-9579	10	30	statistically	statistically	ADV
bam-9579	10	31	significant	significant	ADJ
bam-9579	10	32	(	(	PUNCT
bam-9579	10	33	p	p	X
bam-9579	10	34	<	<	X
bam-9579	10	35	0.05	0.05	NUM
bam-9579	10	36	)	)	PUNCT
bam-9579	10	37	.	.	PUNCT
bam-9579	11	1	also	also	ADV
bam-9579	11	2	,	,	PUNCT
bam-9579	11	3	we	we	PRON
bam-9579	11	4	observed	observe	VERB
bam-9579	11	5	that	that	SCONJ
bam-9579	11	6	the	the	DET
bam-9579	11	7	most	most	ADV
bam-9579	11	8	radiological	radiological	ADJ
bam-9579	11	9	finding	finding	NOUN
bam-9579	11	10	was	be	AUX
bam-9579	11	11	bilateral	bilateral	ADJ
bam-9579	11	12	ground	ground	NOUN
bam-9579	11	13	-	-	PUNCT
bam-9579	11	14	glass	glass	NOUN
bam-9579	11	15	opacity	opacity	NOUN
bam-9579	11	16	in	in	ADP
bam-9579	11	17	both	both	DET
bam-9579	11	18	groups	group	NOUN
bam-9579	11	19	,	,	PUNCT
bam-9579	11	20	however	however	ADV
bam-9579	11	21	,	,	PUNCT
bam-9579	11	22	the	the	DET
bam-9579	11	23	rate	rate	NOUN
bam-9579	11	24	of	of	ADP
bam-9579	11	25	typical	typical	ADJ
bam-9579	11	26	abnormalities	abnormality	NOUN
bam-9579	11	27	in	in	ADP
bam-9579	11	28	both	both	DET
bam-9579	11	29	chest	chest	NOUN
bam-9579	11	30	ct	ct	NUM
bam-9579	11	31	scan	scan	NOUN
bam-9579	11	32	and	and	CCONJ
bam-9579	11	33	chest	chest	NOUN
bam-9579	11	34	x	x	NOUN
bam-9579	11	35	-	-	NOUN
bam-9579	11	36	ray	ray	NOUN
bam-9579	11	37	was	be	AUX
bam-9579	11	38	significantly	significantly	ADV
bam-9579	11	39	higher	high	ADJ
bam-9579	11	40	in	in	ADP
bam-9579	11	41	sever	sever	VERB
bam-9579	11	42	/	/	SYM
bam-9579	11	43	critical	critical	ADJ
bam-9579	11	44	group	group	NOUN
bam-9579	11	45	except	except	SCONJ
bam-9579	11	46	air	air	NOUN
bam-9579	11	47	-	-	PUNCT
bam-9579	11	48	bronchogram	bronchogram	NOUN
bam-9579	11	49	.	.	PUNCT
bam-9579	12	1	taken	take	VERB
bam-9579	12	2	together	together	ADV
bam-9579	12	3	,	,	PUNCT
bam-9579	12	4	we	we	PRON
bam-9579	12	5	showed	show	VERB
bam-9579	12	6	that	that	DET
bam-9579	12	7	combination	combination	NOUN
bam-9579	12	8	of	of	ADP
bam-9579	12	9	oseltamivir	oseltamivir	PROPN
bam-9579	12	10	and	and	CCONJ
bam-9579	12	11	glucocorticosteroid	glucocorticosteroid	VERB
bam-9579	12	12	such	such	ADJ
bam-9579	12	13	as	as	ADP
bam-9579	12	14	dexamethasone	dexamethasone	NOUN
bam-9579	12	15	was	be	AUX
bam-9579	12	16	very	very	ADV
bam-9579	12	17	effective	effective	ADJ
bam-9579	12	18	in	in	ADP
bam-9579	12	19	severe	severe	ADJ
bam-9579	12	20	patients	patient	NOUN
bam-9579	12	21	.	.	PUNCT
bam-9579	13	1	key	key	ADJ
bam-9579	13	2	words	word	NOUN
bam-9579	13	3	:	:	PUNCT
bam-9579	13	4	covid-19	covid-19	PROPN
bam-9579	13	5	;	;	PUNCT
bam-9579	13	6	clinical	clinical	ADJ
bam-9579	13	7	features	feature	NOUN
bam-9579	13	8	;	;	PUNCT
bam-9579	13	9	severity	severity	NOUN
bam-9579	13	10	;	;	PUNCT
bam-9579	13	11	imaging	imaging	NOUN
bam-9579	13	12	;	;	PUNCT
bam-9579	13	13	laboratory	laboratory	NOUN
bam-9579	13	14	test	test	NOUN
bam-9579	13	15	.	.	PUNCT
bam-9579	14	1	eur	eur	PROPN
bam-9579	14	2	j	j	PROPN
bam-9579	14	3	transl	transl	PROPN
bam-9579	14	4	myol	myol	ADV
bam-9579	14	5	31	31	NUM
bam-9579	14	6	(	(	PUNCT
bam-9579	14	7	3	3	NUM
bam-9579	14	8	):	):	PUNCT
bam-9579	14	9	9579	9579	NUM
bam-9579	14	10	,	,	PUNCT
bam-9579	14	11	2021	2021	NUM
bam-9579	14	12	doi	doi	NOUN
bam-9579	14	13	:	:	PUNCT
bam-9579	14	14	10.4081	10.4081	NUM
bam-9579	14	15	/	/	SYM
bam-9579	14	16	ejtm.2021.9579	ejtm.2021.9579	X
bam-9579	14	17	the	the	DET
bam-9579	14	18	new	new	ADJ
bam-9579	14	19	coronavirus	coronavirus	NOUN
bam-9579	14	20	infection	infection	NOUN
bam-9579	14	21	(	(	PUNCT
bam-9579	14	22	covid-19	covid-19	PROPN
bam-9579	14	23	)	)	PUNCT
bam-9579	14	24	is	be	AUX
bam-9579	14	25	an	an	DET
bam-9579	14	26	acute	acute	ADJ
bam-9579	14	27	respiratory	respiratory	ADJ
bam-9579	14	28	disease	disease	NOUN
bam-9579	14	29	caused	cause	VERB
bam-9579	14	30	by	by	ADP
bam-9579	14	31	coronavirus	coronavirus	NOUN
bam-9579	14	32	2	2	NUM
bam-9579	14	33	(	(	PUNCT
bam-9579	14	34	sars	sar	NOUN
bam-9579	14	35	-	-	PUNCT
bam-9579	14	36	cov2	cov2	PROPN
bam-9579	14	37	)	)	PUNCT
bam-9579	14	38	which	which	PRON
bam-9579	14	39	is	be	AUX
bam-9579	14	40	highly	highly	ADV
bam-9579	14	41	contagious	contagious	ADJ
bam-9579	14	42	and	and	CCONJ
bam-9579	14	43	may	may	AUX
bam-9579	14	44	result	result	VERB
bam-9579	14	45	in	in	ADP
bam-9579	14	46	severe	severe	ADJ
bam-9579	14	47	pneumonia	pneumonia	NOUN
bam-9579	14	48	with	with	ADP
bam-9579	14	49	an	an	DET
bam-9579	14	50	acute	acute	ADJ
bam-9579	14	51	respiratory	respiratory	ADJ
bam-9579	14	52	syndrome	syndrome	NOUN
bam-9579	14	53	.	.	PUNCT
bam-9579	15	1	the	the	DET
bam-9579	15	2	disease	disease	NOUN
bam-9579	15	3	was	be	AUX
bam-9579	15	4	discovered	discover	VERB
bam-9579	15	5	in	in	ADP
bam-9579	15	6	wuhan	wuhan	PROPN
bam-9579	15	7	,	,	PUNCT
bam-9579	15	8	hubei	hubei	PROPN
bam-9579	15	9	province	province	NOUN
bam-9579	15	10	in	in	ADP
bam-9579	15	11	december	december	PROPN
bam-9579	15	12	2019	2019	NUM
bam-9579	15	13	,	,	PUNCT
bam-9579	15	14	and	and	CCONJ
bam-9579	15	15	rapidly	rapidly	ADV
bam-9579	15	16	spread	spread	VERB
bam-9579	15	17	worldwide	worldwide	ADV
bam-9579	15	18	.	.	PUNCT
bam-9579	16	1	at	at	ADP
bam-9579	16	2	june	june	PROPN
bam-9579	16	3	26	26	NUM
bam-9579	16	4	,	,	PUNCT
bam-9579	16	5	2020	2020	NUM
bam-9579	16	6	,	,	PUNCT
bam-9579	16	7	there	there	PRON
bam-9579	16	8	were	be	VERB
bam-9579	16	9	about	about	ADV
bam-9579	16	10	10	10	NUM
bam-9579	16	11	million	million	NUM
bam-9579	16	12	confirmed	confirm	VERB
bam-9579	16	13	cases	case	NOUN
bam-9579	16	14	worldwide	worldwide	ADV
bam-9579	16	15	and	and	CCONJ
bam-9579	16	16	about	about	ADV
bam-9579	16	17	500,000	500,000	NUM
bam-9579	16	18	cases	case	NOUN
bam-9579	16	19	of	of	ADP
bam-9579	16	20	death	death	NOUN
bam-9579	16	21	in	in	ADP
bam-9579	16	22	total	total	NOUN
bam-9579	16	23	.	.	PUNCT
bam-9579	17	1	according	accord	VERB
bam-9579	17	2	to	to	ADP
bam-9579	17	3	the	the	DET
bam-9579	17	4	who	who	PRON
bam-9579	17	5	report	report	VERB
bam-9579	17	6	,	,	PUNCT
bam-9579	17	7	about	about	ADV
bam-9579	17	8	13.8	13.8	NUM
bam-9579	17	9	%	%	NOUN
bam-9579	17	10	of	of	ADP
bam-9579	17	11	covid19	covid19	NOUN
bam-9579	17	12	patients	patient	NOUN
bam-9579	17	13	represented	represent	VERB
bam-9579	17	14	a	a	DET
bam-9579	17	15	severe	severe	ADJ
bam-9579	17	16	form	form	NOUN
bam-9579	17	17	and	and	CCONJ
bam-9579	17	18	6.1	6.1	NUM
bam-9579	17	19	%	%	NOUN
bam-9579	17	20	are	be	AUX
bam-9579	17	21	critically	critically	ADV
bam-9579	17	22	ill	ill	ADJ
bam-9579	17	23	patients.1	patients.1	NOUN
bam-9579	17	24	-	-	PUNCT
bam-9579	17	25	3	3	NUM
bam-9579	17	26	in	in	ADP
bam-9579	17	27	addition	addition	NOUN
bam-9579	17	28	,	,	PUNCT
bam-9579	17	29	previous	previous	ADJ
bam-9579	17	30	studies	study	NOUN
bam-9579	17	31	showed	show	VERB
bam-9579	17	32	that	that	SCONJ
bam-9579	17	33	patients	patient	NOUN
bam-9579	17	34	might	might	AUX
bam-9579	17	35	have	have	VERB
bam-9579	17	36	rapid	rapid	ADJ
bam-9579	17	37	disease	disease	NOUN
bam-9579	17	38	progression	progression	NOUN
bam-9579	17	39	with	with	ADP
bam-9579	17	40	poor	poor	ADJ
bam-9579	17	41	prognosis	prognosis	NOUN
bam-9579	17	42	and	and	CCONJ
bam-9579	17	43	high	high	ADJ
bam-9579	17	44	mortality	mortality	NOUN
bam-9579	17	45	rate.4	rate.4	PROPN
bam-9579	17	46	typical	typical	ADJ
bam-9579	17	47	clinical	clinical	ADJ
bam-9579	17	48	manifestations	manifestation	NOUN
bam-9579	17	49	of	of	ADP
bam-9579	17	50	covid-19	covid-19	PROPN
bam-9579	17	51	are	be	AUX
bam-9579	17	52	mainly	mainly	ADV
bam-9579	17	53	fever	fever	NOUN
bam-9579	17	54	,	,	PUNCT
bam-9579	17	55	chest	chest	NOUN
bam-9579	17	56	tightness	tightness	NOUN
bam-9579	17	57	,	,	PUNCT
bam-9579	17	58	cough	cough	NOUN
bam-9579	17	59	and	and	CCONJ
bam-9579	17	60	other	other	ADJ
bam-9579	17	61	respiratory	respiratory	ADJ
bam-9579	17	62	symptoms	symptom	NOUN
bam-9579	17	63	,	,	PUNCT
bam-9579	17	64	and	and	CCONJ
bam-9579	17	65	severe	severe	ADJ
bam-9579	17	66	patients	patient	NOUN
bam-9579	17	67	can	can	AUX
bam-9579	17	68	progress	progress	VERB
bam-9579	17	69	to	to	PART
bam-9579	17	70	dyspnea	dyspnea	VERB
bam-9579	17	71	or	or	CCONJ
bam-9579	17	72	even	even	ADV
bam-9579	17	73	respiratory	respiratory	ADJ
bam-9579	17	74	distress	distress	NOUN
bam-9579	17	75	syndrome	syndrome	NOUN
bam-9579	17	76	.	.	PUNCT
bam-9579	18	1	it	it	PRON
bam-9579	18	2	has	have	AUX
bam-9579	18	3	been	be	AUX
bam-9579	18	4	suggested	suggest	VERB
bam-9579	18	5	that	that	SCONJ
bam-9579	18	6	the	the	DET
bam-9579	18	7	main	main	ADJ
bam-9579	18	8	route	route	NOUN
bam-9579	18	9	of	of	ADP
bam-9579	18	10	transmission	transmission	NOUN
bam-9579	18	11	is	be	AUX
bam-9579	18	12	airborne	airborne	ADJ
bam-9579	18	13	transmission	transmission	NOUN
bam-9579	18	14	.	.	PUNCT
bam-9579	19	1	although	although	SCONJ
bam-9579	19	2	reports	report	NOUN
bam-9579	19	3	are	be	AUX
bam-9579	19	4	in	in	ADP
bam-9579	19	5	contradirectry	contradirectry	NOUN
bam-9579	19	6	,	,	PUNCT
bam-9579	19	7	there	there	PRON
bam-9579	19	8	is	be	VERB
bam-9579	19	9	evidence	evidence	NOUN
bam-9579	19	10	that	that	SCONJ
bam-9579	19	11	covid-19	covid-19	PROPN
bam-9579	19	12	could	could	AUX
bam-9579	19	13	be	be	AUX
bam-9579	19	14	transmitted	transmit	VERB
bam-9579	19	15	through	through	ADP
bam-9579	19	16	respiratory	respiratory	ADJ
bam-9579	19	17	aerosols	aerosol	NOUN
bam-9579	19	18	and	and	CCONJ
bam-9579	19	19	gastreointestinal	gastreointestinal	ADJ
bam-9579	19	20	tract.57	tract.57	PROPN
bam-9579	19	21	although	although	SCONJ
bam-9579	19	22	,	,	PUNCT
bam-9579	19	23	the	the	DET
bam-9579	19	24	clinical	clinical	ADJ
bam-9579	19	25	manifestation	manifestation	NOUN
bam-9579	19	26	of	of	ADP
bam-9579	19	27	covid-19	covid-19	PROPN
bam-9579	19	28	has	have	AUX
bam-9579	19	29	been	be	AUX
bam-9579	19	30	well	well	ADV
bam-9579	19	31	documented	document	VERB
bam-9579	19	32	in	in	ADP
bam-9579	19	33	most	most	ADJ
bam-9579	19	34	regions	region	NOUN
bam-9579	19	35	and	and	CCONJ
bam-9579	19	36	population	population	NOUN
bam-9579	19	37	,	,	PUNCT
bam-9579	19	38	ordinary	ordinary	ADJ
bam-9579	19	39	and	and	CCONJ
bam-9579	19	40	severe	severe	ADJ
bam-9579	19	41	cases	case	NOUN
bam-9579	19	42	of	of	ADP
bam-9579	19	43	covid-19	covid-19	PROPN
bam-9579	19	44	in	in	ADP
bam-9579	19	45	iran	iran	PROPN
bam-9579	19	46	eur	eur	PROPN
bam-9579	19	47	j	j	PROPN
bam-9579	19	48	transl	transl	PROPN
bam-9579	19	49	myol	myol	ADV
bam-9579	19	50	31	31	NUM
bam-9579	19	51	(	(	PUNCT
bam-9579	19	52	3	3	NUM
bam-9579	19	53	):	):	PUNCT
bam-9579	19	54	9579	9579	NUM
bam-9579	19	55	,	,	PUNCT
bam-9579	19	56	2021	2021	NUM
bam-9579	19	57	doi	doi	NOUN
bam-9579	19	58	:	:	PUNCT
bam-9579	19	59	10.4081	10.4081	NUM
bam-9579	19	60	/	/	SYM
bam-9579	19	61	ejtm.2021.9579	ejtm.2021.9579	PUNCT
bam-9579	19	62	2	2	NUM
bam-9579	19	63	the	the	DET
bam-9579	19	64	main	main	ADJ
bam-9579	19	65	presentations	presentation	NOUN
bam-9579	19	66	of	of	ADP
bam-9579	19	67	covid-19	covid-19	PROPN
bam-9579	19	68	in	in	ADP
bam-9579	19	69	iraninan	iraninan	PROPN
bam-9579	19	70	population	population	NOUN
bam-9579	19	71	have	have	AUX
bam-9579	19	72	not	not	PART
bam-9579	19	73	been	be	AUX
bam-9579	19	74	published	publish	VERB
bam-9579	19	75	widely	widely	ADV
bam-9579	19	76	.	.	PUNCT
bam-9579	20	1	in	in	ADP
bam-9579	20	2	this	this	DET
bam-9579	20	3	regard	regard	NOUN
bam-9579	20	4	,	,	PUNCT
bam-9579	20	5	we	we	PRON
bam-9579	20	6	tried	try	VERB
bam-9579	20	7	to	to	PART
bam-9579	20	8	share	share	VERB
bam-9579	20	9	our	our	PRON
bam-9579	20	10	experience	experience	NOUN
bam-9579	20	11	and	and	CCONJ
bam-9579	20	12	clinical	clinical	ADJ
bam-9579	20	13	manifestation	manifestation	NOUN
bam-9579	20	14	of	of	ADP
bam-9579	20	15	covid-19	covid-19	PROPN
bam-9579	20	16	cases	case	NOUN
bam-9579	20	17	in	in	ADP
bam-9579	20	18	iran	iran	PROPN
bam-9579	20	19	.	.	PUNCT
bam-9579	21	1	therefore	therefore	ADV
bam-9579	21	2	,	,	PUNCT
bam-9579	21	3	present	present	ADJ
bam-9579	21	4	study	study	NOUN
bam-9579	21	5	is	be	AUX
bam-9579	21	6	aimed	aim	VERB
bam-9579	21	7	to	to	PART
bam-9579	21	8	evaluate	evaluate	VERB
bam-9579	21	9	and	and	CCONJ
bam-9579	21	10	analyze	analyze	VERB
bam-9579	21	11	the	the	DET
bam-9579	21	12	clinical	clinical	ADJ
bam-9579	21	13	characteristics	characteristic	NOUN
bam-9579	21	14	of	of	ADP
bam-9579	21	15	the	the	DET
bam-9579	21	16	covid-19	covid-19	PROPN
bam-9579	21	17	patients	patient	NOUN
bam-9579	21	18	in	in	ADP
bam-9579	21	19	iran	iran	PROPN
bam-9579	21	20	,	,	PUNCT
bam-9579	21	21	and	and	CCONJ
bam-9579	21	22	summarize	summarize	VERB
bam-9579	21	23	the	the	DET
bam-9579	21	24	treatment	treatment	NOUN
bam-9579	21	25	experience	experience	NOUN
bam-9579	21	26	from	from	ADP
bam-9579	21	27	them	they	PRON
bam-9579	21	28	,	,	PUNCT
bam-9579	21	29	and	and	CCONJ
bam-9579	21	30	provide	provide	VERB
bam-9579	21	31	reference	reference	NOUN
bam-9579	21	32	for	for	ADP
bam-9579	21	33	clinicians	clinician	NOUN
bam-9579	21	34	on	on	ADP
bam-9579	21	35	the	the	DET
bam-9579	21	36	front	front	ADJ
bam-9579	21	37	line	line	NOUN
bam-9579	21	38	of	of	ADP
bam-9579	21	39	antiepidemic	antiepidemic	ADJ
bam-9579	21	40	disease	disease	NOUN
bam-9579	21	41	.	.	PUNCT
bam-9579	22	1	in	in	ADP
bam-9579	22	2	reaching	reach	VERB
bam-9579	22	3	this	this	DET
bam-9579	22	4	goal	goal	NOUN
bam-9579	22	5	,	,	PUNCT
bam-9579	22	6	we	we	PRON
bam-9579	22	7	enrolled	enrol	VERB
bam-9579	22	8	239	239	NUM
bam-9579	22	9	admitted	admit	VERB
bam-9579	22	10	patients	patient	NOUN
bam-9579	22	11	,	,	PUNCT
bam-9579	22	12	including	include	VERB
bam-9579	22	13	63	63	NUM
bam-9579	22	14	severe	severe	ADJ
bam-9579	22	15	cases	case	NOUN
bam-9579	22	16	.	.	PUNCT
bam-9579	23	1	table	table	NOUN
bam-9579	23	2	1	1	NUM
bam-9579	23	3	.	.	PUNCT
bam-9579	23	4	comparison	comparison	NOUN
bam-9579	23	5	of	of	ADP
bam-9579	23	6	clinical	clinical	ADJ
bam-9579	23	7	characteristics	characteristic	NOUN
bam-9579	23	8	of	of	ADP
bam-9579	23	9	239	239	NUM
bam-9579	23	10	covid-19	covid-19	PROPN
bam-9579	23	11	patients	patient	NOUN
bam-9579	23	12	in	in	ADP
bam-9579	23	13	general	general	ADJ
bam-9579	23	14	and	and	CCONJ
bam-9579	23	15	severe	severe	ADJ
bam-9579	23	16	/	/	SYM
bam-9579	23	17	critical	critical	ADJ
bam-9579	23	18	group	group	NOUN
bam-9579	23	19	overall	overall	ADJ
bam-9579	23	20	(	(	PUNCT
bam-9579	23	21	n=239	n=239	PROPN
bam-9579	23	22	)	)	PUNCT
bam-9579	23	23	ordinary	ordinary	ADJ
bam-9579	23	24	group	group	NOUN
bam-9579	23	25	(	(	PUNCT
bam-9579	23	26	n=176	n=176	NOUN
bam-9579	23	27	)	)	PUNCT
bam-9579	23	28	severe	severe	ADJ
bam-9579	23	29	/	/	SYM
bam-9579	23	30	critical	critical	ADJ
bam-9579	23	31	group	group	NOUN
bam-9579	23	32	(	(	PUNCT
bam-9579	23	33	n=63	n=63	NOUN
bam-9579	23	34	)	)	PUNCT
bam-9579	23	35	p	p	NOUN
bam-9579	23	36	value	value	NOUN
bam-9579	23	37	age	age	NOUN
bam-9579	23	38	(	(	PUNCT
bam-9579	23	39	x±s	x±s	PROPN
bam-9579	23	40	)	)	PUNCT
bam-9579	24	1	48.1±17.6	48.1±17.6	NUM
bam-9579	25	1	43.9±14.5	43.9±14.5	NUM
bam-9579	25	2	59.8	59.8	NUM
bam-9579	25	3	±14.1	±14.1	X
bam-9579	25	4	<	<	X
bam-9579	25	5	0.001	0.001	NUM
bam-9579	25	6	gender	gender	NOUN
bam-9579	25	7	(	(	PUNCT
bam-9579	25	8	n	n	CCONJ
bam-9579	25	9	,	,	PUNCT
bam-9579	25	10	%	%	INTJ
bam-9579	25	11	)	)	PUNCT
bam-9579	25	12	female	female	ADJ
bam-9579	25	13	(	(	PUNCT
bam-9579	25	14	n	n	CCONJ
bam-9579	25	15	,	,	PUNCT
bam-9579	25	16	%	%	INTJ
bam-9579	25	17	)	)	PUNCT
bam-9579	25	18	107	107	NUM
bam-9579	25	19	(	(	PUNCT
bam-9579	25	20	44.7	44.7	NUM
bam-9579	25	21	)	)	PUNCT
bam-9579	25	22	90	90	NUM
bam-9579	25	23	(	(	PUNCT
bam-9579	25	24	50.9	50.9	NUM
bam-9579	25	25	)	)	PUNCT
bam-9579	25	26	16	16	NUM
bam-9579	25	27	(	(	PUNCT
bam-9579	25	28	25	25	NUM
bam-9579	25	29	)	)	PUNCT
bam-9579	25	30	0.032	0.032	NUM
bam-9579	25	31	male	male	NOUN
bam-9579	25	32	(	(	PUNCT
bam-9579	25	33	n	n	CCONJ
bam-9579	25	34	,	,	PUNCT
bam-9579	25	35	%	%	INTJ
bam-9579	25	36	)	)	PUNCT
bam-9579	25	37	132	132	NUM
bam-9579	25	38	(	(	PUNCT
bam-9579	25	39	55.3	55.3	NUM
bam-9579	25	40	)	)	PUNCT
bam-9579	25	41	86	86	NUM
bam-9579	25	42	(	(	PUNCT
bam-9579	25	43	49.1	49.1	NUM
bam-9579	25	44	)	)	PUNCT
bam-9579	25	45	47	47	NUM
bam-9579	25	46	(	(	PUNCT
bam-9579	25	47	75	75	NUM
bam-9579	25	48	)	)	PUNCT
bam-9579	25	49	close	close	ADJ
bam-9579	25	50	contact	contact	NOUN
bam-9579	25	51	with	with	ADP
bam-9579	25	52	confirmed	confirm	VERB
bam-9579	25	53	cases	case	NOUN
bam-9579	25	54	(	(	PUNCT
bam-9579	25	55	n	n	CCONJ
bam-9579	25	56	,	,	PUNCT
bam-9579	25	57	%	%	INTJ
bam-9579	25	58	)	)	PUNCT
bam-9579	25	59	194	194	NUM
bam-9579	25	60	(	(	PUNCT
bam-9579	25	61	81	81	NUM
bam-9579	25	62	)	)	PUNCT
bam-9579	25	63	144	144	NUM
bam-9579	25	64	(	(	PUNCT
bam-9579	25	65	81.8	81.8	NUM
bam-9579	25	66	)	)	PUNCT
bam-9579	25	67	50	50	NUM
bam-9579	25	68	(	(	PUNCT
bam-9579	25	69	79.2	79.2	NUM
bam-9579	25	70	)	)	PUNCT
bam-9579	25	71	0.972	0.972	NUM
bam-9579	25	72	comorbidities	comorbiditie	NOUN
bam-9579	25	73	(	(	PUNCT
bam-9579	25	74	n	n	CCONJ
bam-9579	25	75	,	,	PUNCT
bam-9579	25	76	%	%	INTJ
bam-9579	25	77	)	)	PUNCT
bam-9579	25	78	hypertension	hypertension	NOUN
bam-9579	25	79	(	(	PUNCT
bam-9579	25	80	n	n	CCONJ
bam-9579	25	81	,	,	PUNCT
bam-9579	25	82	%	%	INTJ
bam-9579	25	83	)	)	PUNCT
bam-9579	25	84	48	48	NUM
bam-9579	25	85	(	(	PUNCT
bam-9579	25	86	20.3	20.3	NUM
bam-9579	25	87	)	)	PUNCT
bam-9579	25	88	16	16	NUM
bam-9579	25	89	(	(	PUNCT
bam-9579	25	90	9.1	9.1	NUM
bam-9579	25	91	)	)	PUNCT
bam-9579	25	92	32	32	NUM
bam-9579	25	93	(	(	PUNCT
bam-9579	25	94	50.8	50.8	NUM
bam-9579	25	95	)	)	PUNCT
bam-9579	25	96	<	<	X
bam-9579	25	97	0.001	0.001	NUM
bam-9579	25	98	diabetes	diabetes	NOUN
bam-9579	25	99	(	(	PUNCT
bam-9579	25	100	n	n	CCONJ
bam-9579	25	101	,	,	PUNCT
bam-9579	25	102	%	%	INTJ
bam-9579	25	103	)	)	PUNCT
bam-9579	25	104	35	35	NUM
bam-9579	25	105	(	(	PUNCT
bam-9579	25	106	14.5	14.5	NUM
bam-9579	25	107	)	)	PUNCT
bam-9579	25	108	13	13	NUM
bam-9579	25	109	(	(	PUNCT
bam-9579	25	110	7.3	7.3	NUM
bam-9579	25	111	)	)	PUNCT
bam-9579	25	112	22	22	NUM
bam-9579	25	113	(	(	PUNCT
bam-9579	25	114	34.9	34.9	NUM
bam-9579	25	115	)	)	PUNCT
bam-9579	25	116	0.386	0.386	NUM
bam-9579	25	117	cerebrovascular	cerebrovascular	ADJ
bam-9579	25	118	disease	disease	NOUN
bam-9579	25	119	(	(	PUNCT
bam-9579	25	120	n	n	CCONJ
bam-9579	25	121	,	,	PUNCT
bam-9579	25	122	%	%	INTJ
bam-9579	25	123	)	)	PUNCT
bam-9579	25	124	9	9	NUM
bam-9579	25	125	(	(	PUNCT
bam-9579	25	126	3.8	3.8	NUM
bam-9579	25	127	)	)	PUNCT
bam-9579	25	128	0	0	NUM
bam-9579	25	129	9	9	NUM
bam-9579	25	130	(	(	PUNCT
bam-9579	25	131	14.3	14.3	NUM
bam-9579	25	132	)	)	PUNCT
bam-9579	25	133	0.026	0.026	NUM
bam-9579	25	134	chronic	chronic	ADJ
bam-9579	25	135	kidney	kidney	NOUN
bam-9579	25	136	disease	disease	NOUN
bam-9579	25	137	(	(	PUNCT
bam-9579	25	138	n	n	CCONJ
bam-9579	25	139	,	,	PUNCT
bam-9579	25	140	%	%	INTJ
bam-9579	25	141	)	)	PUNCT
bam-9579	25	142	9	9	NUM
bam-9579	25	143	(	(	PUNCT
bam-9579	25	144	3.8	3.8	NUM
bam-9579	25	145	)	)	PUNCT
bam-9579	25	146	6	6	NUM
bam-9579	25	147	(	(	PUNCT
bam-9579	25	148	3.6	3.6	NUM
bam-9579	25	149	)	)	PUNCT
bam-9579	25	150	3	3	NUM
bam-9579	25	151	(	(	PUNCT
bam-9579	25	152	4.8	4.8	NUM
bam-9579	25	153	)	)	PUNCT
bam-9579	25	154	＞0.99	＞0.99	PROPN
bam-9579	25	155	chronic	chronic	ADJ
bam-9579	25	156	liver	liver	NOUN
bam-9579	25	157	disease	disease	NOUN
bam-9579	25	158	(	(	PUNCT
bam-9579	25	159	n	n	CCONJ
bam-9579	25	160	,	,	PUNCT
bam-9579	25	161	%	%	INTJ
bam-9579	25	162	)	)	PUNCT
bam-9579	25	163	9	9	NUM
bam-9579	25	164	(	(	PUNCT
bam-9579	25	165	3.8	3.8	NUM
bam-9579	25	166	)	)	PUNCT
bam-9579	25	167	9	9	NUM
bam-9579	25	168	(	(	PUNCT
bam-9579	25	169	5.5	5.5	NUM
bam-9579	25	170	)	)	PUNCT
bam-9579	25	171	0	0	NUM
bam-9579	26	1	0.549	0.549	NUM
bam-9579	26	2	coronary	coronary	ADJ
bam-9579	26	3	heart	heart	NOUN
bam-9579	26	4	disease	disease	NOUN
bam-9579	26	5	(	(	PUNCT
bam-9579	26	6	n	n	CCONJ
bam-9579	26	7	,	,	PUNCT
bam-9579	26	8	%	%	INTJ
bam-9579	26	9	)	)	PUNCT
bam-9579	26	10	9	9	NUM
bam-9579	26	11	(	(	PUNCT
bam-9579	26	12	3.8	3.8	NUM
bam-9579	26	13	)	)	PUNCT
bam-9579	26	14	3	3	NUM
bam-9579	26	15	(	(	PUNCT
bam-9579	26	16	1.8	1.8	NUM
bam-9579	26	17	)	)	PUNCT
bam-9579	26	18	6	6	NUM
bam-9579	26	19	(	(	PUNCT
bam-9579	26	20	9.5	9.5	NUM
bam-9579	26	21	)	)	PUNCT
bam-9579	26	22	0.218	0.218	NUM
bam-9579	26	23	malignant	malignant	ADJ
bam-9579	26	24	tumor	tumor	NOUN
bam-9579	26	25	(	(	PUNCT
bam-9579	26	26	n	n	CCONJ
bam-9579	26	27	,	,	PUNCT
bam-9579	26	28	%	%	INTJ
bam-9579	26	29	)	)	PUNCT
bam-9579	26	30	3	3	NUM
bam-9579	26	31	(	(	PUNCT
bam-9579	26	32	1.3	1.3	NUM
bam-9579	26	33	)	)	PUNCT
bam-9579	26	34	3	3	NUM
bam-9579	26	35	(	(	PUNCT
bam-9579	26	36	1.8	1.8	NUM
bam-9579	26	37	)	)	PUNCT
bam-9579	26	38	0	0	NUM
bam-9579	27	1	＞0.99	＞0.99	PROPN
bam-9579	27	2	immunosuppressive	immunosuppressive	ADJ
bam-9579	27	3	(	(	PUNCT
bam-9579	27	4	n	n	CCONJ
bam-9579	27	5	,	,	PUNCT
bam-9579	27	6	%	%	INTJ
bam-9579	27	7	)	)	PUNCT
bam-9579	27	8	3	3	NUM
bam-9579	27	9	(	(	PUNCT
bam-9579	27	10	1.3	1.3	NUM
bam-9579	27	11	)	)	PUNCT
bam-9579	27	12	3	3	NUM
bam-9579	27	13	(	(	PUNCT
bam-9579	27	14	1.8	1.8	NUM
bam-9579	27	15	)	)	PUNCT
bam-9579	27	16	0	0	NUM
bam-9579	28	1	＞0.99	＞0.99	PROPN
bam-9579	28	2	copd	copd	NOUN
bam-9579	28	3	(	(	PUNCT
bam-9579	28	4	n	n	CCONJ
bam-9579	28	5	,	,	PUNCT
bam-9579	28	6	%	%	INTJ
bam-9579	28	7	)	)	PUNCT
bam-9579	28	8	23	23	NUM
bam-9579	28	9	(	(	PUNCT
bam-9579	28	10	9.6	9.6	NUM
bam-9579	28	11	)	)	PUNCT
bam-9579	28	12	7	7	NUM
bam-9579	28	13	(	(	PUNCT
bam-9579	28	14	3.9	3.9	NUM
bam-9579	28	15	)	)	PUNCT
bam-9579	28	16	16	16	NUM
bam-9579	28	17	(	(	PUNCT
bam-9579	28	18	25.4	25.4	NUM
bam-9579	28	19	)	)	PUNCT
bam-9579	28	20	<	<	X
bam-9579	28	21	0.001	0.001	NUM
bam-9579	28	22	no	no	DET
bam-9579	28	23	comorbidity	comorbidity	NOUN
bam-9579	28	24	(	(	PUNCT
bam-9579	28	25	n	n	CCONJ
bam-9579	28	26	,	,	PUNCT
bam-9579	28	27	%	%	INTJ
bam-9579	28	28	)	)	PUNCT
bam-9579	28	29	157	157	NUM
bam-9579	28	30	(	(	PUNCT
bam-9579	28	31	65.8	65.8	NUM
bam-9579	28	32	)	)	PUNCT
bam-9579	28	33	14	14	NUM
bam-9579	28	34	1(80	1(80	NUM
bam-9579	28	35	)	)	PUNCT
bam-9579	28	36	16(25.4	16(25.4	NUM
bam-9579	28	37	)	)	PUNCT
bam-9579	28	38	<	<	X
bam-9579	28	39	0.001	0.001	NUM
bam-9579	28	40	1	1	NUM
bam-9579	28	41	comorbidity	comorbidity	NOUN
bam-9579	28	42	(	(	PUNCT
bam-9579	28	43	n	n	CCONJ
bam-9579	28	44	,	,	PUNCT
bam-9579	28	45	%	%	INTJ
bam-9579	28	46	)	)	PUNCT
bam-9579	28	47	58	58	NUM
bam-9579	28	48	(	(	PUNCT
bam-9579	28	49	24.1	24.1	NUM
bam-9579	28	50	)	)	SYM
bam-9579	28	51	19	19	NUM
bam-9579	28	52	(	(	PUNCT
bam-9579	28	53	10.9	10.9	NUM
bam-9579	28	54	)	)	PUNCT
bam-9579	28	55	39(61.9	39(61.9	NUM
bam-9579	28	56	)	)	PUNCT
bam-9579	28	57	2	2	NUM
bam-9579	28	58	comorbidities	comorbiditie	NOUN
bam-9579	28	59	(	(	PUNCT
bam-9579	28	60	n	n	CCONJ
bam-9579	28	61	,	,	PUNCT
bam-9579	28	62	%	%	INTJ
bam-9579	28	63	)	)	PUNCT
bam-9579	28	64	15	15	NUM
bam-9579	28	65	(	(	PUNCT
bam-9579	28	66	6.3	6.3	NUM
bam-9579	28	67	)	)	PUNCT
bam-9579	28	68	13	13	NUM
bam-9579	28	69	(	(	PUNCT
bam-9579	28	70	7.3	7.3	NUM
bam-9579	28	71	)	)	PUNCT
bam-9579	28	72	2(3.2	2(3.2	NUM
bam-9579	28	73	)	)	PUNCT
bam-9579	29	1	≥3	≥3	NOUN
bam-9579	29	2	comorbidities	comorbiditie	NOUN
bam-9579	29	3	(	(	PUNCT
bam-9579	29	4	n	n	CCONJ
bam-9579	29	5	,	,	PUNCT
bam-9579	29	6	%	%	INTJ
bam-9579	29	7	)	)	PUNCT
bam-9579	29	8	9	9	NUM
bam-9579	29	9	(	(	PUNCT
bam-9579	29	10	3.8	3.8	NUM
bam-9579	29	11	)	)	PUNCT
bam-9579	29	12	3	3	NUM
bam-9579	29	13	(	(	PUNCT
bam-9579	29	14	1.8	1.8	NUM
bam-9579	29	15	)	)	PUNCT
bam-9579	29	16	6(9.5	6(9.5	NUM
bam-9579	29	17	)	)	PUNCT
bam-9579	29	18	symptoms	symptom	NOUN
bam-9579	29	19	(	(	PUNCT
bam-9579	29	20	n	n	CCONJ
bam-9579	29	21	,	,	PUNCT
bam-9579	29	22	%	%	INTJ
bam-9579	29	23	)	)	PUNCT
bam-9579	29	24	fever≥37.3	fever≥37.3	ADJ
bam-9579	29	25	℃	℃	PROPN
bam-9579	29	26	(	(	PUNCT
bam-9579	29	27	n	n	CCONJ
bam-9579	29	28	,	,	PUNCT
bam-9579	29	29	%	%	INTJ
bam-9579	29	30	)	)	PUNCT
bam-9579	29	31	203	203	NUM
bam-9579	29	32	(	(	PUNCT
bam-9579	29	33	84.8	84.8	NUM
bam-9579	29	34	)	)	PUNCT
bam-9579	29	35	147	147	NUM
bam-9579	29	36	(	(	PUNCT
bam-9579	29	37	83.6	83.6	NUM
bam-9579	29	38	)	)	PUNCT
bam-9579	29	39	56	56	NUM
bam-9579	29	40	(	(	PUNCT
bam-9579	29	41	88.9	88.9	NUM
bam-9579	29	42	)	)	PUNCT
bam-9579	29	43	0.921	0.921	NUM
bam-9579	29	44	dry	dry	ADJ
bam-9579	29	45	cough	cough	NOUN
bam-9579	29	46	(	(	PUNCT
bam-9579	29	47	n	n	CCONJ
bam-9579	29	48	,	,	PUNCT
bam-9579	29	49	%	%	INTJ
bam-9579	29	50	)	)	PUNCT
bam-9579	29	51	136	136	NUM
bam-9579	29	52	(	(	PUNCT
bam-9579	29	53	57	57	NUM
bam-9579	29	54	)	)	SYM
bam-9579	29	55	99	99	NUM
bam-9579	29	56	(	(	PUNCT
bam-9579	29	57	56.4	56.4	NUM
bam-9579	29	58	)	)	PUNCT
bam-9579	29	59	37	37	NUM
bam-9579	29	60	(	(	PUNCT
bam-9579	29	61	58.7	58.7	NUM
bam-9579	29	62	)	)	PUNCT
bam-9579	29	63	0.871	0.871	NUM
bam-9579	29	64	fatigue	fatigue	NOUN
bam-9579	29	65	,	,	PUNCT
bam-9579	29	66	muscle	muscle	NOUN
bam-9579	29	67	aches	ache	VERB
bam-9579	29	68	(	(	PUNCT
bam-9579	29	69	n	n	CCONJ
bam-9579	29	70	,	,	PUNCT
bam-9579	29	71	%	%	INTJ
bam-9579	29	72	)	)	PUNCT
bam-9579	29	73	73	73	NUM
bam-9579	29	74	(	(	PUNCT
bam-9579	29	75	30.4	30.4	NUM
bam-9579	29	76	)	)	PUNCT
bam-9579	29	77	54	54	NUM
bam-9579	29	78	(	(	PUNCT
bam-9579	29	79	30.9	30.9	NUM
bam-9579	29	80	)	)	SYM
bam-9579	29	81	19	19	NUM
bam-9579	29	82	(	(	PUNCT
bam-9579	29	83	30.9	30.9	NUM
bam-9579	29	84	)	)	PUNCT
bam-9579	29	85	0.877	0.877	NUM
bam-9579	29	86	dyspnea	dyspnea	NOUN
bam-9579	29	87	(	(	PUNCT
bam-9579	29	88	n	n	CCONJ
bam-9579	29	89	,	,	PUNCT
bam-9579	29	90	%	%	INTJ
bam-9579	29	91	)	)	PUNCT
bam-9579	29	92	27	27	NUM
bam-9579	29	93	(	(	PUNCT
bam-9579	29	94	11.4	11.4	NUM
bam-9579	29	95	)	)	PUNCT
bam-9579	29	96	1	1	NUM
bam-9579	29	97	6(9.1	6(9.1	NUM
bam-9579	29	98	)	)	PUNCT
bam-9579	29	99	11	11	NUM
bam-9579	29	100	(	(	PUNCT
bam-9579	29	101	17.5	17.5	NUM
bam-9579	29	102	)	)	PUNCT
bam-9579	29	103	0.555	0.555	NUM
bam-9579	29	104	expectorant	expectorant	NOUN
bam-9579	29	105	(	(	PUNCT
bam-9579	29	106	n	n	CCONJ
bam-9579	29	107	,	,	PUNCT
bam-9579	29	108	%	%	INTJ
bam-9579	29	109	)	)	PUNCT
bam-9579	29	110	30	30	NUM
bam-9579	29	111	(	(	PUNCT
bam-9579	29	112	12.7	12.7	NUM
bam-9579	29	113	)	)	PUNCT
bam-9579	29	114	22	22	NUM
bam-9579	29	115	(	(	PUNCT
bam-9579	29	116	12.7	12.7	NUM
bam-9579	29	117	)	)	PUNCT
bam-9579	29	118	8	8	NUM
bam-9579	29	119	(	(	PUNCT
bam-9579	29	120	12.7	12.7	NUM
bam-9579	29	121	)	)	PUNCT
bam-9579	29	122	0.734	0.734	NUM
bam-9579	29	123	dizziness	dizziness	NOUN
bam-9579	29	124	,	,	PUNCT
bam-9579	29	125	headache	headache	NOUN
bam-9579	29	126	(	(	PUNCT
bam-9579	29	127	n	n	CCONJ
bam-9579	29	128	,	,	PUNCT
bam-9579	29	129	%	%	INTJ
bam-9579	29	130	)	)	PUNCT
bam-9579	29	131	18	18	NUM
bam-9579	29	132	(	(	PUNCT
bam-9579	29	133	7.6	7.6	NUM
bam-9579	29	134	)	)	PUNCT
bam-9579	29	135	6	6	NUM
bam-9579	29	136	(	(	PUNCT
bam-9579	29	137	3.6	3.6	NUM
bam-9579	29	138	)	)	PUNCT
bam-9579	29	139	12	12	NUM
bam-9579	29	140	(	(	PUNCT
bam-9579	29	141	19.0	19.0	NUM
bam-9579	29	142	)	)	PUNCT
bam-9579	29	143	0.121	0.121	NUM
bam-9579	29	144	poor	poor	ADJ
bam-9579	29	145	appetite	appetite	NOUN
bam-9579	29	146	(	(	PUNCT
bam-9579	29	147	n	n	CCONJ
bam-9579	29	148	,	,	PUNCT
bam-9579	29	149	%	%	INTJ
bam-9579	29	150	)	)	PUNCT
bam-9579	29	151	1	1	NUM
bam-9579	29	152	5(6.3	5(6.3	NUM
bam-9579	29	153	)	)	PUNCT
bam-9579	29	154	10	10	NUM
bam-9579	29	155	(	(	PUNCT
bam-9579	29	156	5.5	5.5	NUM
bam-9579	29	157	)	)	SYM
bam-9579	29	158	5	5	NUM
bam-9579	29	159	(	(	PUNCT
bam-9579	29	160	7.9	7.9	NUM
bam-9579	29	161	)	)	PUNCT
bam-9579	29	162	0.985	0.985	NUM
bam-9579	29	163	sore	sore	ADJ
bam-9579	29	164	throat	throat	NOUN
bam-9579	29	165	(	(	PUNCT
bam-9579	29	166	n	n	CCONJ
bam-9579	29	167	,	,	PUNCT
bam-9579	29	168	%	%	INTJ
bam-9579	29	169	)	)	PUNCT
bam-9579	29	170	9	9	NUM
bam-9579	29	171	(	(	PUNCT
bam-9579	29	172	3.8	3.8	NUM
bam-9579	29	173	)	)	PUNCT
bam-9579	29	174	3	3	NUM
bam-9579	29	175	(	(	PUNCT
bam-9579	29	176	1.8	1.8	NUM
bam-9579	29	177	)	)	PUNCT
bam-9579	29	178	6	6	NUM
bam-9579	29	179	(	(	PUNCT
bam-9579	29	180	9.5	9.5	NUM
bam-9579	29	181	)	)	PUNCT
bam-9579	29	182	0.218	0.218	NUM
bam-9579	29	183	diarrhea	diarrhea	NOUN
bam-9579	29	184	(	(	PUNCT
bam-9579	29	185	n	n	CCONJ
bam-9579	29	186	,	,	PUNCT
bam-9579	29	187	%	%	INTJ
bam-9579	29	188	)	)	PUNCT
bam-9579	29	189	12	12	NUM
bam-9579	29	190	(	(	PUNCT
bam-9579	29	191	5.1	5.1	NUM
bam-9579	29	192	)	)	PUNCT
bam-9579	29	193	3	3	NUM
bam-9579	29	194	(	(	PUNCT
bam-9579	29	195	1.8	1.8	NUM
bam-9579	29	196	)	)	PUNCT
bam-9579	29	197	9	9	NUM
bam-9579	29	198	(	(	PUNCT
bam-9579	29	199	14.3	14.3	NUM
bam-9579	29	200	)	)	PUNCT
bam-9579	29	201	0.152	0.152	NUM
bam-9579	29	202	vomiting	vomiting	NOUN
bam-9579	29	203	(	(	PUNCT
bam-9579	29	204	n	n	CCONJ
bam-9579	29	205	,	,	PUNCT
bam-9579	29	206	%	%	INTJ
bam-9579	29	207	)	)	PUNCT
bam-9579	29	208	23	23	NUM
bam-9579	29	209	(	(	PUNCT
bam-9579	29	210	9.6	9.6	NUM
bam-9579	29	211	)	)	PUNCT
bam-9579	29	212	12	12	NUM
bam-9579	29	213	(	(	PUNCT
bam-9579	29	214	6.8	6.8	NUM
bam-9579	29	215	)	)	PUNCT
bam-9579	29	216	11	11	NUM
bam-9579	29	217	(	(	PUNCT
bam-9579	29	218	17.5	17.5	NUM
bam-9579	29	219	)	)	PUNCT
bam-9579	29	220	0.831	0.831	NUM
bam-9579	29	221	stomachache	stomachache	NOUN
bam-9579	29	222	(	(	PUNCT
bam-9579	29	223	n	n	CCONJ
bam-9579	29	224	,	,	PUNCT
bam-9579	29	225	%	%	INTJ
bam-9579	29	226	)	)	PUNCT
bam-9579	29	227	23	23	NUM
bam-9579	29	228	(	(	PUNCT
bam-9579	29	229	9.6	9.6	NUM
bam-9579	29	230	)	)	PUNCT
bam-9579	29	231	12	12	NUM
bam-9579	29	232	(	(	PUNCT
bam-9579	29	233	6.8	6.8	NUM
bam-9579	29	234	)	)	PUNCT
bam-9579	29	235	11	11	NUM
bam-9579	29	236	(	(	PUNCT
bam-9579	29	237	17.5	17.5	NUM
bam-9579	29	238	)	)	PUNCT
bam-9579	29	239	0.831	0.831	NUM
bam-9579	29	240	onset	onset	NOUN
bam-9579	29	241	of	of	ADP
bam-9579	29	242	symptom	symptom	NOUN
bam-9579	29	243	to	to	ADP
bam-9579	29	244	hospital	hospital	NOUN
bam-9579	29	245	admission	admission	NOUN
bam-9579	29	246	5	5	NUM
bam-9579	29	247	(	(	PUNCT
bam-9579	29	248	4~8	4~8	NUM
bam-9579	29	249	)	)	PUNCT
bam-9579	29	250	5	5	NUM
bam-9579	29	251	(	(	PUNCT
bam-9579	29	252	4~7	4~7	X
bam-9579	29	253	)	)	PUNCT
bam-9579	29	254	6.5	6.5	NUM
bam-9579	29	255	(	(	PUNCT
bam-9579	29	256	4~10	4~10	NUM
bam-9579	29	257	)	)	PUNCT
bam-9579	29	258	0.018	0.018	NUM
bam-9579	29	259	signs	sign	NOUN
bam-9579	29	260	[	[	X
bam-9579	29	261	median	median	ADJ
bam-9579	29	262	(	(	PUNCT
bam-9579	29	263	iqr	iqr	NOUN
bam-9579	29	264	)	)	PUNCT
bam-9579	29	265	]	]	PUNCT
bam-9579	29	266	pulse	pulse	NOUN
bam-9579	30	1	[	[	X
bam-9579	30	2	median	median	ADJ
bam-9579	30	3	(	(	PUNCT
bam-9579	30	4	iqr	iqr	NOUN
bam-9579	30	5	)	)	PUNCT
bam-9579	30	6	]	]	PUNCT
bam-9579	30	7	85	85	NUM
bam-9579	30	8	(	(	PUNCT
bam-9579	30	9	79~92	79~92	NUM
bam-9579	30	10	)	)	PUNCT
bam-9579	30	11	86	86	NUM
bam-9579	30	12	(	(	PUNCT
bam-9579	30	13	80~92	80~92	NUM
bam-9579	30	14	)	)	PUNCT
bam-9579	30	15	82	82	NUM
bam-9579	30	16	(	(	PUNCT
bam-9579	30	17	74~93	74~93	NUM
bam-9579	30	18	)	)	PUNCT
bam-9579	30	19	0.096	0.096	NUM
bam-9579	30	20	respiratory	respiratory	ADJ
bam-9579	30	21	rate	rate	NOUN
bam-9579	31	1	[	[	X
bam-9579	31	2	median	median	ADJ
bam-9579	31	3	(	(	PUNCT
bam-9579	31	4	iqr	iqr	NOUN
bam-9579	31	5	)	)	PUNCT
bam-9579	31	6	]	]	PUNCT
bam-9579	31	7	20	20	NUM
bam-9579	31	8	(	(	PUNCT
bam-9579	31	9	19~20	19~20	NUM
bam-9579	31	10	)	)	PUNCT
bam-9579	31	11	20	20	NUM
bam-9579	31	12	(	(	PUNCT
bam-9579	31	13	19~20	19~20	NUM
bam-9579	31	14	)	)	PUNCT
bam-9579	31	15	20	20	NUM
bam-9579	31	16	(	(	PUNCT
bam-9579	31	17	18~20	18~20	NUM
bam-9579	31	18	)	)	PUNCT
bam-9579	31	19	0.368	0.368	NUM
bam-9579	31	20	systolic	systolic	ADJ
bam-9579	31	21	pressure	pressure	NOUN
bam-9579	31	22	(	(	PUNCT
bam-9579	31	23	x±s	x±s	NOUN
bam-9579	31	24	)	)	PUNCT
bam-9579	31	25	124.8±13.2	124.8±13.2	NUM
bam-9579	31	26	121.2±9.5	121.2±9.5	NUM
bam-9579	31	27	133.3±16.5	133.3±16.5	NUM
bam-9579	31	28	<	<	X
bam-9579	31	29	0.001	0.001	NUM
bam-9579	31	30	diastolic	diastolic	NOUN
bam-9579	31	31	pressure	pressure	NOUN
bam-9579	31	32	(	(	PUNCT
bam-9579	31	33	x±s	x±s	NOUN
bam-9579	31	34	)	)	PUNCT
bam-9579	31	35	77.0±11.0	77.0±11.0	NUM
bam-9579	32	1	74.2±9.5	74.2±9.5	NUM
bam-9579	32	2	83.3±11.7	83.3±11.7	PROPN
bam-9579	32	3	<	<	X
bam-9579	32	4	0.001	0.001	NUM
bam-9579	32	5	blood	blood	NOUN
bam-9579	32	6	oxygen	oxygen	NOUN
bam-9579	32	7	saturation	saturation	NOUN
bam-9579	32	8	[	[	X
bam-9579	32	9	median	median	NOUN
bam-9579	32	10	(	(	PUNCT
bam-9579	32	11	iqr	iqr	NOUN
bam-9579	32	12	)	)	PUNCT
bam-9579	32	13	]	]	PUNCT
bam-9579	32	14	97(93~98	97(93~98	X
bam-9579	32	15	)	)	PUNCT
bam-9579	32	16	97(96~98	97(96~98	NUM
bam-9579	32	17	)	)	PUNCT
bam-9579	32	18	91(89~93	91(89~93	NUM
bam-9579	32	19	)	)	PUNCT
bam-9579	32	20	<	<	X
bam-9579	32	21	0.001	0.001	NUM
bam-9579	32	22	ordinary	ordinary	ADJ
bam-9579	32	23	and	and	CCONJ
bam-9579	32	24	severe	severe	ADJ
bam-9579	32	25	cases	case	NOUN
bam-9579	32	26	of	of	ADP
bam-9579	32	27	covid-19	covid-19	PROPN
bam-9579	32	28	in	in	ADP
bam-9579	32	29	iran	iran	PROPN
bam-9579	33	1	eur	eur	PROPN
bam-9579	33	2	j	j	PROPN
bam-9579	33	3	transl	transl	PROPN
bam-9579	33	4	myol	myol	ADV
bam-9579	33	5	31	31	NUM
bam-9579	33	6	(	(	PUNCT
bam-9579	33	7	3	3	NUM
bam-9579	33	8	):	):	PUNCT
bam-9579	33	9	9579	9579	NUM
bam-9579	33	10	,	,	PUNCT
bam-9579	33	11	2021	2021	NUM
bam-9579	33	12	doi	doi	NOUN
bam-9579	33	13	:	:	PUNCT
bam-9579	33	14	10.4081	10.4081	NUM
bam-9579	33	15	/	/	SYM
bam-9579	33	16	ejtm.2021.9579	ejtm.2021.9579	NUM
bam-9579	33	17	3	3	NUM
bam-9579	33	18	materials	material	NOUN
bam-9579	33	19	and	and	CCONJ
bam-9579	33	20	methods	method	NOUN
bam-9579	33	21	this	this	DET
bam-9579	33	22	study	study	NOUN
bam-9579	33	23	was	be	AUX
bam-9579	33	24	a	a	DET
bam-9579	33	25	single	single	ADJ
bam-9579	33	26	-	-	PUNCT
bam-9579	33	27	center	center	NOUN
bam-9579	33	28	,	,	PUNCT
bam-9579	33	29	retrospective	retrospective	ADJ
bam-9579	33	30	observational	observational	ADJ
bam-9579	33	31	study	study	NOUN
bam-9579	33	32	and	and	CCONJ
bam-9579	33	33	collected	collect	VERB
bam-9579	33	34	clinical	clinical	ADJ
bam-9579	33	35	data	datum	NOUN
bam-9579	33	36	from	from	ADP
bam-9579	33	37	239	239	NUM
bam-9579	33	38	patients	patient	NOUN
bam-9579	33	39	diagnosed	diagnose	VERB
bam-9579	33	40	with	with	ADP
bam-9579	33	41	covid-19	covid-19	PROPN
bam-9579	33	42	from	from	ADP
bam-9579	33	43	march	march	PROPN
bam-9579	33	44	22nd	22nd	NOUN
bam-9579	33	45	to	to	ADP
bam-9579	33	46	may	may	PROPN
bam-9579	33	47	18th	18th	NOUN
bam-9579	33	48	,	,	PUNCT
bam-9579	33	49	2020	2020	NUM
bam-9579	33	50	.	.	PUNCT
bam-9579	34	1	the	the	DET
bam-9579	34	2	collection	collection	NOUN
bam-9579	34	3	and	and	CCONJ
bam-9579	34	4	use	use	NOUN
bam-9579	34	5	of	of	ADP
bam-9579	34	6	relevant	relevant	ADJ
bam-9579	34	7	information	information	NOUN
bam-9579	34	8	fully	fully	ADV
bam-9579	34	9	guarantee	guarantee	VERB
bam-9579	34	10	the	the	DET
bam-9579	34	11	privacy	privacy	NOUN
bam-9579	34	12	of	of	ADP
bam-9579	34	13	patients	patient	NOUN
bam-9579	34	14	and	and	CCONJ
bam-9579	34	15	comply	comply	VERB
bam-9579	34	16	with	with	ADP
bam-9579	34	17	ethical	ethical	ADJ
bam-9579	34	18	regulations	regulation	NOUN
bam-9579	34	19	.	.	PUNCT
bam-9579	35	1	the	the	DET
bam-9579	35	2	study	study	NOUN
bam-9579	35	3	done	do	VERB
bam-9579	35	4	accoriding	accoride	VERB
bam-9579	35	5	the	the	DET
bam-9579	35	6	declaration	declaration	NOUN
bam-9579	35	7	of	of	ADP
bam-9579	35	8	helsinki	helsinki	PROPN
bam-9579	35	9	on	on	ADP
bam-9579	35	10	human	human	ADJ
bam-9579	35	11	subjects	subject	NOUN
bam-9579	35	12	.	.	PUNCT
bam-9579	36	1	the	the	DET
bam-9579	36	2	ethical	ethical	ADJ
bam-9579	36	3	committee	committee	NOUN
bam-9579	36	4	approved	approve	VERB
bam-9579	36	5	with	with	ADP
bam-9579	36	6	protocol	protocol	NOUN
bam-9579	36	7	number(ir.ajaums.rec.1399.06	number(ir.ajaums.rec.1399.06	PROPN
bam-9579	36	8	)	)	PUNCT
bam-9579	36	9	in	in	ADP
bam-9579	36	10	this	this	DET
bam-9579	36	11	study	study	NOUN
bam-9579	36	12	,	,	PUNCT
bam-9579	36	13	all	all	DET
bam-9579	36	14	cases	case	NOUN
bam-9579	36	15	have	have	VERB
bam-9579	36	16	at	at	ADP
bam-9579	36	17	leats	leat	NOUN
bam-9579	37	1	one	one	NUM
bam-9579	37	2	positive	positive	ADJ
bam-9579	37	3	real	real	ADJ
bam-9579	37	4	-	-	PUNCT
bam-9579	37	5	time	time	NOUN
bam-9579	37	6	fluorescence	fluorescence	NOUN
bam-9579	37	7	quantitative	quantitative	ADJ
bam-9579	37	8	polymerase	polymerase	NOUN
bam-9579	37	9	chain	chain	NOUN
bam-9579	37	10	reaction	reaction	NOUN
bam-9579	37	11	(	(	PUNCT
bam-9579	37	12	rt	rt	NOUN
bam-9579	37	13	-	-	PUNCT
bam-9579	37	14	pcr	pcr	NOUN
bam-9579	37	15	)	)	PUNCT
bam-9579	37	16	for	for	ADP
bam-9579	37	17	sars	sar	NOUN
bam-9579	37	18	-	-	PUNCT
bam-9579	37	19	cov-2	cov-2	NOUN
bam-9579	37	20	nucleic	nucleic	ADJ
bam-9579	37	21	acid.8	acid.8	PROPN
bam-9579	37	22	patients	patient	NOUN
bam-9579	37	23	groups	group	NOUN
bam-9579	37	24	we	we	PRON
bam-9579	37	25	divided	divide	VERB
bam-9579	37	26	the	the	DET
bam-9579	37	27	covid-19	covid-19	PROPN
bam-9579	37	28	patients	patient	NOUN
bam-9579	37	29	in	in	ADP
bam-9579	37	30	three	three	NUM
bam-9579	37	31	subgoups	subgoup	NOUN
bam-9579	37	32	:	:	PUNCT
bam-9579	37	33	1ordinary	1ordinary	NUM
bam-9579	37	34	type	type	NOUN
bam-9579	37	35	:	:	PUNCT
bam-9579	37	36	patients	patient	NOUN
bam-9579	37	37	with	with	ADP
bam-9579	37	38	mild	mild	ADJ
bam-9579	37	39	symptoms	symptom	NOUN
bam-9579	37	40	such	such	ADJ
bam-9579	37	41	as	as	ADP
bam-9579	37	42	low	low	ADJ
bam-9579	37	43	grade	grade	NOUN
bam-9579	37	44	fever	fever	NOUN
bam-9579	37	45	,	,	PUNCT
bam-9579	37	46	cough	cough	NOUN
bam-9579	37	47	,	,	PUNCT
bam-9579	37	48	and	and	CCONJ
bam-9579	37	49	etc	etc	X
bam-9579	37	50	.	.	X
bam-9579	37	51	2	2	NUM
bam-9579	37	52	severe	severe	ADJ
bam-9579	37	53	:	:	PUNCT
bam-9579	37	54	patients	patient	NOUN
bam-9579	37	55	with	with	ADP
bam-9579	37	56	two	two	NUM
bam-9579	37	57	of	of	ADP
bam-9579	37	58	the	the	DET
bam-9579	37	59	following	follow	VERB
bam-9579	37	60	conditions	condition	NOUN
bam-9579	37	61	(	(	PUNCT
bam-9579	37	62	1	1	X
bam-9579	37	63	)	)	PUNCT
bam-9579	37	64	shortness	shortness	NOUN
bam-9579	37	65	of	of	ADP
bam-9579	37	66	breath	breath	NOUN
bam-9579	37	67	,	,	PUNCT
bam-9579	37	68	respiratory	respiratory	ADJ
bam-9579	37	69	rate	rate	NOUN
bam-9579	37	70	≥30	≥30	PROPN
bam-9579	37	71	/	/	SYM
bam-9579	37	72	min	min	PROPN
bam-9579	37	73	;	;	PUNCT
bam-9579	37	74	(	(	PUNCT
bam-9579	37	75	2	2	X
bam-9579	37	76	)	)	PUNCT
bam-9579	37	77	fingertip	fingertip	NOUN
bam-9579	37	78	oxygen	oxygen	NOUN
bam-9579	37	79	saturation	saturation	NOUN
bam-9579	37	80	≤93	≤93	NOUN
bam-9579	37	81	%	%	NOUN
bam-9579	37	82	at	at	ADP
bam-9579	37	83	rest	rest	NOUN
bam-9579	37	84	;	;	PUNCT
bam-9579	37	85	(	(	PUNCT
bam-9579	37	86	3	3	X
bam-9579	37	87	)	)	PUNCT
bam-9579	37	88	arterial	arterial	ADJ
bam-9579	37	89	partial	partial	ADJ
bam-9579	37	90	pressure	pressure	NOUN
bam-9579	37	91	of	of	ADP
bam-9579	37	92	oxygen	oxygen	NOUN
bam-9579	37	93	(	(	PUNCT
bam-9579	37	94	pao2	pao2	NOUN
bam-9579	37	95	)	)	PUNCT
bam-9579	37	96	/	/	SYM
bam-9579	37	97	fraction	fraction	NOUN
bam-9579	37	98	of	of	ADP
bam-9579	37	99	inspiration	inspiration	NOUN
bam-9579	37	100	oxygen	oxygen	NOUN
bam-9579	37	101	(	(	PUNCT
bam-9579	37	102	fio2	fio2	PROPN
bam-9579	37	103	)	)	PUNCT
bam-9579	37	104	≤300	≤300	NUM
bam-9579	38	1	mmhg	mmhg	NOUN
bam-9579	38	2	(	(	PUNCT
bam-9579	38	3	1	1	NUM
bam-9579	38	4	mmhg	mmhg	NOUN
bam-9579	38	5	=	=	PUNCT
bam-9579	38	6	0.133	0.133	NUM
bam-9579	38	7	kpa	kpa	NOUN
bam-9579	38	8	)	)	PUNCT
bam-9579	38	9	;	;	PUNCT
bam-9579	38	10	(	(	PUNCT
bam-9579	38	11	4	4	X
bam-9579	38	12	)	)	PUNCT
bam-9579	38	13	pulmonary	pulmonary	ADJ
bam-9579	38	14	imaging	imaging	NOUN
bam-9579	38	15	showed	show	VERB
bam-9579	38	16	significant	significant	ADJ
bam-9579	38	17	progress	progress	NOUN
bam-9579	38	18	of	of	ADP
bam-9579	38	19	the	the	DET
bam-9579	38	20	lesion	lesion	NOUN
bam-9579	38	21	within	within	ADP
bam-9579	38	22	24	24	NUM
bam-9579	38	23	to	to	ADP
bam-9579	38	24	48	48	NUM
bam-9579	38	25	h	h	NOUN
bam-9579	38	26	>	>	NOUN
bam-9579	38	27	50	50	NUM
bam-9579	38	28	%	%	NOUN
bam-9579	38	29	was	be	AUX
bam-9579	38	30	managed	manage	VERB
bam-9579	38	31	3critical	3critical	NUM
bam-9579	38	32	and	and	CCONJ
bam-9579	38	33	severe	severe	ADJ
bam-9579	38	34	:	:	PUNCT
bam-9579	38	35	patients	patient	NOUN
bam-9579	38	36	consistent	consistent	ADJ
bam-9579	38	37	with	with	ADP
bam-9579	38	38	one	one	NUM
bam-9579	38	39	of	of	ADP
bam-9579	38	40	the	the	DET
bam-9579	38	41	following	following	ADJ
bam-9579	38	42	conditions	condition	NOUN
bam-9579	38	43	:	:	PUNCT
bam-9579	38	44	a	a	X
bam-9579	38	45	)	)	PUNCT
bam-9579	38	46	respiratory	respiratory	ADJ
bam-9579	38	47	failure	failure	NOUN
bam-9579	38	48	occurrred	occurrre	VERB
bam-9579	38	49	and	and	CCONJ
bam-9579	38	50	mechanical	mechanical	ADJ
bam-9579	38	51	ventilation	ventilation	NOUN
bam-9579	38	52	was	be	AUX
bam-9579	38	53	required	require	VERB
bam-9579	38	54	;	;	PUNCT
bam-9579	38	55	b	b	X
bam-9579	38	56	)	)	PUNCT
bam-9579	38	57	shock	shock	NOUN
bam-9579	38	58	occured	occur	VERB
bam-9579	38	59	;	;	PUNCT
bam-9579	38	60	c	c	X
bam-9579	38	61	)	)	PUNCT
bam-9579	38	62	combining	combine	VERB
bam-9579	38	63	other	other	ADJ
bam-9579	38	64	organ	organ	NOUN
bam-9579	38	65	failures	failure	NOUN
bam-9579	38	66	required	require	VERB
bam-9579	38	67	icu	icu	PROPN
bam-9579	38	68	monitoring	monitoring	NOUN
bam-9579	38	69	treatment	treatment	NOUN
bam-9579	38	70	.	.	PUNCT
bam-9579	39	1	table	table	NOUN
bam-9579	39	2	2	2	NUM
bam-9579	39	3	.	.	PUNCT
bam-9579	39	4	comparison	comparison	NOUN
bam-9579	39	5	of	of	ADP
bam-9579	39	6	laboratory	laboratory	NOUN
bam-9579	39	7	tests	test	NOUN
bam-9579	39	8	in	in	ADP
bam-9579	39	9	patients	patient	NOUN
bam-9579	39	10	with	with	ADP
bam-9579	39	11	covid-19	covid-19	PROPN
bam-9579	39	12	on	on	ADP
bam-9579	39	13	admission	admission	NOUN
bam-9579	39	14	to	to	ADP
bam-9579	39	15	hospital	hospital	NOUN
bam-9579	39	16	.	.	PUNCT
bam-9579	40	1	item	item	NOUN
bam-9579	40	2	(	(	PUNCT
bam-9579	40	3	unit	unit	NOUN
bam-9579	40	4	,	,	PUNCT
bam-9579	40	5	normal	normal	ADJ
bam-9579	40	6	range	range	NOUN
bam-9579	40	7	)	)	PUNCT
bam-9579	40	8	overall(n=239	overall(n=239	PROPN
bam-9579	40	9	)	)	PUNCT
bam-9579	40	10	,	,	PUNCT
bam-9579	40	11	median	median	NOUN
bam-9579	40	12	(	(	PUNCT
bam-9579	40	13	iqr	iqr	NOUN
bam-9579	40	14	)	)	PUNCT
bam-9579	40	15	ordinary	ordinary	ADJ
bam-9579	40	16	group(n=176	group(n=176	PROPN
bam-9579	40	17	)	)	PUNCT
bam-9579	40	18	,	,	PUNCT
bam-9579	40	19	median	median	NOUN
bam-9579	40	20	(	(	PUNCT
bam-9579	40	21	iqr	iqr	NOUN
bam-9579	40	22	)	)	PUNCT
bam-9579	40	23	severe	severe	ADJ
bam-9579	40	24	/	/	SYM
bam-9579	40	25	critical	critical	ADJ
bam-9579	40	26	group(n=63	group(n=63	PROPN
bam-9579	40	27	)	)	PUNCT
bam-9579	40	28	,	,	PUNCT
bam-9579	40	29	median	median	NOUN
bam-9579	40	30	(	(	PUNCT
bam-9579	40	31	iqr	iqr	NOUN
bam-9579	40	32	)	)	PUNCT
bam-9579	40	33	p	p	NOUN
bam-9579	40	34	value	value	NOUN
bam-9579	40	35	blood	blood	NOUN
bam-9579	40	36	routine	routine	NOUN
bam-9579	40	37	wbc	wbc	PROPN
bam-9579	40	38	count(×109·l-1，3.5~9.5	count(×109·l-1，3.5~9.5	PROPN
bam-9579	40	39	)	)	PUNCT
bam-9579	40	40	5.4	5.4	NUM
bam-9579	40	41	(	(	PUNCT
bam-9579	40	42	4.1~6.8	4.1~6.8	NOUN
bam-9579	40	43	)	)	PUNCT
bam-9579	40	44	4.9	4.9	NUM
bam-9579	40	45	(	(	PUNCT
bam-9579	40	46	4.0~5.9	4.0~5.9	NOUN
bam-9579	40	47	)	)	PUNCT
bam-9579	40	48	6.5	6.5	NUM
bam-9579	40	49	(	(	PUNCT
bam-9579	40	50	5.1~11.5	5.1~11.5	NUM
bam-9579	40	51	)	)	PUNCT
bam-9579	40	52	0.003	0.003	NUM
bam-9579	40	53	neu%	neu%	NOUN
bam-9579	40	54	(	(	PUNCT
bam-9579	40	55	40~75	40~75	NUM
bam-9579	40	56	)	)	PUNCT
bam-9579	40	57	68.3	68.3	NUM
bam-9579	40	58	(	(	PUNCT
bam-9579	40	59	56.8~78.8	56.8~78.8	NOUN
bam-9579	40	60	)	)	PUNCT
bam-9579	40	61	61.6	61.6	NUM
bam-9579	40	62	(	(	PUNCT
bam-9579	40	63	51.8~72.4	51.8~72.4	NUM
bam-9579	40	64	)	)	PUNCT
bam-9579	40	65	84.2	84.2	NUM
bam-9579	40	66	(	(	PUNCT
bam-9579	40	67	75.1~91.2	75.1~91.2	NOUN
bam-9579	40	68	)	)	PUNCT
bam-9579	40	69	<	<	X
bam-9579	40	70	0.001	0.001	NUM
bam-9579	40	71	neu	neu	NOUN
bam-9579	40	72	count(×109·l-1，1.8~6.3	count(×109·l-1，1.8~6.3	PROPN
bam-9579	40	73	)	)	PUNCT
bam-9579	40	74	3.4	3.4	NUM
bam-9579	40	75	(	(	PUNCT
bam-9579	40	76	2.2~5.2	2.2~5.2	NUM
bam-9579	40	77	)	)	PUNCT
bam-9579	40	78	2.8	2.8	NUM
bam-9579	40	79	(	(	PUNCT
bam-9579	40	80	2.0~4.0	2.0~4.0	NUM
bam-9579	40	81	)	)	PUNCT
bam-9579	40	82	5.5	5.5	NUM
bam-9579	40	83	(	(	PUNCT
bam-9579	40	84	3.8~10.8	3.8~10.8	NUM
bam-9579	40	85	)	)	PUNCT
bam-9579	40	86	<	<	X
bam-9579	40	87	0.001	0.001	NUM
bam-9579	40	88	lym	lym	PROPN
bam-9579	40	89	%	%	NOUN
bam-9579	40	90	(	(	PUNCT
bam-9579	40	91	20~50	20~50	NUM
bam-9579	40	92	)	)	PUNCT
bam-9579	40	93	23.5	23.5	NUM
bam-9579	40	94	(	(	PUNCT
bam-9579	40	95	13.3~34.2	13.3~34.2	NUM
bam-9579	40	96	)	)	PUNCT
bam-9579	40	97	28.0	28.0	NUM
bam-9579	40	98	(	(	PUNCT
bam-9579	40	99	20.4~37.4	20.4~37.4	NUM
bam-9579	40	100	)	)	PUNCT
bam-9579	40	101	9.9	9.9	NUM
bam-9579	40	102	(	(	PUNCT
bam-9579	40	103	6.4~19.3	6.4~19.3	NUM
bam-9579	40	104	)	)	PUNCT
bam-9579	40	105	<	<	X
bam-9579	40	106	0.001	0.001	NUM
bam-9579	40	107	lym	lym	PROPN
bam-9579	40	108	count(×109·l-1，1.1~3.2	count(×109·l-1，1.1~3.2	PROPN
bam-9579	40	109	)	)	PUNCT
bam-9579	40	110	1.1	1.1	NUM
bam-9579	40	111	(	(	PUNCT
bam-9579	40	112	0.7~1.5	0.7~1.5	NOUN
bam-9579	40	113	)	)	PUNCT
bam-9579	40	114	1.3	1.3	NUM
bam-9579	40	115	(	(	PUNCT
bam-9579	40	116	0.9~1.7	0.9~1.7	NUM
bam-9579	40	117	)	)	PUNCT
bam-9579	40	118	0.7	0.7	NUM
bam-9579	40	119	(	(	PUNCT
bam-9579	40	120	0.4~1.1	0.4~1.1	NUM
bam-9579	40	121	)	)	PUNCT
bam-9579	40	122	<	<	X
bam-9579	40	123	0.001	0.001	NUM
bam-9579	40	124	plt(×109·l-1，125~350	plt(×109·l-1，125~350	PROPN
bam-9579	40	125	)	)	PUNCT
bam-9579	40	126	164(133~218	164(133~218	PROPN
bam-9579	40	127	)	)	PUNCT
bam-9579	40	128	163(140~216	163(140~216	NUM
bam-9579	40	129	)	)	PUNCT
bam-9579	40	130	182(129~227	182(129~227	NUM
bam-9579	40	131	)	)	PUNCT
bam-9579	40	132	0.717	0.717	NUM
bam-9579	40	133	indicators	indicator	NOUN
bam-9579	40	134	of	of	ADP
bam-9579	40	135	inflammation	inflammation	ADJ
bam-9579	40	136	crp	crp	PROPN
bam-9579	40	137	(	(	PUNCT
bam-9579	40	138	mg	mg	PROPN
bam-9579	40	139	·	·	SYM
bam-9579	40	140	l-1	l-1	NUM
bam-9579	40	141	,	,	PUNCT
bam-9579	40	142	0~8	0~8	NUM
bam-9579	40	143	)	)	PUNCT
bam-9579	40	144	13.6	13.6	NUM
bam-9579	40	145	(	(	PUNCT
bam-9579	40	146	3.7~34.1	3.7~34.1	NUM
bam-9579	40	147	)	)	PUNCT
bam-9579	40	148	5.6	5.6	NUM
bam-9579	40	149	(	(	PUNCT
bam-9579	40	150	0.8~21.4	0.8~21.4	NOUN
bam-9579	40	151	)	)	PUNCT
bam-9579	40	152	36.9	36.9	NUM
bam-9579	40	153	(	(	PUNCT
bam-9579	40	154	19.3~96.1	19.3~96.1	NUM
bam-9579	40	155	)	)	PUNCT
bam-9579	40	156	<	<	X
bam-9579	40	157	0.001	0.001	NUM
bam-9579	40	158	pct	pct	NOUN
bam-9579	40	159	&	&	CCONJ
bam-9579	40	160	lt	lt	PROPN
bam-9579	40	161	;	;	PUNCT
bam-9579	40	162	0.5	0.5	NUM
bam-9579	40	163	,	,	PUNCT
bam-9579	40	164	(	(	PUNCT
bam-9579	40	165	n	n	CCONJ
bam-9579	40	166	,	,	PUNCT
bam-9579	40	167	%	%	INTJ
bam-9579	40	168	)	)	PUNCT
bam-9579	40	169	78.0	78.0	NUM
bam-9579	40	170	(	(	PUNCT
bam-9579	40	171	98.7	98.7	NUM
bam-9579	40	172	)	)	PUNCT
bam-9579	40	173	55.0	55.0	NUM
bam-9579	40	174	(	(	PUNCT
bam-9579	40	175	100	100	NUM
bam-9579	40	176	)	)	PUNCT
bam-9579	40	177	23.0	23.0	NUM
bam-9579	40	178	(	(	PUNCT
bam-9579	40	179	95.8	95.8	NUM
bam-9579	40	180	)	)	PUNCT
bam-9579	40	181	0.304	0.304	NUM
bam-9579	40	182	coagulation	coagulation	NOUN
bam-9579	40	183	pt(s，9.5~14.5	pt(s，9.5~14.5	PROPN
bam-9579	40	184	)	)	PUNCT
bam-9579	40	185	14.3	14.3	NUM
bam-9579	40	186	(	(	PUNCT
bam-9579	40	187	13.4~15.9	13.4~15.9	NUM
bam-9579	40	188	)	)	PUNCT
bam-9579	40	189	14.4	14.4	NUM
bam-9579	40	190	(	(	PUNCT
bam-9579	40	191	13.5~16.0	13.5~16.0	NOUN
bam-9579	40	192	)	)	PUNCT
bam-9579	40	193	14.3	14.3	NUM
bam-9579	40	194	(	(	PUNCT
bam-9579	40	195	13.3~15.0	13.3~15.0	NUM
bam-9579	40	196	)	)	PUNCT
bam-9579	40	197	0.713	0.713	NUM
bam-9579	40	198	d	d	NOUN
bam-9579	40	199	-	-	PUNCT
bam-9579	40	200	dimer	dimer	NOUN
bam-9579	40	201	(	(	PUNCT
bam-9579	40	202	μg·ml~1	μg·ml~1	PROPN
bam-9579	40	203	,	,	PUNCT
bam-9579	40	204	0~1.1	0~1.1	NOUN
bam-9579	40	205	)	)	PUNCT
bam-9579	40	206	0.22	0.22	NUM
bam-9579	40	207	(	(	PUNCT
bam-9579	40	208	0.14~0.35	0.14~0.35	NOUN
bam-9579	40	209	)	)	PUNCT
bam-9579	40	210	0.19	0.19	NUM
bam-9579	40	211	(	(	PUNCT
bam-9579	40	212	0.09~0.26	0.09~0.26	SYM
bam-9579	40	213	)	)	PUNCT
bam-9579	40	214	0.45	0.45	NUM
bam-9579	40	215	(	(	PUNCT
bam-9579	40	216	0.22~0.64	0.22~0.64	PROPN
bam-9579	40	217	)	)	PUNCT
bam-9579	40	218	<	<	X
bam-9579	40	219	0.001	0.001	NUM
bam-9579	40	220	myocardial	myocardial	ADJ
bam-9579	40	221	enzymes	enzyme	NOUN
bam-9579	40	222	ck	ck	VERB
bam-9579	40	223	(	(	PUNCT
bam-9579	40	224	iu·l-1	iu·l-1	PROPN
bam-9579	40	225	,	,	PUNCT
bam-9579	40	226	22~269	22~269	NUM
bam-9579	40	227	)	)	PUNCT
bam-9579	40	228	91.4	91.4	NUM
bam-9579	40	229	(	(	PUNCT
bam-9579	40	230	54.8~158.2	54.8~158.2	NOUN
bam-9579	40	231	)	)	PUNCT
bam-9579	40	232	92.7	92.7	NUM
bam-9579	40	233	(	(	PUNCT
bam-9579	40	234	55.5~154.4	55.5~154.4	NUM
bam-9579	40	235	)	)	PUNCT
bam-9579	40	236	86.2	86.2	NUM
bam-9579	40	237	(	(	PUNCT
bam-9579	40	238	46.0~178.1	46.0~178.1	NOUN
bam-9579	40	239	)	)	PUNCT
bam-9579	40	240	0.543	0.543	NUM
bam-9579	40	241	ck	ck	PROPN
bam-9579	40	242	-	-	PUNCT
bam-9579	40	243	mb	mb	NOUN
bam-9579	40	244	(	(	PUNCT
bam-9579	40	245	u·l-11	u·l-11	PROPN
bam-9579	40	246	,	,	PUNCT
bam-9579	40	247	0~25	0~25	NUM
bam-9579	40	248	)	)	PUNCT
bam-9579	40	249	11.1	11.1	NUM
bam-9579	40	250	(	(	PUNCT
bam-9579	40	251	9.5~15.7	9.5~15.7	NUM
bam-9579	40	252	)	)	PUNCT
bam-9579	40	253	11.3	11.3	NUM
bam-9579	40	254	(	(	PUNCT
bam-9579	40	255	9.4~15.8	9.4~15.8	NUM
bam-9579	40	256	)	)	PUNCT
bam-9579	40	257	11.1	11.1	NUM
bam-9579	40	258	(	(	PUNCT
bam-9579	40	259	9.6~13.6	9.6~13.6	NUM
bam-9579	40	260	)	)	PUNCT
bam-9579	40	261	0.598	0.598	NUM
bam-9579	40	262	ldh	ldh	PROPN
bam-9579	40	263	(	(	PUNCT
bam-9579	40	264	u·l-1	u·l-1	ADP
bam-9579	40	265	,	,	PUNCT
bam-9579	40	266	120~250	120~250	NUM
bam-9579	40	267	)	)	PUNCT
bam-9579	40	268	246	246	NUM
bam-9579	40	269	(	(	PUNCT
bam-9579	40	270	178~306	178~306	NUM
bam-9579	40	271	)	)	PUNCT
bam-9579	40	272	202	202	NUM
bam-9579	40	273	(	(	PUNCT
bam-9579	40	274	169~270	169~270	NUM
bam-9579	40	275	)	)	PUNCT
bam-9579	40	276	295	295	NUM
bam-9579	40	277	(	(	PUNCT
bam-9579	40	278	265~374	265~374	NUM
bam-9579	40	279	)	)	PUNCT
bam-9579	40	280	<	<	X
bam-9579	40	281	0.001	0.001	NUM
bam-9579	40	282	biochemical	biochemical	ADJ
bam-9579	40	283	indicators	indicator	NOUN
bam-9579	40	284	alt	alt	VERB
bam-9579	40	285	(	(	PUNCT
bam-9579	40	286	iu·l-1	iu·l-1	PROPN
bam-9579	40	287	,	,	PUNCT
bam-9579	40	288	9~50	9~50	NUM
bam-9579	40	289	)	)	PUNCT
bam-9579	40	290	23	23	NUM
bam-9579	40	291	(	(	PUNCT
bam-9579	40	292	15~42	15~42	NUM
bam-9579	40	293	)	)	PUNCT
bam-9579	40	294	20	20	NUM
bam-9579	40	295	(	(	PUNCT
bam-9579	40	296	15~35	15~35	NUM
bam-9579	40	297	)	)	PUNCT
bam-9579	40	298	29	29	NUM
bam-9579	40	299	(	(	PUNCT
bam-9579	40	300	21~43	21~43	NUM
bam-9579	40	301	)	)	PUNCT
bam-9579	40	302	0.098	0.098	NUM
bam-9579	40	303	ast	ast	NOUN
bam-9579	40	304	(	(	PUNCT
bam-9579	40	305	iu·l-1	iu·l-1	ADJ
bam-9579	40	306	,	,	PUNCT
bam-9579	40	307	15~45	15~45	NUM
bam-9579	40	308	)	)	PUNCT
bam-9579	40	309	27	27	NUM
bam-9579	40	310	(	(	PUNCT
bam-9579	40	311	21~36	21~36	NUM
bam-9579	40	312	)	)	PUNCT
bam-9579	40	313	25	25	NUM
bam-9579	40	314	(	(	PUNCT
bam-9579	40	315	21~35	21~35	NUM
bam-9579	40	316	)	)	PUNCT
bam-9579	40	317	40	40	NUM
bam-9579	40	318	(	(	PUNCT
bam-9579	40	319	23~37	23~37	NUM
bam-9579	40	320	)	)	PUNCT
bam-9579	40	321	0.159	0.159	NUM
bam-9579	40	322	alb	alb	PROPN
bam-9579	40	323	(	(	PUNCT
bam-9579	40	324	g·l-1	g·l-1	ADJ
bam-9579	40	325	,	,	PUNCT
bam-9579	40	326	40~55	40~55	NUM
bam-9579	40	327	)	)	PUNCT
bam-9579	40	328	42.4	42.4	NUM
bam-9579	40	329	(	(	PUNCT
bam-9579	40	330	38.3~46.9	38.3~46.9	NOUN
bam-9579	40	331	)	)	PUNCT
bam-9579	40	332	44.3	44.3	NUM
bam-9579	40	333	(	(	PUNCT
bam-9579	40	334	41.2~47.7	41.2~47.7	NOUN
bam-9579	40	335	)	)	PUNCT
bam-9579	40	336	36.3	36.3	NUM
bam-9579	40	337	(	(	PUNCT
bam-9579	40	338	33.0~39.1	33.0~39.1	NUM
bam-9579	40	339	)	)	PUNCT
bam-9579	40	340	<	<	X
bam-9579	40	341	0.001	0.001	NUM
bam-9579	40	342	tb	tb	X
bam-9579	40	343	(	(	PUNCT
bam-9579	40	344	umol·l-1，3.4~21	umol·l-1，3.4~21	NOUN
bam-9579	40	345	)	)	PUNCT
bam-9579	40	346	16.4	16.4	NUM
bam-9579	40	347	(	(	PUNCT
bam-9579	40	348	11.8~21.1	11.8~21.1	NUM
bam-9579	40	349	)	)	PUNCT
bam-9579	40	350	14.7	14.7	NUM
bam-9579	40	351	(	(	PUNCT
bam-9579	40	352	11.4~20.1	11.4~20.1	NUM
bam-9579	40	353	)	)	PUNCT
bam-9579	40	354	17.2	17.2	NUM
bam-9579	40	355	(	(	PUNCT
bam-9579	40	356	12.9~21.3	12.9~21.3	PROPN
bam-9579	40	357	)	)	PUNCT
bam-9579	40	358	0.263	0.263	NUM
bam-9579	40	359	cr	cr	PROPN
bam-9579	40	360	(	(	PUNCT
bam-9579	40	361	umol·l-1，57~111	umol·l-1，57~111	PROPN
bam-9579	40	362	)	)	PUNCT
bam-9579	40	363	69	69	NUM
bam-9579	40	364	(	(	PUNCT
bam-9579	40	365	58~81	58~81	NUM
bam-9579	40	366	)	)	PUNCT
bam-9579	40	367	70	70	NUM
bam-9579	40	368	(	(	PUNCT
bam-9579	40	369	59~80	59~80	NUM
bam-9579	40	370	)	)	PUNCT
bam-9579	40	371	69	69	NUM
bam-9579	40	372	(	(	PUNCT
bam-9579	40	373	56~81	56~81	NUM
bam-9579	40	374	)	)	PUNCT
bam-9579	40	375	0.819	0.819	NUM
bam-9579	40	376	bun	bun	NOUN
bam-9579	40	377	(	(	PUNCT
bam-9579	40	378	mmol·l-1，3.1~8	mmol·l-1，3.1~8	PROPN
bam-9579	40	379	)	)	PUNCT
bam-9579	40	380	4.0	4.0	NUM
bam-9579	40	381	(	(	PUNCT
bam-9579	40	382	3.0~5.4	3.0~5.4	NUM
bam-9579	40	383	)	)	PUNCT
bam-9579	40	384	3.6	3.6	NUM
bam-9579	40	385	(	(	PUNCT
bam-9579	40	386	3.0~4.5	3.0~4.5	NUM
bam-9579	40	387	)	)	PUNCT
bam-9579	40	388	5.4	5.4	NUM
bam-9579	40	389	(	(	PUNCT
bam-9579	40	390	4.3~6.0	4.3~6.0	NUM
bam-9579	40	391	)	)	PUNCT
bam-9579	40	392	<	<	X
bam-9579	40	393	0.001	0.001	NUM
bam-9579	40	394	_	_	PUNCT
bam-9579	41	1	_	_	PUNCT
bam-9579	42	1	_	_	PUNCT
bam-9579	43	1	_	_	PUNCT
bam-9579	44	1	_	_	PUNCT
bam-9579	45	1	_	_	PUNCT
bam-9579	46	1	_	_	PUNCT
bam-9579	47	1	_	_	PUNCT
bam-9579	48	1	_	_	PUNCT
bam-9579	49	1	_	_	PUNCT
bam-9579	50	1	_	_	PUNCT
bam-9579	51	1	_	_	PUNCT
bam-9579	52	1	_	_	PUNCT
bam-9579	53	1	_	_	PUNCT
bam-9579	54	1	_	_	PUNCT
bam-9579	55	1	_	_	PUNCT
bam-9579	56	1	_	_	PUNCT
bam-9579	57	1	_	_	PUNCT
bam-9579	58	1	_	_	PUNCT
bam-9579	59	1	_	_	PUNCT
bam-9579	60	1	_	_	PUNCT
bam-9579	61	1	_	_	PUNCT
bam-9579	62	1	_	_	PUNCT
bam-9579	63	1	_	_	PUNCT
bam-9579	64	1	_	_	PUNCT
bam-9579	65	1	_	_	PUNCT
bam-9579	66	1	_	_	PUNCT
bam-9579	67	1	_	_	PUNCT
bam-9579	68	1	_	_	PUNCT
bam-9579	69	1	_	_	PUNCT
bam-9579	70	1	_	_	PUNCT
bam-9579	71	1	_	_	PUNCT
bam-9579	72	1	_	_	PUNCT
bam-9579	73	1	_	_	PUNCT
bam-9579	74	1	_	_	PUNCT
bam-9579	75	1	_	_	PUNCT
bam-9579	76	1	_	_	PUNCT
bam-9579	77	1	_	_	PUNCT
bam-9579	78	1	_	_	PUNCT
bam-9579	79	1	_	_	PUNCT
bam-9579	80	1	_	_	PUNCT
bam-9579	81	1	_	_	PUNCT
bam-9579	82	1	_	_	PUNCT
bam-9579	83	1	_	_	PUNCT
bam-9579	84	1	_	_	PUNCT
bam-9579	85	1	_	_	PUNCT
bam-9579	86	1	_	_	PUNCT
bam-9579	87	1	_	_	PUNCT
bam-9579	88	1	_	_	PUNCT
bam-9579	89	1	_	_	PUNCT
bam-9579	90	1	_	_	PUNCT
bam-9579	91	1	_	_	PUNCT
bam-9579	92	1	_	_	PUNCT
bam-9579	93	1	_	_	PUNCT
bam-9579	94	1	_	_	PUNCT
bam-9579	95	1	_	_	PUNCT
bam-9579	96	1	_	_	PUNCT
bam-9579	97	1	_	_	PUNCT
bam-9579	98	1	_	_	PUNCT
bam-9579	99	1	_	_	PUNCT
bam-9579	100	1	_	_	PUNCT
bam-9579	101	1	_	_	PUNCT
bam-9579	102	1	_	_	PUNCT
bam-9579	103	1	_	_	PUNCT
bam-9579	104	1	_	_	PUNCT
bam-9579	105	1	_	_	PUNCT
bam-9579	106	1	_	_	PUNCT
bam-9579	107	1	_	_	PUNCT
bam-9579	108	1	_	_	PUNCT
bam-9579	109	1	_	_	PUNCT
bam-9579	110	1	_	_	PUNCT
bam-9579	111	1	_	_	PUNCT
bam-9579	112	1	_	_	PUNCT
bam-9579	113	1	_	_	PUNCT
bam-9579	114	1	_	_	PUNCT
bam-9579	115	1	_	_	PUNCT
bam-9579	116	1	_	_	PUNCT
bam-9579	117	1	_	_	PUNCT
bam-9579	118	1	_	_	PUNCT
bam-9579	119	1	_	_	PUNCT
bam-9579	120	1	_	_	PUNCT
bam-9579	121	1	_	_	PUNCT
bam-9579	122	1	_	_	PUNCT
bam-9579	123	1	_	_	PUNCT
bam-9579	124	1	_	_	PUNCT
bam-9579	125	1	_	_	PUNCT
bam-9579	126	1	_	_	PUNCT
bam-9579	127	1	_	_	PUNCT
bam-9579	128	1	_	_	PUNCT
bam-9579	129	1	_	_	PUNCT
bam-9579	130	1	_	_	PUNCT
bam-9579	131	1	_	_	PUNCT
bam-9579	132	1	_	_	PUNCT
bam-9579	133	1	_	_	PUNCT
bam-9579	134	1	_	_	PUNCT
bam-9579	135	1	_	_	PUNCT
bam-9579	136	1	_	_	PUNCT
bam-9579	137	1	_	_	PUNCT
bam-9579	138	1	_	_	PUNCT
bam-9579	139	1	_	_	PUNCT
bam-9579	140	1	_	_	PUNCT
bam-9579	141	1	_	_	PUNCT
bam-9579	142	1	_	_	PUNCT
bam-9579	143	1	_	_	PUNCT
bam-9579	144	1	_	_	PUNCT
bam-9579	145	1	_	_	PUNCT
bam-9579	146	1	_	_	PUNCT
bam-9579	147	1	_	_	PUNCT
bam-9579	148	1	_	_	PUNCT
bam-9579	149	1	_	_	PUNCT
bam-9579	150	1	_	_	PUNCT
bam-9579	151	1	_	_	PUNCT
bam-9579	152	1	_	_	PUNCT
bam-9579	153	1	_	_	PUNCT
bam-9579	154	1	_	_	PUNCT
bam-9579	155	1	_	_	PUNCT
bam-9579	156	1	_	_	PUNCT
bam-9579	157	1	_	_	PUNCT
bam-9579	158	1	_	_	PUNCT
bam-9579	159	1	wbc	wbc	ADJ
bam-9579	159	2	:	:	PUNCT
bam-9579	159	3	white	white	ADJ
bam-9579	159	4	blood	blood	NOUN
bam-9579	159	5	cells	cell	NOUN
bam-9579	159	6	,	,	PUNCT
bam-9579	159	7	neu	neu	NOUN
bam-9579	159	8	:	:	PUNCT
bam-9579	159	9	neutrophils	neutrophil	NOUN
bam-9579	159	10	,	,	PUNCT
bam-9579	159	11	lym	lym	PROPN
bam-9579	159	12	:	:	PUNCT
bam-9579	159	13	lymphocytes	lymphocyte	NOUN
bam-9579	159	14	,	,	PUNCT
bam-9579	159	15	plt	plt	NOUN
bam-9579	159	16	:	:	PUNCT
bam-9579	159	17	platelets	platelet	NOUN
bam-9579	159	18	,	,	PUNCT
bam-9579	159	19	crp	crp	NOUN
bam-9579	159	20	:	:	PUNCT
bam-9579	159	21	c	c	X
bam-9579	159	22	-	-	PUNCT
bam-9579	159	23	reactive	reactive	ADJ
bam-9579	159	24	protein	protein	NOUN
bam-9579	159	25	,	,	PUNCT
bam-9579	159	26	pct	pct	NOUN
bam-9579	159	27	:	:	PUNCT
bam-9579	159	28	procalcitonin	procalcitonin	ADJ
bam-9579	159	29	,	,	PUNCT
bam-9579	159	30	pt	pt	ADJ
bam-9579	159	31	:	:	PUNCT
bam-9579	159	32	prothrombin	prothrombin	ADJ
bam-9579	159	33	time	time	NOUN
bam-9579	159	34	,	,	PUNCT
bam-9579	159	35	ck	ck	PROPN
bam-9579	159	36	:	:	PUNCT
bam-9579	159	37	creatine	creatine	PROPN
bam-9579	159	38	kinase	kinase	PROPN
bam-9579	159	39	,	,	PUNCT
bam-9579	159	40	ck	ck	PROPN
bam-9579	159	41	-	-	PUNCT
bam-9579	159	42	mb	mb	NOUN
bam-9579	159	43	:	:	PUNCT
bam-9579	159	44	creatine	creatine	PROPN
bam-9579	159	45	kinase	kinase	PROPN
bam-9579	159	46	isoenzyme	isoenzyme	PROPN
bam-9579	159	47	,	,	PUNCT
bam-9579	159	48	ldh	ldh	PROPN
bam-9579	159	49	:	:	PUNCT
bam-9579	159	50	lactate	lactate	NOUN
bam-9579	159	51	dehydrogenas	dehydrogena	NOUN
bam-9579	159	52	,	,	PUNCT
bam-9579	159	53	alt	alt	ADV
bam-9579	159	54	:	:	PUNCT
bam-9579	159	55	alanine	alanine	NOUN
bam-9579	159	56	aminotransferase	aminotransferase	PROPN
bam-9579	159	57	,	,	PUNCT
bam-9579	159	58	ast	ast	NOUN
bam-9579	159	59	:	:	PUNCT
bam-9579	159	60	aspartate	aspartate	NOUN
bam-9579	159	61	aminotransferase	aminotransferase	NOUN
bam-9579	159	62	,	,	PUNCT
bam-9579	159	63	tb	tb	NOUN
bam-9579	159	64	:	:	PUNCT
bam-9579	160	1	total	total	ADJ
bam-9579	160	2	bilirubin	bilirubin	NOUN
bam-9579	160	3	,	,	PUNCT
bam-9579	160	4	cr	cr	NOUN
bam-9579	160	5	:	:	PUNCT
bam-9579	160	6	creatinine	creatinine	NOUN
bam-9579	160	7	,	,	PUNCT
bam-9579	160	8	bun	bun	NOUN
bam-9579	160	9	:	:	PUNCT
bam-9579	160	10	urea	urea	PROPN
bam-9579	160	11	nitrogen	nitrogen	NOUN
bam-9579	160	12	.	.	PUNCT
bam-9579	161	1	ordinary	ordinary	ADJ
bam-9579	161	2	and	and	CCONJ
bam-9579	161	3	severe	severe	ADJ
bam-9579	161	4	cases	case	NOUN
bam-9579	161	5	of	of	ADP
bam-9579	161	6	covid-19	covid-19	PROPN
bam-9579	161	7	in	in	ADP
bam-9579	161	8	iran	iran	PROPN
bam-9579	161	9	eur	eur	PROPN
bam-9579	161	10	j	j	PROPN
bam-9579	161	11	transl	transl	PROPN
bam-9579	161	12	myol	myol	ADV
bam-9579	161	13	31	31	NUM
bam-9579	161	14	(	(	PUNCT
bam-9579	161	15	3	3	NUM
bam-9579	161	16	):	):	PUNCT
bam-9579	161	17	9579	9579	NUM
bam-9579	161	18	,	,	PUNCT
bam-9579	161	19	2021	2021	NUM
bam-9579	161	20	doi	doi	NOUN
bam-9579	161	21	:	:	PUNCT
bam-9579	161	22	10.4081	10.4081	NUM
bam-9579	161	23	/	/	SYM
bam-9579	161	24	ejtm.2021.9579	ejtm.2021.9579	NUM
bam-9579	161	25	4	4	NUM
bam-9579	161	26	data	datum	NOUN
bam-9579	161	27	collection	collection	NOUN
bam-9579	161	28	the	the	DET
bam-9579	161	29	relevant	relevant	ADJ
bam-9579	161	30	data	datum	NOUN
bam-9579	161	31	was	be	AUX
bam-9579	161	32	collected	collect	VERB
bam-9579	161	33	and	and	CCONJ
bam-9579	161	34	obtained	obtain	VERB
bam-9579	161	35	through	through	ADP
bam-9579	161	36	the	the	DET
bam-9579	161	37	in	in	ADP
bam-9579	161	38	-	-	PUNCT
bam-9579	161	39	hospital	hospital	NOUN
bam-9579	161	40	electronic	electronic	ADJ
bam-9579	161	41	medical	medical	ADJ
bam-9579	161	42	record	record	NOUN
bam-9579	161	43	system	system	NOUN
bam-9579	161	44	,	,	PUNCT
bam-9579	161	45	which	which	PRON
bam-9579	161	46	was	be	AUX
bam-9579	161	47	summarized	summarize	VERB
bam-9579	161	48	in	in	ADP
bam-9579	161	49	an	an	DET
bam-9579	161	50	electronic	electronic	ADJ
bam-9579	161	51	format	format	NOUN
bam-9579	161	52	and	and	CCONJ
bam-9579	161	53	reviewed	review	VERB
bam-9579	161	54	by	by	ADP
bam-9579	161	55	senior	senior	ADJ
bam-9579	161	56	physicians	physician	NOUN
bam-9579	161	57	.	.	PUNCT
bam-9579	162	1	the	the	DET
bam-9579	162	2	information	information	NOUN
bam-9579	162	3	collected	collect	VERB
bam-9579	162	4	included	include	VERB
bam-9579	162	5	demographic	demographic	ADJ
bam-9579	162	6	data	datum	NOUN
bam-9579	162	7	,	,	PUNCT
bam-9579	162	8	previous	previous	ADJ
bam-9579	162	9	medical	medical	ADJ
bam-9579	162	10	history	history	NOUN
bam-9579	162	11	,	,	PUNCT
bam-9579	162	12	history	history	NOUN
bam-9579	162	13	of	of	ADP
bam-9579	162	14	epidemic	epidemic	NOUN
bam-9579	162	15	exposure	exposure	NOUN
bam-9579	162	16	,	,	PUNCT
bam-9579	162	17	clinical	clinical	ADJ
bam-9579	162	18	symptoms	symptom	NOUN
bam-9579	162	19	and	and	CCONJ
bam-9579	162	20	signs	sign	NOUN
bam-9579	162	21	,	,	PUNCT
bam-9579	162	22	laboratory	laboratory	NOUN
bam-9579	162	23	tests	test	NOUN
bam-9579	162	24	,	,	PUNCT
bam-9579	162	25	chest	chest	NOUN
bam-9579	162	26	imaging	imaging	NOUN
bam-9579	162	27	findings	finding	NOUN
bam-9579	162	28	,	,	PUNCT
bam-9579	162	29	treatment	treatment	NOUN
bam-9579	162	30	measures	measure	NOUN
bam-9579	162	31	,	,	PUNCT
bam-9579	162	32	and	and	CCONJ
bam-9579	162	33	prognosis	prognosis	NOUN
bam-9579	162	34	.	.	PUNCT
bam-9579	163	1	the	the	DET
bam-9579	163	2	laboratory	laboratory	NOUN
bam-9579	163	3	tests	test	VERB
bam-9579	163	4	at	at	ADP
bam-9579	163	5	least	least	ADJ
bam-9579	163	6	included	include	VERB
bam-9579	163	7	:	:	PUNCT
bam-9579	163	8	blood	blood	NOUN
bam-9579	163	9	routine	routine	NOUN
bam-9579	163	10	,	,	PUNCT
bam-9579	163	11	crp	crp	PROPN
bam-9579	163	12	,	,	PUNCT
bam-9579	163	13	pct	pct	NOUN
bam-9579	163	14	,	,	PUNCT
bam-9579	163	15	prothrombin	prothrombin	ADJ
bam-9579	163	16	time	time	NOUN
bam-9579	163	17	(	(	PUNCT
bam-9579	163	18	pt	pt	NOUN
bam-9579	163	19	)	)	PUNCT
bam-9579	163	20	,	,	PUNCT
bam-9579	163	21	d	d	X
bam-9579	163	22	-	-	PUNCT
bam-9579	163	23	dimer	dimer	ADJ
bam-9579	163	24	,	,	PUNCT
bam-9579	163	25	creatine	creatine	PROPN
bam-9579	163	26	kinase	kinase	PROPN
bam-9579	163	27	(	(	PUNCT
bam-9579	163	28	ck	ck	PROPN
bam-9579	163	29	)	)	PUNCT
bam-9579	163	30	,	,	PUNCT
bam-9579	163	31	creatine	creatine	PROPN
bam-9579	163	32	kinase	kinase	PROPN
bam-9579	163	33	isoform	isoform	NOUN
bam-9579	163	34	enzymes	enzyme	NOUN
bam-9579	163	35	(	(	PUNCT
bam-9579	163	36	ck	ck	NOUN
bam-9579	163	37	-	-	PUNCT
bam-9579	163	38	mb	mb	NOUN
bam-9579	163	39	)	)	PUNCT
bam-9579	163	40	,	,	PUNCT
bam-9579	163	41	ldh	ldh	PROPN
bam-9579	163	42	,	,	PUNCT
bam-9579	163	43	alanine	alanine	NOUN
bam-9579	163	44	aminotransferase	aminotransferase	NOUN
bam-9579	163	45	(	(	PUNCT
bam-9579	163	46	alt	alt	PROPN
bam-9579	163	47	)	)	PUNCT
bam-9579	163	48	,	,	PUNCT
bam-9579	163	49	aspartate	aspartate	NOUN
bam-9579	163	50	aminotransferase	aminotransferase	NOUN
bam-9579	163	51	(	(	PUNCT
bam-9579	163	52	ast	ast	PROPN
bam-9579	163	53	)	)	PUNCT
bam-9579	163	54	,	,	PUNCT
bam-9579	163	55	serum	serum	NOUN
bam-9579	163	56	albumin	albumin	NOUN
bam-9579	163	57	(	(	PUNCT
bam-9579	163	58	alb	alb	PROPN
bam-9579	163	59	)	)	PUNCT
bam-9579	163	60	,	,	PUNCT
bam-9579	163	61	total	total	ADJ
bam-9579	163	62	bilirubin	bilirubin	NOUN
bam-9579	163	63	(	(	PUNCT
bam-9579	163	64	tb	tb	NOUN
bam-9579	163	65	)	)	PUNCT
bam-9579	163	66	,	,	PUNCT
bam-9579	163	67	creatinine	creatinine	NOUN
bam-9579	163	68	(	(	PUNCT
bam-9579	163	69	cr	cr	NOUN
bam-9579	163	70	)	)	PUNCT
bam-9579	163	71	,	,	PUNCT
bam-9579	163	72	and	and	CCONJ
bam-9579	163	73	bun	bun	NOUN
bam-9579	163	74	.	.	PUNCT
bam-9579	164	1	the	the	DET
bam-9579	164	2	laboratory	laboratory	NOUN
bam-9579	164	3	examination	examination	NOUN
bam-9579	164	4	data	datum	NOUN
bam-9579	164	5	of	of	ADP
bam-9579	164	6	ordinary	ordinary	ADJ
bam-9579	164	7	patients	patient	NOUN
bam-9579	164	8	were	be	AUX
bam-9579	164	9	collected	collect	VERB
bam-9579	164	10	within	within	ADP
bam-9579	164	11	48	48	NUM
bam-9579	164	12	hours	hour	NOUN
bam-9579	164	13	of	of	ADP
bam-9579	164	14	admission	admission	NOUN
bam-9579	164	15	,	,	PUNCT
bam-9579	164	16	and	and	CCONJ
bam-9579	164	17	the	the	DET
bam-9579	164	18	severe	severe	ADJ
bam-9579	164	19	and	and	CCONJ
bam-9579	164	20	critically	critically	ADV
bam-9579	164	21	ill	ill	ADJ
bam-9579	164	22	patients	patient	NOUN
bam-9579	164	23	were	be	AUX
bam-9579	164	24	collected	collect	VERB
bam-9579	164	25	within	within	ADP
bam-9579	164	26	48	48	NUM
bam-9579	164	27	hours	hour	NOUN
bam-9579	164	28	of	of	ADP
bam-9579	164	29	admission	admission	NOUN
bam-9579	164	30	to	to	ADP
bam-9579	164	31	the	the	DET
bam-9579	164	32	intensive	intensive	ADJ
bam-9579	164	33	care	care	NOUN
bam-9579	164	34	unit	unit	NOUN
bam-9579	164	35	.	.	PUNCT
bam-9579	165	1	the	the	DET
bam-9579	165	2	statistical	statistical	ADJ
bam-9579	165	3	content	content	NOUN
bam-9579	165	4	of	of	ADP
bam-9579	165	5	treatment	treatment	NOUN
bam-9579	165	6	measures	measure	NOUN
bam-9579	165	7	included	include	VERB
bam-9579	165	8	the	the	DET
bam-9579	165	9	application	application	NOUN
bam-9579	165	10	of	of	ADP
bam-9579	165	11	antiviral	antiviral	ADJ
bam-9579	165	12	drugs	drug	NOUN
bam-9579	165	13	,	,	PUNCT
bam-9579	165	14	antibacterial	antibacterial	ADJ
bam-9579	165	15	drugs	drug	NOUN
bam-9579	165	16	,	,	PUNCT
bam-9579	165	17	glucocorticoids	glucocorticoid	NOUN
bam-9579	165	18	,	,	PUNCT
bam-9579	165	19	oxygen	oxygen	NOUN
bam-9579	165	20	therapy	therapy	NOUN
bam-9579	165	21	and	and	CCONJ
bam-9579	165	22	respiratory	respiratory	ADJ
bam-9579	165	23	support	support	NOUN
bam-9579	165	24	.	.	PUNCT
bam-9579	166	1	statistics	statistic	NOUN
bam-9579	166	2	all	all	DET
bam-9579	166	3	statistical	statistical	ADJ
bam-9579	166	4	analyses	analysis	NOUN
bam-9579	166	5	were	be	AUX
bam-9579	166	6	performed	perform	VERB
bam-9579	166	7	by	by	ADP
bam-9579	166	8	using	use	VERB
bam-9579	166	9	spss	spss	PROPN
bam-9579	166	10	25.0	25.0	NUM
bam-9579	166	11	software	software	NOUN
bam-9579	166	12	,	,	PUNCT
bam-9579	166	13	the	the	DET
bam-9579	166	14	t	t	NOUN
bam-9579	166	15	-	-	PUNCT
bam-9579	166	16	test	test	NOUN
bam-9579	166	17	and	and	CCONJ
bam-9579	166	18	chi	chi	ADJ
bam-9579	166	19	-	-	PUNCT
bam-9579	166	20	square	square	NOUN
bam-9579	166	21	test	test	NOUN
bam-9579	166	22	were	be	AUX
bam-9579	166	23	used	use	VERB
bam-9579	166	24	to	to	PART
bam-9579	166	25	compare	compare	VERB
bam-9579	166	26	the	the	DET
bam-9579	166	27	mean	mean	NOUN
bam-9579	166	28	of	of	ADP
bam-9579	166	29	two	two	NUM
bam-9579	166	30	groups	group	NOUN
bam-9579	166	31	of	of	ADP
bam-9579	166	32	samples	sample	NOUN
bam-9579	166	33	.	.	PUNCT
bam-9579	167	1	the	the	DET
bam-9579	167	2	measurement	measurement	NOUN
bam-9579	167	3	data	datum	NOUN
bam-9579	167	4	of	of	ADP
bam-9579	167	5	normal	normal	ADJ
bam-9579	167	6	distribution	distribution	NOUN
bam-9579	167	7	is	be	AUX
bam-9579	167	8	represented	represent	VERB
bam-9579	167	9	by	by	ADP
bam-9579	167	10	mean	mean	PROPN
bam-9579	167	11	(	(	PUNCT
bam-9579	167	12	x̄	x̄	PROPN
bam-9579	167	13	)	)	PUNCT
bam-9579	167	14	±	±	NUM
bam-9579	167	15	sd	sd	NOUN
bam-9579	167	16	;	;	PUNCT
bam-9579	167	17	p	p	NOUN
bam-9579	167	18	value	value	NOUN
bam-9579	167	19	under	under	ADP
bam-9579	167	20	0.05	0.05	NUM
bam-9579	167	21	was	be	AUX
bam-9579	167	22	consider	consider	VERB
bam-9579	167	23	as	as	ADP
bam-9579	167	24	a	a	DET
bam-9579	167	25	significance	significance	NOUN
bam-9579	167	26	level	level	NOUN
bam-9579	167	27	.	.	PUNCT
bam-9579	168	1	results	result	VERB
bam-9579	168	2	general	general	ADJ
bam-9579	168	3	information	information	NOUN
bam-9579	168	4	table	table	NOUN
bam-9579	168	5	1	1	NUM
bam-9579	168	6	shows	show	VERB
bam-9579	168	7	the	the	DET
bam-9579	168	8	general	general	ADJ
bam-9579	168	9	data	datum	NOUN
bam-9579	168	10	of	of	ADP
bam-9579	168	11	239	239	NUM
bam-9579	168	12	covid-19	covid-19	PROPN
bam-9579	168	13	patients	patient	NOUN
bam-9579	168	14	collected	collect	VERB
bam-9579	168	15	in	in	ADP
bam-9579	168	16	this	this	DET
bam-9579	168	17	study	study	NOUN
bam-9579	168	18	.	.	PUNCT
bam-9579	169	1	the	the	DET
bam-9579	169	2	average	average	ADJ
bam-9579	169	3	age	age	NOUN
bam-9579	169	4	of	of	ADP
bam-9579	169	5	the	the	DET
bam-9579	169	6	patients	patient	NOUN
bam-9579	169	7	was	be	AUX
bam-9579	169	8	48.1±17.6	48.1±17.6	NUM
bam-9579	169	9	years	year	NOUN
bam-9579	169	10	.	.	PUNCT
bam-9579	170	1	among	among	ADP
bam-9579	170	2	them	they	PRON
bam-9579	170	3	,	,	PUNCT
bam-9579	170	4	132	132	NUM
bam-9579	170	5	were	be	AUX
bam-9579	170	6	male	male	ADJ
bam-9579	170	7	(	(	PUNCT
bam-9579	170	8	55.3	55.3	NUM
bam-9579	170	9	%	%	NOUN
bam-9579	170	10	)	)	PUNCT
bam-9579	170	11	and	and	CCONJ
bam-9579	170	12	107	107	NUM
bam-9579	170	13	were	be	AUX
bam-9579	170	14	female	female	ADJ
bam-9579	170	15	(	(	PUNCT
bam-9579	170	16	44.7	44.7	NUM
bam-9579	170	17	%	%	NOUN
bam-9579	170	18	)	)	PUNCT
bam-9579	170	19	.	.	PUNCT
bam-9579	171	1	in	in	ADP
bam-9579	171	2	terms	term	NOUN
bam-9579	171	3	of	of	ADP
bam-9579	171	4	disease	disease	NOUN
bam-9579	171	5	susceptibility	susceptibility	NOUN
bam-9579	171	6	,	,	PUNCT
bam-9579	171	7	there	there	PRON
bam-9579	171	8	was	be	VERB
bam-9579	171	9	no	no	DET
bam-9579	171	10	statistically	statistically	ADV
bam-9579	171	11	significant	significant	ADJ
bam-9579	171	12	difference	difference	NOUN
bam-9579	171	13	between	between	ADP
bam-9579	171	14	men	man	NOUN
bam-9579	171	15	and	and	CCONJ
bam-9579	171	16	women	woman	NOUN
bam-9579	171	17	(	(	PUNCT
bam-9579	171	18	p	p	X
bam-9579	171	19	=	=	NOUN
bam-9579	171	20	0.42	0.42	NUM
bam-9579	171	21	)	)	PUNCT
bam-9579	171	22	,	,	PUNCT
bam-9579	171	23	but	but	CCONJ
bam-9579	171	24	men	man	NOUN
bam-9579	171	25	were	be	AUX
bam-9579	171	26	more	more	ADV
bam-9579	171	27	likely	likely	ADJ
bam-9579	171	28	to	to	PART
bam-9579	171	29	develop	develop	VERB
bam-9579	171	30	severe	severe	ADJ
bam-9579	171	31	pneumonia	pneumonia	NOUN
bam-9579	171	32	(	(	PUNCT
bam-9579	171	33	47	47	NUM
bam-9579	171	34	cases	case	NOUN
bam-9579	171	35	(	(	PUNCT
bam-9579	171	36	75	75	NUM
bam-9579	171	37	%	%	NOUN
bam-9579	171	38	)	)	PUNCT
bam-9579	171	39	vs	vs	ADP
bam-9579	171	40	16	16	NUM
bam-9579	171	41	cases	case	NOUN
bam-9579	171	42	(	(	PUNCT
bam-9579	171	43	25	25	NUM
bam-9579	171	44	%	%	NOUN
bam-9579	171	45	)	)	PUNCT
bam-9579	171	46	,	,	PUNCT
bam-9579	171	47	p=0.032	p=0.032	NUM
bam-9579	171	48	)	)	PUNCT
bam-9579	171	49	.	.	PUNCT
bam-9579	172	1	compared	compare	VERB
bam-9579	172	2	with	with	ADP
bam-9579	172	3	the	the	DET
bam-9579	172	4	common	common	ADJ
bam-9579	172	5	type	type	NOUN
bam-9579	172	6	,	,	PUNCT
bam-9579	172	7	patients	patient	NOUN
bam-9579	172	8	with	with	ADP
bam-9579	172	9	severe	severe	ADJ
bam-9579	172	10	and	and	CCONJ
bam-9579	172	11	critically	critically	ADV
bam-9579	172	12	ill	ill	ADJ
bam-9579	172	13	patients	patient	NOUN
bam-9579	172	14	are	be	AUX
bam-9579	172	15	older	old	ADJ
bam-9579	172	16	[	[	X
bam-9579	172	17	(	(	PUNCT
bam-9579	172	18	59.8±14.1	59.8±14.1	NUM
bam-9579	172	19	)	)	PUNCT
bam-9579	172	20	years	year	NOUN
bam-9579	172	21	vs	vs	ADP
bam-9579	172	22	(	(	PUNCT
bam-9579	172	23	43.9±14.5	43.9±14.5	PROPN
bam-9579	172	24	)	)	PUNCT
bam-9579	172	25	years	year	NOUN
bam-9579	172	26	,	,	PUNCT
bam-9579	172	27	p	p	X
bam-9579	172	28	<	<	X
bam-9579	172	29	0.001	0.001	NUM
bam-9579	172	30	]	]	PUNCT
bam-9579	172	31	,	,	PUNCT
bam-9579	172	32	and	and	CCONJ
bam-9579	172	33	previously	previously	ADV
bam-9579	172	34	had	have	VERB
bam-9579	172	35	hypertension	hypertension	NOUN
bam-9579	172	36	[	[	PUNCT
bam-9579	172	37	32	32	NUM
bam-9579	172	38	cases	case	NOUN
bam-9579	172	39	(	(	PUNCT
bam-9579	172	40	50.8	50.8	NUM
bam-9579	172	41	%	%	NOUN
bam-9579	172	42	)	)	PUNCT
bam-9579	172	43	vs	vs	ADP
bam-9579	172	44	16	16	NUM
bam-9579	172	45	cases	case	NOUN
bam-9579	172	46	(	(	PUNCT
bam-9579	172	47	9.1	9.1	NUM
bam-9579	172	48	%	%	NOUN
bam-9579	172	49	)	)	PUNCT
bam-9579	172	50	,	,	PUNCT
bam-9579	172	51	p	p	X
bam-9579	172	52	<	<	X
bam-9579	172	53	0.001	0.001	NUM
bam-9579	172	54	]	]	PUNCT
bam-9579	172	55	and	and	CCONJ
bam-9579	172	56	cerebrovascular	cerebrovascular	ADJ
bam-9579	172	57	diseases	disease	NOUN
bam-9579	172	58	[	[	PUNCT
bam-9579	172	59	9	9	NUM
bam-9579	172	60	cases	case	NOUN
bam-9579	172	61	(	(	PUNCT
bam-9579	172	62	14.3	14.3	NUM
bam-9579	172	63	%	%	NOUN
bam-9579	172	64	)	)	PUNCT
bam-9579	172	65	vs	vs	ADP
bam-9579	172	66	0	0	NUM
bam-9579	172	67	cases	case	NOUN
bam-9579	172	68	,	,	PUNCT
bam-9579	172	69	p	p	X
bam-9579	172	70	=	=	PROPN
bam-9579	172	71	0.026	0.026	NUM
bam-9579	172	72	]	]	PUNCT
bam-9579	172	73	,	,	PUNCT
bam-9579	172	74	and	and	CCONJ
bam-9579	172	75	the	the	DET
bam-9579	172	76	number	number	NOUN
bam-9579	172	77	of	of	ADP
bam-9579	172	78	underlying	underlie	VERB
bam-9579	172	79	diseases	disease	NOUN
bam-9579	172	80	of	of	ADP
bam-9579	172	81	previous	previous	ADJ
bam-9579	172	82	diseases	disease	NOUN
bam-9579	172	83	was	be	AUX
bam-9579	172	84	higher	high	ADJ
bam-9579	172	85	than	than	ADP
bam-9579	172	86	that	that	PRON
bam-9579	172	87	of	of	ADP
bam-9579	172	88	the	the	DET
bam-9579	172	89	ordinary	ordinary	ADJ
bam-9579	172	90	group	group	NOUN
bam-9579	172	91	(	(	PUNCT
bam-9579	172	92	p	p	X
bam-9579	172	93	<	<	X
bam-9579	172	94	0.001	0.001	NUM
bam-9579	172	95	)	)	PUNCT
bam-9579	172	96	.	.	PUNCT
bam-9579	173	1	other	other	ADJ
bam-9579	173	2	indicators	indicator	NOUN
bam-9579	173	3	such	such	ADJ
bam-9579	173	4	as	as	ADP
bam-9579	173	5	contact	contact	NOUN
bam-9579	173	6	history	history	NOUN
bam-9579	173	7	,	,	PUNCT
bam-9579	173	8	onset	onset	NOUN
bam-9579	173	9	symptoms	symptom	NOUN
bam-9579	173	10	,	,	PUNCT
bam-9579	173	11	pulse	pulse	NOUN
bam-9579	173	12	,	,	PUNCT
bam-9579	173	13	breathing	breathing	NOUN
bam-9579	173	14	frequency	frequency	NOUN
bam-9579	173	15	and	and	CCONJ
bam-9579	173	16	other	other	ADJ
bam-9579	173	17	indicators	indicator	NOUN
bam-9579	173	18	showed	show	VERB
bam-9579	173	19	no	no	DET
bam-9579	173	20	significant	significant	ADJ
bam-9579	173	21	differences	difference	NOUN
bam-9579	173	22	(	(	PUNCT
bam-9579	173	23	all	all	PRON
bam-9579	173	24	p	p	X
bam-9579	173	25	>	>	X
bam-9579	173	26	0.05	0.05	NUM
bam-9579	173	27	)	)	PUNCT
bam-9579	173	28	.	.	PUNCT
bam-9579	174	1	laboratory	laboratory	NOUN
bam-9579	174	2	findings	finding	NOUN
bam-9579	174	3	table	table	NOUN
bam-9579	174	4	2	2	NUM
bam-9579	174	5	shows	show	VERB
bam-9579	174	6	the	the	DET
bam-9579	174	7	comparison	comparison	NOUN
bam-9579	174	8	of	of	ADP
bam-9579	174	9	laboratory	laboratory	NOUN
bam-9579	174	10	examination	examination	NOUN
bam-9579	174	11	items	item	NOUN
bam-9579	174	12	between	between	ADP
bam-9579	174	13	63	63	NUM
bam-9579	174	14	severe	severe	ADJ
bam-9579	174	15	/critically	/critically	ADV
bam-9579	174	16	ill	ill	ADJ
bam-9579	174	17	patients	patient	NOUN
bam-9579	174	18	and	and	CCONJ
bam-9579	174	19	176	176	NUM
bam-9579	174	20	ordinary	ordinary	ADJ
bam-9579	174	21	patients	patient	NOUN
bam-9579	174	22	.	.	PUNCT
bam-9579	175	1	in	in	ADP
bam-9579	175	2	blood	blood	NOUN
bam-9579	175	3	tests	test	NOUN
bam-9579	175	4	and	and	CCONJ
bam-9579	175	5	26	26	NUM
bam-9579	175	6	patients	patient	NOUN
bam-9579	175	7	(	(	PUNCT
bam-9579	175	8	11.0	11.0	NUM
bam-9579	175	9	%	%	NOUN
bam-9579	175	10	)	)	PUNCT
bam-9579	175	11	,	,	PUNCT
bam-9579	175	12	table	table	NOUN
bam-9579	175	13	3	3	NUM
bam-9579	175	14	.	.	PUNCT
bam-9579	175	15	comparison	comparison	NOUN
bam-9579	175	16	of	of	ADP
bam-9579	175	17	laboratory	laboratory	NOUN
bam-9579	175	18	tests	test	NOUN
bam-9579	175	19	in	in	ADP
bam-9579	175	20	patients	patient	NOUN
bam-9579	175	21	with	with	ADP
bam-9579	175	22	covid-19	covid-19	PROPN
bam-9579	175	23	on	on	ADP
bam-9579	175	24	admission	admission	NOUN
bam-9579	175	25	to	to	ADP
bam-9579	175	26	hospital	hospital	NOUN
bam-9579	175	27	item	item	NOUN
bam-9579	175	28	(	(	PUNCT
bam-9579	175	29	unit	unit	NOUN
bam-9579	175	30	,	,	PUNCT
bam-9579	175	31	normal	normal	ADJ
bam-9579	175	32	range	range	NOUN
bam-9579	175	33	)	)	PUNCT
bam-9579	175	34	overall	overall	ADV
bam-9579	175	35	(	(	PUNCT
bam-9579	175	36	n=207	n=207	NOUN
bam-9579	175	37	)	)	PUNCT
bam-9579	175	38	ordinary	ordinary	ADJ
bam-9579	175	39	group	group	NOUN
bam-9579	175	40	(	(	PUNCT
bam-9579	175	41	n=144	n=144	NUM
bam-9579	175	42	)	)	PUNCT
bam-9579	175	43	severe	severe	ADJ
bam-9579	175	44	/	/	SYM
bam-9579	175	45	critical	critical	ADJ
bam-9579	175	46	group	group	NOUN
bam-9579	175	47	(	(	PUNCT
bam-9579	175	48	n=63	n=63	NOUN
bam-9579	175	49	)	)	PUNCT
bam-9579	175	50	p	p	NOUN
bam-9579	175	51	value	value	NOUN
bam-9579	175	52	chest	chest	NOUN
bam-9579	176	1	ct	ct	NUM
bam-9579	176	2	abnormalities	abnormality	NOUN
bam-9579	176	3	any	any	DET
bam-9579	176	4	typical	typical	ADJ
bam-9579	176	5	abnormalities	abnormality	NOUN
bam-9579	176	6	191	191	NUM
bam-9579	176	7	(	(	PUNCT
bam-9579	176	8	92.3	92.3	NUM
bam-9579	176	9	%	%	NOUN
bam-9579	176	10	)	)	PUNCT
bam-9579	176	11	129	129	NUM
bam-9579	176	12	(	(	PUNCT
bam-9579	176	13	89.6	89.6	NUM
bam-9579	176	14	%	%	NOUN
bam-9579	176	15	)	)	PUNCT
bam-9579	176	16	62	62	NUM
bam-9579	176	17	(	(	PUNCT
bam-9579	176	18	98.4	98.4	NUM
bam-9579	176	19	%	%	NOUN
bam-9579	176	20	)	)	PUNCT
bam-9579	176	21	0.003	0.003	NUM
bam-9579	176	22	consolidation	consolidation	NOUN
bam-9579	176	23	41	41	NUM
bam-9579	176	24	(	(	PUNCT
bam-9579	176	25	19.8	19.8	NUM
bam-9579	176	26	%	%	NOUN
bam-9579	176	27	)	)	PUNCT
bam-9579	176	28	3	3	NUM
bam-9579	176	29	3(22.9	3(22.9	NUM
bam-9579	176	30	%	%	NOUN
bam-9579	176	31	)	)	PUNCT
bam-9579	176	32	8	8	NUM
bam-9579	176	33	(	(	PUNCT
bam-9579	176	34	12.9	12.9	NUM
bam-9579	176	35	%	%	NOUN
bam-9579	176	36	)	)	PUNCT
bam-9579	176	37	<	<	X
bam-9579	176	38	0.001	0.001	NUM
bam-9579	176	39	ground	ground	NOUN
bam-9579	176	40	-	-	PUNCT
bam-9579	176	41	glass	glass	NOUN
bam-9579	176	42	opacity	opacity	NOUN
bam-9579	176	43	89	89	NUM
bam-9579	176	44	(	(	PUNCT
bam-9579	176	45	43.0	43.0	NUM
bam-9579	176	46	%	%	NOUN
bam-9579	176	47	)	)	PUNCT
bam-9579	176	48	71	71	NUM
bam-9579	176	49	(	(	PUNCT
bam-9579	176	50	49.3	49.3	NUM
bam-9579	176	51	%	%	NOUN
bam-9579	176	52	)	)	PUNCT
bam-9579	176	53	18	18	NUM
bam-9579	176	54	(	(	PUNCT
bam-9579	176	55	29.0	29.0	NUM
bam-9579	176	56	%	%	NOUN
bam-9579	176	57	)	)	PUNCT
bam-9579	176	58	<	<	X
bam-9579	176	59	0.001	0.001	NUM
bam-9579	176	60	mixed	mixed	ADJ
bam-9579	176	61	ground	ground	NOUN
bam-9579	176	62	-	-	PUNCT
bam-9579	176	63	glass	glass	NOUN
bam-9579	176	64	opacity	opacity	NOUN
bam-9579	176	65	and	and	CCONJ
bam-9579	176	66	consolidation	consolidation	NOUN
bam-9579	176	67	38	38	NUM
bam-9579	176	68	(	(	PUNCT
bam-9579	176	69	18.4	18.4	NUM
bam-9579	176	70	%	%	NOUN
bam-9579	176	71	)	)	PUNCT
bam-9579	176	72	6	6	NUM
bam-9579	176	73	(	(	PUNCT
bam-9579	176	74	4.2	4.2	NUM
bam-9579	176	75	%	%	NOUN
bam-9579	176	76	)	)	PUNCT
bam-9579	176	77	32	32	NUM
bam-9579	176	78	(	(	PUNCT
bam-9579	176	79	51.6	51.6	NUM
bam-9579	176	80	%	%	NOUN
bam-9579	176	81	)	)	PUNCT
bam-9579	176	82	<	<	X
bam-9579	176	83	0.001	0.001	NUM
bam-9579	176	84	crazy	crazy	ADJ
bam-9579	176	85	-	-	PUNCT
bam-9579	176	86	paving	pave	VERB
bam-9579	176	87	pattern	pattern	NOUN
bam-9579	176	88	22	22	NUM
bam-9579	176	89	(	(	PUNCT
bam-9579	176	90	10.6	10.6	NUM
bam-9579	176	91	%	%	NOUN
bam-9579	176	92	)	)	PUNCT
bam-9579	176	93	20	20	NUM
bam-9579	176	94	(	(	PUNCT
bam-9579	176	95	13.9	13.9	NUM
bam-9579	176	96	%	%	NOUN
bam-9579	176	97	)	)	PUNCT
bam-9579	176	98	2	2	NUM
bam-9579	176	99	(	(	PUNCT
bam-9579	176	100	3.2	3.2	NUM
bam-9579	176	101	%	%	NOUN
bam-9579	176	102	)	)	PUNCT
bam-9579	176	103	<	<	X
bam-9579	176	104	0.001	0.001	NUM
bam-9579	176	105	air	air	NOUN
bam-9579	176	106	bronchogram	bronchogram	PROPN
bam-9579	176	107	29	29	NUM
bam-9579	176	108	(	(	PUNCT
bam-9579	176	109	14	14	NUM
bam-9579	176	110	%	%	NOUN
bam-9579	176	111	)	)	PUNCT
bam-9579	176	112	8	8	NUM
bam-9579	176	113	(	(	PUNCT
bam-9579	176	114	5.6	5.6	NUM
bam-9579	176	115	%	%	NOUN
bam-9579	176	116	)	)	PUNCT
bam-9579	176	117	21	21	NUM
bam-9579	176	118	(	(	PUNCT
bam-9579	176	119	33.9	33.9	NUM
bam-9579	176	120	%	%	NOUN
bam-9579	176	121	)	)	PUNCT
bam-9579	176	122	0.717	0.717	NUM
bam-9579	176	123	bilateral	bilateral	ADJ
bam-9579	176	124	involvement	involvement	NOUN
bam-9579	176	125	163	163	NUM
bam-9579	176	126	(	(	PUNCT
bam-9579	176	127	78.7	78.7	NUM
bam-9579	176	128	%	%	NOUN
bam-9579	176	129	)	)	PUNCT
bam-9579	176	130	101	101	NUM
bam-9579	176	131	(	(	PUNCT
bam-9579	176	132	70.1	70.1	NUM
bam-9579	176	133	%	%	NOUN
bam-9579	176	134	)	)	PUNCT
bam-9579	176	135	62	62	NUM
bam-9579	176	136	(	(	PUNCT
bam-9579	176	137	98.4	98.4	NUM
bam-9579	176	138	%	%	NOUN
bam-9579	176	139	)	)	PUNCT
bam-9579	176	140	<	<	X
bam-9579	176	141	0.001	0.001	NUM
bam-9579	176	142	peripheral	peripheral	ADJ
bam-9579	176	143	distribution	distribution	NOUN
bam-9579	176	144	125	125	NUM
bam-9579	176	145	(	(	PUNCT
bam-9579	176	146	60.4	60.4	NUM
bam-9579	176	147	%	%	NOUN
bam-9579	176	148	)	)	PUNCT
bam-9579	176	149	95	95	NUM
bam-9579	176	150	(	(	PUNCT
bam-9579	176	151	66.0	66.0	NUM
bam-9579	176	152	%	%	NOUN
bam-9579	176	153	)	)	PUNCT
bam-9579	176	154	30	30	NUM
bam-9579	176	155	(	(	PUNCT
bam-9579	176	156	48.4	48.4	NUM
bam-9579	176	157	%	%	NOUN
bam-9579	176	158	)	)	PUNCT
bam-9579	176	159	<	<	X
bam-9579	176	160	0.001	0.001	NUM
bam-9579	176	161	isolated	isolate	VERB
bam-9579	176	162	lower	low	ADJ
bam-9579	176	163	lobe	lobe	ADJ
bam-9579	176	164	involvement	involvement	NOUN
bam-9579	176	165	51	51	NUM
bam-9579	176	166	(	(	PUNCT
bam-9579	176	167	24.6	24.6	NUM
bam-9579	176	168	%	%	NOUN
bam-9579	176	169	)	)	PUNCT
bam-9579	176	170	40	40	NUM
bam-9579	176	171	(	(	PUNCT
bam-9579	176	172	27.8	27.8	NUM
bam-9579	176	173	%	%	NOUN
bam-9579	176	174	)	)	PUNCT
bam-9579	176	175	11	11	NUM
bam-9579	176	176	(	(	PUNCT
bam-9579	176	177	17.7	17.7	NUM
bam-9579	176	178	%	%	NOUN
bam-9579	176	179	)	)	PUNCT
bam-9579	176	180	<	<	X
bam-9579	176	181	0.001	0.001	NUM
bam-9579	176	182	chest	chest	NOUN
bam-9579	176	183	x	x	NOUN
bam-9579	176	184	-	-	NOUN
bam-9579	176	185	ray	ray	NOUN
bam-9579	176	186	abnormalities	abnormality	NOUN
bam-9579	176	187	overall	overall	ADV
bam-9579	176	188	(	(	PUNCT
bam-9579	176	189	n=88	n=88	ADJ
bam-9579	176	190	)	)	PUNCT
bam-9579	176	191	ordinary	ordinary	ADJ
bam-9579	176	192	group	group	NOUN
bam-9579	176	193	(	(	PUNCT
bam-9579	176	194	n=57	n=57	NOUN
bam-9579	176	195	)	)	PUNCT
bam-9579	176	196	severe	severe	ADJ
bam-9579	176	197	/	/	SYM
bam-9579	176	198	critical	critical	ADJ
bam-9579	176	199	group	group	NOUN
bam-9579	176	200	(	(	PUNCT
bam-9579	176	201	n=31	n=31	PROPN
bam-9579	176	202	)	)	PUNCT
bam-9579	176	203	,	,	PUNCT
bam-9579	176	204	p	p	NOUN
bam-9579	176	205	value	value	NOUN
bam-9579	176	206	any	any	DET
bam-9579	176	207	typical	typical	ADJ
bam-9579	176	208	abnormalities	abnormality	NOUN
bam-9579	176	209	81	81	NUM
bam-9579	176	210	(	(	PUNCT
bam-9579	176	211	92.0	92.0	NUM
bam-9579	176	212	%	%	NOUN
bam-9579	176	213	)	)	PUNCT
bam-9579	176	214	53	53	NUM
bam-9579	176	215	(	(	PUNCT
bam-9579	176	216	93.0	93.0	NUM
bam-9579	176	217	%	%	NOUN
bam-9579	176	218	)	)	PUNCT
bam-9579	176	219	28	28	NUM
bam-9579	176	220	(	(	PUNCT
bam-9579	176	221	90.3	90.3	NUM
bam-9579	176	222	%	%	NOUN
bam-9579	176	223	)	)	PUNCT
bam-9579	176	224	<	<	X
bam-9579	176	225	0.001	0.001	NUM
bam-9579	176	226	consolidation	consolidation	NOUN
bam-9579	176	227	13	13	NUM
bam-9579	176	228	(	(	PUNCT
bam-9579	176	229	14.8	14.8	NUM
bam-9579	176	230	%	%	NOUN
bam-9579	176	231	)	)	PUNCT
bam-9579	176	232	3	3	NUM
bam-9579	176	233	(	(	PUNCT
bam-9579	176	234	5.2	5.2	NUM
bam-9579	176	235	%	%	NOUN
bam-9579	176	236	)	)	PUNCT
bam-9579	176	237	10	10	NUM
bam-9579	176	238	(	(	PUNCT
bam-9579	176	239	32.3	32.3	NUM
bam-9579	176	240	%	%	NOUN
bam-9579	176	241	)	)	PUNCT
bam-9579	176	242	<	<	X
bam-9579	176	243	0.001	0.001	NUM
bam-9579	176	244	ground	ground	NOUN
bam-9579	176	245	-	-	PUNCT
bam-9579	176	246	glass	glass	NOUN
bam-9579	176	247	opacity	opacity	NOUN
bam-9579	176	248	21	21	NUM
bam-9579	176	249	(	(	PUNCT
bam-9579	176	250	23.9	23.9	NUM
bam-9579	176	251	%	%	NOUN
bam-9579	176	252	)	)	PUNCT
bam-9579	176	253	10	10	NUM
bam-9579	176	254	(	(	PUNCT
bam-9579	176	255	17.5	17.5	NUM
bam-9579	176	256	%	%	NOUN
bam-9579	176	257	)	)	PUNCT
bam-9579	176	258	11	11	NUM
bam-9579	176	259	(	(	PUNCT
bam-9579	176	260	35.5	35.5	NUM
bam-9579	176	261	%	%	NOUN
bam-9579	176	262	)	)	PUNCT
bam-9579	176	263	<	<	X
bam-9579	176	264	0.001	0.001	NUM
bam-9579	176	265	bilateral	bilateral	ADJ
bam-9579	176	266	involvement	involvement	NOUN
bam-9579	176	267	78	78	NUM
bam-9579	176	268	(	(	PUNCT
bam-9579	176	269	88.6	88.6	NUM
bam-9579	176	270	%	%	NOUN
bam-9579	176	271	)	)	PUNCT
bam-9579	176	272	54	54	NUM
bam-9579	176	273	(	(	PUNCT
bam-9579	176	274	94.7	94.7	NUM
bam-9579	176	275	%	%	NOUN
bam-9579	176	276	)	)	PUNCT
bam-9579	176	277	31	31	NUM
bam-9579	176	278	(	(	PUNCT
bam-9579	176	279	100	100	NUM
bam-9579	176	280	%	%	NOUN
bam-9579	176	281	)	)	PUNCT
bam-9579	176	282	0.561	0.561	NUM
bam-9579	176	283	peripheral	peripheral	ADJ
bam-9579	176	284	distribution	distribution	NOUN
bam-9579	176	285	7	7	NUM
bam-9579	176	286	(	(	PUNCT
bam-9579	176	287	8.0	8.0	NUM
bam-9579	176	288	%	%	NOUN
bam-9579	176	289	)	)	PUNCT
bam-9579	176	290	4	4	NUM
bam-9579	176	291	(	(	PUNCT
bam-9579	176	292	7.0	7.0	NUM
bam-9579	176	293	%	%	NOUN
bam-9579	176	294	)	)	PUNCT
bam-9579	176	295	3	3	NUM
bam-9579	176	296	(	(	PUNCT
bam-9579	176	297	9.7	9.7	NUM
bam-9579	176	298	%	%	NOUN
bam-9579	176	299	)	)	PUNCT
bam-9579	176	300	0.341	0.341	NUM
bam-9579	176	301	isolated	isolate	VERB
bam-9579	176	302	lower	low	ADJ
bam-9579	176	303	lobe	lobe	ADJ
bam-9579	176	304	involvement	involvement	NOUN
bam-9579	176	305	11	11	NUM
bam-9579	176	306	(	(	PUNCT
bam-9579	176	307	12.5	12.5	NUM
bam-9579	176	308	%	%	NOUN
bam-9579	176	309	)	)	PUNCT
bam-9579	176	310	5	5	NUM
bam-9579	176	311	(	(	PUNCT
bam-9579	176	312	8.8	8.8	NUM
bam-9579	176	313	%	%	NOUN
bam-9579	176	314	)	)	PUNCT
bam-9579	176	315	6	6	NUM
bam-9579	176	316	(	(	PUNCT
bam-9579	176	317	19.4	19.4	NUM
bam-9579	176	318	%	%	NOUN
bam-9579	176	319	)	)	PUNCT
bam-9579	176	320	<	<	X
bam-9579	176	321	0.001	0.001	NUM
bam-9579	176	322	ordinary	ordinary	ADJ
bam-9579	176	323	and	and	CCONJ
bam-9579	176	324	severe	severe	ADJ
bam-9579	176	325	cases	case	NOUN
bam-9579	176	326	of	of	ADP
bam-9579	176	327	covid-19	covid-19	PROPN
bam-9579	176	328	in	in	ADP
bam-9579	176	329	iran	iran	PROPN
bam-9579	176	330	eur	eur	PROPN
bam-9579	176	331	j	j	PROPN
bam-9579	176	332	transl	transl	PROPN
bam-9579	176	333	myol	myol	ADV
bam-9579	176	334	31	31	NUM
bam-9579	176	335	(	(	PUNCT
bam-9579	176	336	3	3	NUM
bam-9579	176	337	):	):	PUNCT
bam-9579	176	338	9579	9579	NUM
bam-9579	176	339	,	,	PUNCT
bam-9579	176	340	2021	2021	NUM
bam-9579	176	341	doi	doi	NOUN
bam-9579	176	342	:	:	PUNCT
bam-9579	176	343	10.4081	10.4081	NUM
bam-9579	176	344	/	/	SYM
bam-9579	176	345	ejtm.2021.9579	ejtm.2021.9579	NUM
bam-9579	176	346	5	5	NUM
bam-9579	176	347	86	86	NUM
bam-9579	176	348	patients	patient	NOUN
bam-9579	176	349	(	(	PUNCT
bam-9579	176	350	36.4	36.4	NUM
bam-9579	176	351	%	%	NOUN
bam-9579	176	352	)	)	PUNCT
bam-9579	176	353	,	,	PUNCT
bam-9579	176	354	41	41	NUM
bam-9579	176	355	patients	patient	NOUN
bam-9579	176	356	(	(	PUNCT
bam-9579	176	357	17.4	17.4	NUM
bam-9579	176	358	%	%	NOUN
bam-9579	176	359	)	)	PUNCT
bam-9579	176	360	,	,	PUNCT
bam-9579	176	361	and	and	CCONJ
bam-9579	176	362	184	184	NUM
bam-9579	176	363	patients	patient	NOUN
bam-9579	176	364	(	(	PUNCT
bam-9579	176	365	77.9	77.9	NUM
bam-9579	176	366	%	%	NOUN
bam-9579	176	367	)	)	PUNCT
bam-9579	176	368	had	have	AUX
bam-9579	176	369	elevated	elevate	VERB
bam-9579	176	370	white	white	ADJ
bam-9579	176	371	blood	blood	NOUN
bam-9579	176	372	cell	cell	NOUN
bam-9579	176	373	counts	count	NOUN
bam-9579	176	374	,	,	PUNCT
bam-9579	176	375	neu%	neu%	PROPN
bam-9579	176	376	,	,	PUNCT
bam-9579	176	377	neu	neu	NOUN
bam-9579	176	378	absolute	absolute	ADJ
bam-9579	176	379	value	value	NOUN
bam-9579	176	380	,	,	PUNCT
bam-9579	176	381	and	and	CCONJ
bam-9579	176	382	crp	crp	PROPN
bam-9579	176	383	,	,	PUNCT
bam-9579	176	384	respectively	respectively	ADV
bam-9579	176	385	in	in	ADP
bam-9579	176	386	ordinary	ordinary	ADJ
bam-9579	176	387	and	and	CCONJ
bam-9579	176	388	severe	severe	ADJ
bam-9579	176	389	/	/	SYM
bam-9579	176	390	critically	critically	ADV
bam-9579	176	391	ill	ill	ADJ
bam-9579	176	392	patients	patient	NOUN
bam-9579	176	393	.	.	PUNCT
bam-9579	177	1	in	in	ADP
bam-9579	177	2	addition	addition	NOUN
bam-9579	177	3	,	,	PUNCT
bam-9579	177	4	we	we	PRON
bam-9579	177	5	observed	observe	VERB
bam-9579	177	6	that	that	SCONJ
bam-9579	177	7	44	44	NUM
bam-9579	177	8	patients	patient	NOUN
bam-9579	177	9	(	(	PUNCT
bam-9579	177	10	18.6	18.6	NUM
bam-9579	177	11	%	%	NOUN
bam-9579	177	12	)	)	PUNCT
bam-9579	177	13	,	,	PUNCT
bam-9579	177	14	117	117	NUM
bam-9579	177	15	patients	patient	NOUN
bam-9579	177	16	(	(	PUNCT
bam-9579	177	17	49.6	49.6	NUM
bam-9579	177	18	%	%	NOUN
bam-9579	177	19	)	)	PUNCT
bam-9579	177	20	,	,	PUNCT
bam-9579	177	21	and	and	CCONJ
bam-9579	177	22	45	45	NUM
bam-9579	177	23	patients	patient	NOUN
bam-9579	177	24	(	(	PUNCT
bam-9579	177	25	19.1	19.1	NUM
bam-9579	177	26	%	%	NOUN
bam-9579	177	27	)	)	PUNCT
bam-9579	177	28	were	be	AUX
bam-9579	177	29	accompanied	accompany	VERB
bam-9579	177	30	by	by	ADP
bam-9579	177	31	a	a	DET
bam-9579	177	32	decrease	decrease	NOUN
bam-9579	177	33	in	in	ADP
bam-9579	177	34	the	the	DET
bam-9579	177	35	total	total	ADJ
bam-9579	177	36	number	number	NOUN
bam-9579	177	37	of	of	ADP
bam-9579	177	38	white	white	ADJ
bam-9579	177	39	blood	blood	NOUN
bam-9579	177	40	cells	cell	NOUN
bam-9579	177	41	,	,	PUNCT
bam-9579	177	42	the	the	DET
bam-9579	177	43	absolute	absolute	ADJ
bam-9579	177	44	value	value	NOUN
bam-9579	177	45	of	of	ADP
bam-9579	177	46	lym	lym	PROPN
bam-9579	177	47	,	,	PUNCT
bam-9579	177	48	and	and	CCONJ
bam-9579	177	49	platelets	platelet	NOUN
bam-9579	177	50	(	(	PUNCT
bam-9579	177	51	plt	plt	NOUN
bam-9579	177	52	)	)	PUNCT
bam-9579	177	53	,	,	PUNCT
bam-9579	177	54	respectively	respectively	ADV
bam-9579	177	55	in	in	ADP
bam-9579	177	56	both	both	DET
bam-9579	177	57	groups	group	NOUN
bam-9579	177	58	.	.	PUNCT
bam-9579	178	1	also	also	ADV
bam-9579	178	2	,	,	PUNCT
bam-9579	178	3	96	96	NUM
bam-9579	178	4	patients	patient	NOUN
bam-9579	178	5	(	(	PUNCT
bam-9579	178	6	40.7	40.7	NUM
bam-9579	178	7	%	%	NOUN
bam-9579	178	8	)	)	PUNCT
bam-9579	178	9	,	,	PUNCT
bam-9579	178	10	72	72	NUM
bam-9579	178	11	patients	patient	NOUN
bam-9579	178	12	(	(	PUNCT
bam-9579	178	13	30.5	30.5	NUM
bam-9579	178	14	%	%	NOUN
bam-9579	178	15	)	)	PUNCT
bam-9579	178	16	,	,	PUNCT
bam-9579	178	17	and	and	CCONJ
bam-9579	178	18	9	9	NUM
bam-9579	178	19	patients	patient	NOUN
bam-9579	178	20	(	(	PUNCT
bam-9579	178	21	3.8	3.8	NUM
bam-9579	178	22	%	%	NOUN
bam-9579	178	23	)	)	PUNCT
bam-9579	178	24	had	have	AUX
bam-9579	178	25	increased	increase	VERB
bam-9579	178	26	or	or	CCONJ
bam-9579	178	27	prolonged	prolonged	ADJ
bam-9579	178	28	pt	pt	PROPN
bam-9579	178	29	,	,	PUNCT
bam-9579	178	30	aptt	aptt	ADJ
bam-9579	178	31	,	,	PUNCT
bam-9579	178	32	and	and	CCONJ
bam-9579	178	33	d	d	X
bam-9579	178	34	-	-	PUNCT
bam-9579	178	35	dimer	dimer	ADJ
bam-9579	178	36	,	,	PUNCT
bam-9579	178	37	respectively	respectively	ADV
bam-9579	178	38	in	in	ADP
bam-9579	178	39	both	both	DET
bam-9579	178	40	groups	group	NOUN
bam-9579	178	41	;	;	PUNCT
bam-9579	178	42	28	28	NUM
bam-9579	178	43	cases	case	NOUN
bam-9579	178	44	(	(	PUNCT
bam-9579	178	45	11.9	11.9	NUM
bam-9579	178	46	%	%	NOUN
bam-9579	178	47	)	)	PUNCT
bam-9579	178	48	,	,	PUNCT
bam-9579	178	49	14	14	NUM
bam-9579	178	50	cases	case	NOUN
bam-9579	178	51	(	(	PUNCT
bam-9579	178	52	5.9	5.9	NUM
bam-9579	178	53	%	%	NOUN
bam-9579	178	54	)	)	PUNCT
bam-9579	178	55	,	,	PUNCT
bam-9579	178	56	and	and	CCONJ
bam-9579	178	57	117	117	NUM
bam-9579	178	58	cases	case	NOUN
bam-9579	178	59	(	(	PUNCT
bam-9579	178	60	49.6	49.6	NUM
bam-9579	178	61	%	%	NOUN
bam-9579	178	62	)	)	PUNCT
bam-9579	178	63	were	be	AUX
bam-9579	178	64	accompanied	accompany	VERB
bam-9579	178	65	by	by	ADP
bam-9579	178	66	increased	increase	VERB
bam-9579	178	67	ck	ck	PROPN
bam-9579	178	68	,	,	PUNCT
bam-9579	178	69	ck	ck	NOUN
bam-9579	178	70	-	-	PUNCT
bam-9579	178	71	mb	mb	NOUN
bam-9579	178	72	,	,	PUNCT
bam-9579	178	73	and	and	CCONJ
bam-9579	178	74	ldh	ldh	PROPN
bam-9579	178	75	.	.	PROPN
bam-9579	179	1	in	in	ADP
bam-9579	179	2	the	the	DET
bam-9579	179	3	biochemical	biochemical	ADJ
bam-9579	179	4	examination	examination	NOUN
bam-9579	179	5	,	,	PUNCT
bam-9579	179	6	36	36	NUM
bam-9579	179	7	patients	patient	NOUN
bam-9579	179	8	(	(	PUNCT
bam-9579	179	9	15.2	15.2	NUM
bam-9579	179	10	%	%	NOUN
bam-9579	179	11	)	)	PUNCT
bam-9579	179	12	,	,	PUNCT
bam-9579	179	13	27	27	NUM
bam-9579	179	14	patients	patient	NOUN
bam-9579	179	15	(	(	PUNCT
bam-9579	179	16	11.4	11.4	NUM
bam-9579	179	17	%	%	NOUN
bam-9579	179	18	)	)	PUNCT
bam-9579	179	19	,	,	PUNCT
bam-9579	179	20	60	60	NUM
bam-9579	179	21	patients	patient	NOUN
bam-9579	179	22	(	(	PUNCT
bam-9579	179	23	25.5	25.5	NUM
bam-9579	179	24	%	%	NOUN
bam-9579	179	25	)	)	PUNCT
bam-9579	179	26	,	,	PUNCT
bam-9579	179	27	12	12	NUM
bam-9579	179	28	patients	patient	NOUN
bam-9579	179	29	(	(	PUNCT
bam-9579	179	30	5.1	5.1	NUM
bam-9579	179	31	%	%	NOUN
bam-9579	179	32	)	)	PUNCT
bam-9579	179	33	,	,	PUNCT
bam-9579	179	34	9	9	NUM
bam-9579	179	35	patients	patient	NOUN
bam-9579	179	36	(	(	PUNCT
bam-9579	179	37	3.8	3.8	NUM
bam-9579	179	38	%	%	NOUN
bam-9579	179	39	)	)	PUNCT
bam-9579	179	40	developed	develop	VERB
bam-9579	179	41	alt	alt	ADJ
bam-9579	179	42	,	,	PUNCT
bam-9579	179	43	ast	ast	INTJ
bam-9579	179	44	,	,	PUNCT
bam-9579	179	45	tb	tb	NOUN
bam-9579	179	46	,	,	PUNCT
bam-9579	179	47	cr	cr	PROPN
bam-9579	179	48	,	,	PUNCT
bam-9579	179	49	bun	bun	PROPN
bam-9579	179	50	increased	increase	VERB
bam-9579	179	51	and	and	CCONJ
bam-9579	179	52	alb	alb	VERB
bam-9579	179	53	decreased	decrease	VERB
bam-9579	179	54	in	in	ADP
bam-9579	179	55	93	93	NUM
bam-9579	179	56	cases	case	NOUN
bam-9579	179	57	(	(	PUNCT
bam-9579	179	58	39.3	39.3	NUM
bam-9579	179	59	%	%	NOUN
bam-9579	179	60	)	)	PUNCT
bam-9579	179	61	.	.	PUNCT
bam-9579	180	1	during	during	ADP
bam-9579	180	2	routine	routine	ADJ
bam-9579	180	3	blood	blood	NOUN
bam-9579	180	4	tests	test	NOUN
bam-9579	180	5	,	,	PUNCT
bam-9579	180	6	the	the	DET
bam-9579	180	7	total	total	ADJ
bam-9579	180	8	number	number	NOUN
bam-9579	180	9	of	of	ADP
bam-9579	180	10	white	white	ADJ
bam-9579	180	11	blood	blood	NOUN
bam-9579	180	12	cells	cell	NOUN
bam-9579	180	13	in	in	ADP
bam-9579	180	14	the	the	DET
bam-9579	180	15	ordinary	ordinary	ADJ
bam-9579	180	16	group	group	NOUN
bam-9579	180	17	[	[	X
bam-9579	180	18	4.9	4.9	NUM
bam-9579	180	19	(	(	PUNCT
bam-9579	180	20	4.0~5.9	4.0~5.9	NOUN
bam-9579	180	21	)	)	PUNCT
bam-9579	180	22	×	×	NOUN
bam-9579	180	23	10	10	NUM
bam-9579	180	24	9	9	NUM
bam-9579	180	25	l	l	NOUN
bam-9579	180	26	1	1	NUM
bam-9579	180	27	vs	vs	ADP
bam-9579	180	28	6.5	6.5	NUM
bam-9579	180	29	(	(	PUNCT
bam-9579	180	30	5.1	5.1	NUM
bam-9579	180	31	~	~	SYM
bam-9579	180	32	11.5	11.5	NUM
bam-9579	180	33	)	)	PUNCT
bam-9579	180	34	×	×	NOUN
bam-9579	180	35	10	10	NUM
bam-9579	180	36	9	9	NUM
bam-9579	180	37	l	l	NOUN
bam-9579	180	38	-1	-1	NOUN
bam-9579	180	39	,	,	PUNCT
bam-9579	180	40	p	p	X
bam-9579	180	41	=	=	NOUN
bam-9579	180	42	0.003	0.003	NUM
bam-9579	180	43	]	]	PUNCT
bam-9579	180	44	,	,	PUNCT
bam-9579	180	45	neu%	neu%	PROPN
bam-9579	180	46	[	[	X
bam-9579	180	47	61.6	61.6	NUM
bam-9579	180	48	%	%	NOUN
bam-9579	180	49	(	(	PUNCT
bam-9579	180	50	51.8~72.4	51.8~72.4	NUM
bam-9579	180	51	)	)	PUNCT
bam-9579	180	52	vs	vs	ADP
bam-9579	180	53	84.2%(75.1~91.2	84.2%(75.1~91.2	NUM
bam-9579	180	54	)	)	PUNCT
bam-9579	180	55	,	,	PUNCT
bam-9579	180	56	p	p	X
bam-9579	180	57	<	<	X
bam-9579	180	58	0.001	0.001	NUM
bam-9579	180	59	]	]	PUNCT
bam-9579	180	60	and	and	CCONJ
bam-9579	180	61	absolute	absolute	ADJ
bam-9579	180	62	value	value	NOUN
bam-9579	180	63	[	[	X
bam-9579	180	64	2.8	2.8	NUM
bam-9579	180	65	(	(	PUNCT
bam-9579	180	66	2.0~4.0)×10	2.0~4.0)×10	NUM
bam-9579	180	67	9	9	NUM
bam-9579	180	68	l	l	NOUN
bam-9579	180	69	-1	-1	NOUN
bam-9579	180	70	vs	vs	ADP
bam-9579	180	71	5.5(3.8~10.8)×10	5.5(3.8~10.8)×10	NOUN
bam-9579	180	72	9	9	NUM
bam-9579	180	73	l	l	NOUN
bam-9579	180	74	-1	-1	NOUN
bam-9579	180	75	,	,	PUNCT
bam-9579	180	76	p	p	X
bam-9579	180	77	<	<	X
bam-9579	180	78	0.001	0.001	NUM
bam-9579	180	79	]	]	PUNCT
bam-9579	180	80	significantly	significantly	ADV
bam-9579	180	81	lower	low	ADJ
bam-9579	180	82	than	than	ADP
bam-9579	180	83	the	the	DET
bam-9579	180	84	heavy	heavy	ADJ
bam-9579	180	85	and	and	CCONJ
bam-9579	180	86	critical	critical	ADJ
bam-9579	180	87	groups	group	NOUN
bam-9579	180	88	;	;	PUNCT
bam-9579	180	89	the	the	DET
bam-9579	180	90	percentage	percentage	NOUN
bam-9579	180	91	of	of	ADP
bam-9579	180	92	lym	lym	PROPN
bam-9579	180	93	in	in	ADP
bam-9579	180	94	the	the	DET
bam-9579	180	95	heavy	heavy	ADJ
bam-9579	180	96	and	and	CCONJ
bam-9579	180	97	critical	critical	ADJ
bam-9579	180	98	groups	group	NOUN
bam-9579	180	99	[	[	X
bam-9579	180	100	9.9	9.9	NUM
bam-9579	180	101	%	%	NOUN
bam-9579	180	102	(	(	PUNCT
bam-9579	180	103	6.4~19.3	6.4~19.3	NOUN
bam-9579	180	104	)	)	PUNCT
bam-9579	180	105	vs	vs	ADP
bam-9579	180	106	28	28	NUM
bam-9579	180	107	%	%	NOUN
bam-9579	180	108	(	(	PUNCT
bam-9579	180	109	20.4~37.4	20.4~37.4	NUM
bam-9579	180	110	)	)	PUNCT
bam-9579	180	111	,	,	PUNCT
bam-9579	180	112	p	p	X
bam-9579	180	113	<	<	X
bam-9579	180	114	0.001	0.001	NUM
bam-9579	180	115	]	]	PUNCT
bam-9579	180	116	and	and	CCONJ
bam-9579	180	117	the	the	DET
bam-9579	180	118	absolute	absolute	ADJ
bam-9579	180	119	value	value	NOUN
bam-9579	180	120	[	[	X
bam-9579	180	121	0.7(0.4~1.1	0.7(0.4~1.1	NOUN
bam-9579	180	122	)	)	PUNCT
bam-9579	180	123	×10	×10	NOUN
bam-9579	180	124	9	9	NUM
bam-9579	180	125	l	l	NOUN
bam-9579	180	126	-1	-1	NOUN
bam-9579	180	127	vs	vs	ADP
bam-9579	180	128	1.3	1.3	NUM
bam-9579	180	129	(	(	PUNCT
bam-9579	180	130	0.9~1.7)×10	0.9~1.7)×10	NUM
bam-9579	180	131	9	9	NUM
bam-9579	180	132	l	l	NOUN
bam-9579	180	133	-1	-1	NOUN
bam-9579	180	134	,	,	PUNCT
bam-9579	180	135	p	p	X
bam-9579	180	136	<	<	X
bam-9579	180	137	0.001	0.001	NUM
bam-9579	180	138	]	]	PUNCT
bam-9579	180	139	significantly	significantly	ADV
bam-9579	180	140	lower	low	ADJ
bam-9579	180	141	than	than	ADP
bam-9579	180	142	the	the	DET
bam-9579	180	143	normal	normal	ADJ
bam-9579	180	144	group	group	NOUN
bam-9579	180	145	.	.	PUNCT
bam-9579	181	1	crp	crp	PROPN
bam-9579	182	1	[	[	X
bam-9579	182	2	36.9(19.3~96.1)mg·l	36.9(19.3~96.1)mg·l	NUM
bam-9579	182	3	-1	-1	NOUN
bam-9579	182	4	vs	vs	ADP
bam-9579	182	5	5.6(0.8~21.4)mg·l	5.6(0.8~21.4)mg·l	NUM
bam-9579	182	6	-1	-1	NOUN
bam-9579	182	7	,	,	PUNCT
bam-9579	182	8	p	p	X
bam-9579	182	9	<	<	X
bam-9579	182	10	0.001	0.001	NUM
bam-9579	182	11	]	]	PUNCT
bam-9579	182	12	,	,	PUNCT
bam-9579	182	13	d	d	X
bam-9579	182	14	dimer	dimer	NOUN
bam-9579	183	1	[	[	X
bam-9579	183	2	0.45(0.22~0.64	0.45(0.22~0.64	X
bam-9579	183	3	)	)	PUNCT
bam-9579	183	4	μg·ml	μg·ml	NUM
bam-9579	183	5	-1	-1	NOUN
bam-9579	183	6	vs	vs	ADP
bam-9579	183	7	0.19(0.09~0.26	0.19(0.09~0.26	PROPN
bam-9579	183	8	)	)	PUNCT
bam-9579	183	9	μg·ml	μg·ml	NUM
bam-9579	184	1	-1	-1	NOUN
bam-9579	184	2	,	,	PUNCT
bam-9579	184	3	p	p	X
bam-9579	184	4	<	<	X
bam-9579	184	5	0.001	0.001	NUM
bam-9579	184	6	]	]	PUNCT
bam-9579	184	7	,	,	PUNCT
bam-9579	184	8	and	and	CCONJ
bam-9579	184	9	ldh	ldh	VERB
bam-9579	184	10	[	[	X
bam-9579	184	11	295(265~374	295(265~374	NUM
bam-9579	184	12	)	)	PUNCT
bam-9579	184	13	u·l	u·l	NOUN
bam-9579	185	1	-1	-1	ADP
bam-9579	185	2	vs	vs	ADP
bam-9579	185	3	202(169~270	202(169~270	PROPN
bam-9579	185	4	)	)	PUNCT
bam-9579	185	5	u·l	u·l	NOUN
bam-9579	186	1	-1	-1	NOUN
bam-9579	186	2	,	,	PUNCT
bam-9579	186	3	p	p	X
bam-9579	186	4	<	<	X
bam-9579	186	5	0.001	0.001	NUM
bam-9579	186	6	]	]	PUNCT
bam-9579	186	7	,	,	PUNCT
bam-9579	186	8	p	p	NOUN
bam-9579	186	9	=	=	NOUN
bam-9579	186	10	0.001	0.001	NUM
bam-9579	186	11	]	]	PUNCT
bam-9579	186	12	detection	detection	NOUN
bam-9579	186	13	value	value	NOUN
bam-9579	186	14	was	be	AUX
bam-9579	186	15	significantly	significantly	ADV
bam-9579	186	16	higher	high	ADJ
bam-9579	186	17	than	than	ADP
bam-9579	186	18	that	that	PRON
bam-9579	186	19	of	of	ADP
bam-9579	186	20	normal	normal	ADJ
bam-9579	186	21	group	group	NOUN
bam-9579	186	22	patients	patient	NOUN
bam-9579	186	23	.	.	PUNCT
bam-9579	187	1	the	the	DET
bam-9579	187	2	alb	alb	PROPN
bam-9579	187	3	detection	detection	NOUN
bam-9579	187	4	value	value	NOUN
bam-9579	187	5	of	of	ADP
bam-9579	187	6	the	the	DET
bam-9579	187	7	heavy	heavy	ADJ
bam-9579	187	8	and	and	CCONJ
bam-9579	187	9	critical	critical	ADJ
bam-9579	187	10	groups	group	NOUN
bam-9579	187	11	was	be	AUX
bam-9579	187	12	significantly	significantly	ADV
bam-9579	187	13	lower	low	ADJ
bam-9579	187	14	than	than	ADP
bam-9579	187	15	that	that	PRON
bam-9579	187	16	of	of	ADP
bam-9579	187	17	the	the	DET
bam-9579	187	18	normal	normal	ADJ
bam-9579	187	19	group	group	NOUN
bam-9579	187	20	[	[	X
bam-9579	187	21	36.3(33.0~39.1	36.3(33.0~39.1	NUM
bam-9579	187	22	)	)	PUNCT
bam-9579	187	23	g·l	g·l	NOUN
bam-9579	187	24	-1	-1	ADP
bam-9579	187	25	vs	vs	ADP
bam-9579	187	26	44.3(41.2~47.7	44.3(41.2~47.7	NUM
bam-9579	187	27	)	)	PUNCT
bam-9579	187	28	g·l	g·l	NOUN
bam-9579	187	29	-1	-1	ADP
bam-9579	187	30	,	,	PUNCT
bam-9579	187	31	p	p	X
bam-9579	187	32	<	<	X
bam-9579	187	33	0.001	0.001	NUM
bam-9579	187	34	]	]	PUNCT
bam-9579	187	35	.	.	PUNCT
bam-9579	188	1	there	there	PRON
bam-9579	188	2	was	be	VERB
bam-9579	188	3	no	no	DET
bam-9579	188	4	significant	significant	ADJ
bam-9579	188	5	difference	difference	NOUN
bam-9579	188	6	in	in	ADP
bam-9579	188	7	cr	cr	NOUN
bam-9579	188	8	detection	detection	NOUN
bam-9579	188	9	value	value	NOUN
bam-9579	188	10	between	between	ADP
bam-9579	188	11	the	the	DET
bam-9579	188	12	two	two	NUM
bam-9579	188	13	groups	group	NOUN
bam-9579	188	14	(	(	PUNCT
bam-9579	188	15	p	p	X
bam-9579	188	16	=	=	NOUN
bam-9579	188	17	0.819	0.819	NUM
bam-9579	188	18	)	)	PUNCT
bam-9579	188	19	;	;	PUNCT
bam-9579	188	20	bun	bun	PROPN
bam-9579	188	21	increased	increase	VERB
bam-9579	188	22	more	more	ADV
bam-9579	188	23	significantly	significantly	ADV
bam-9579	188	24	in	in	ADP
bam-9579	188	25	severe	severe	ADJ
bam-9579	188	26	and	and	CCONJ
bam-9579	188	27	critically	critically	ADV
bam-9579	188	28	ill	ill	ADJ
bam-9579	188	29	patients	patient	NOUN
bam-9579	188	30	[	[	X
bam-9579	188	31	5.4	5.4	NUM
bam-9579	188	32	(	(	PUNCT
bam-9579	188	33	4.3	4.3	NUM
bam-9579	188	34	~	~	SYM
bam-9579	188	35	6.0	6.0	NUM
bam-9579	188	36	)	)	PUNCT
bam-9579	188	37	mmol	mmol	NOUN
bam-9579	188	38	l	l	NOUN
bam-9579	188	39	-1	-1	NOUN
bam-9579	188	40	vs	vs	ADP
bam-9579	188	41	3.6	3.6	NUM
bam-9579	188	42	(	(	PUNCT
bam-9579	188	43	3.0	3.0	NUM
bam-9579	188	44	~	~	SYM
bam-9579	188	45	4.5	4.5	NUM
bam-9579	188	46	)	)	PUNCT
bam-9579	188	47	mmol	mmol	NOUN
bam-9579	188	48	l	l	NOUN
bam-9579	188	49	-1	-1	NOUN
bam-9579	188	50	]	]	PUNCT
bam-9579	189	1	(	(	PUNCT
bam-9579	189	2	p	p	X
bam-9579	189	3	<	<	X
bam-9579	189	4	0.001	0.001	NUM
bam-9579	189	5	)	)	PUNCT
bam-9579	189	6	,	,	PUNCT
bam-9579	189	7	but	but	CCONJ
bam-9579	189	8	the	the	DET
bam-9579	189	9	mean	mean	NOUN
bam-9579	189	10	is	be	AUX
bam-9579	189	11	still	still	ADV
bam-9579	189	12	within	within	ADP
bam-9579	189	13	normal	normal	ADJ
bam-9579	189	14	range	range	NOUN
bam-9579	189	15	.	.	PUNCT
bam-9579	190	1	comparison	comparison	NOUN
bam-9579	190	2	of	of	ADP
bam-9579	190	3	lung	lung	NOUN
bam-9579	190	4	ct	ct	PROPN
bam-9579	190	5	changes	change	NOUN
bam-9579	190	6	among	among	ADP
bam-9579	190	7	236	236	NUM
bam-9579	190	8	patients	patient	NOUN
bam-9579	190	9	.	.	PUNCT
bam-9579	191	1	207	207	NUM
bam-9579	191	2	patients	patient	NOUN
bam-9579	191	3	were	be	AUX
bam-9579	191	4	undergoing	undergo	VERB
bam-9579	191	5	lung	lung	NOUN
bam-9579	191	6	ct	ct	PROPN
bam-9579	191	7	examination	examination	NOUN
bam-9579	191	8	and	and	CCONJ
bam-9579	191	9	88	88	NUM
bam-9579	191	10	patients	patient	NOUN
bam-9579	191	11	were	be	AUX
bam-9579	191	12	undergoing	undergo	VERB
bam-9579	191	13	chest	chest	NOUN
bam-9579	191	14	x	x	NOUN
bam-9579	191	15	-	-	NOUN
bam-9579	191	16	ray	ray	NOUN
bam-9579	191	17	upon	upon	SCONJ
bam-9579	191	18	admission	admission	NOUN
bam-9579	191	19	.	.	PUNCT
bam-9579	192	1	207	207	NUM
bam-9579	192	2	patients	patient	NOUN
bam-9579	192	3	had	have	VERB
bam-9579	192	4	lung	lung	NOUN
bam-9579	192	5	ct	ct	PROPN
bam-9579	192	6	imaging	imaging	NOUN
bam-9579	192	7	on	on	ADP
bam-9579	192	8	admission	admission	NOUN
bam-9579	192	9	,	,	PUNCT
bam-9579	192	10	including	include	VERB
bam-9579	192	11	patients	patient	NOUN
bam-9579	192	12	144	144	NUM
bam-9579	192	13	(	(	PUNCT
bam-9579	192	14	81.8	81.8	NUM
bam-9579	192	15	%	%	NOUN
bam-9579	192	16	)	)	PUNCT
bam-9579	192	17	in	in	ADP
bam-9579	192	18	ordinary	ordinary	ADJ
bam-9579	192	19	patients	patient	NOUN
bam-9579	192	20	and	and	CCONJ
bam-9579	192	21	63	63	NUM
bam-9579	192	22	patients	patient	NOUN
bam-9579	192	23	(	(	PUNCT
bam-9579	192	24	100	100	NUM
bam-9579	192	25	%	%	NOUN
bam-9579	192	26	)	)	PUNCT
bam-9579	192	27	in	in	ADP
bam-9579	192	28	severe	severe	ADJ
bam-9579	192	29	patients	patient	NOUN
bam-9579	192	30	with	with	ADP
bam-9579	192	31	ct	ct	NUM
bam-9579	192	32	imaging	imaging	NOUN
bam-9579	192	33	changes	change	NOUN
bam-9579	192	34	in	in	ADP
bam-9579	192	35	the	the	DET
bam-9579	192	36	lungs	lung	NOUN
bam-9579	192	37	.	.	PUNCT
bam-9579	193	1	in	in	ADP
bam-9579	193	2	addition	addition	NOUN
bam-9579	193	3	,	,	PUNCT
bam-9579	193	4	among	among	ADP
bam-9579	193	5	88	88	NUM
bam-9579	193	6	patients	patient	NOUN
bam-9579	193	7	with	with	ADP
bam-9579	193	8	chest	chest	NOUN
bam-9579	193	9	x	x	NOUN
bam-9579	193	10	-	-	NOUN
bam-9579	193	11	ray	ray	NOUN
bam-9579	193	12	evaluation	evaluation	NOUN
bam-9579	193	13	,	,	PUNCT
bam-9579	193	14	57	57	NUM
bam-9579	193	15	patients	patient	NOUN
bam-9579	193	16	(	(	PUNCT
bam-9579	193	17	32.3	32.3	NUM
bam-9579	193	18	%	%	NOUN
bam-9579	193	19	)	)	PUNCT
bam-9579	193	20	was	be	AUX
bam-9579	193	21	placed	place	VERB
bam-9579	193	22	into	into	ADP
bam-9579	193	23	ordinary	ordinary	ADJ
bam-9579	193	24	group	group	NOUN
bam-9579	193	25	and	and	CCONJ
bam-9579	193	26	31	31	NUM
bam-9579	193	27	patients	patient	NOUN
bam-9579	193	28	(	(	PUNCT
bam-9579	193	29	49.2	49.2	NUM
bam-9579	193	30	%	%	NOUN
bam-9579	193	31	)	)	PUNCT
bam-9579	193	32	were	be	AUX
bam-9579	193	33	severe	severe	ADJ
bam-9579	193	34	/	/	SYM
bam-9579	193	35	critically	critically	ADV
bam-9579	193	36	ill	ill	ADJ
bam-9579	193	37	patients	patient	NOUN
bam-9579	193	38	.	.	PUNCT
bam-9579	194	1	table	table	NOUN
bam-9579	194	2	3	3	NUM
bam-9579	194	3	shows	show	VERB
bam-9579	194	4	the	the	DET
bam-9579	194	5	detailed	detailed	ADJ
bam-9579	194	6	findings	finding	NOUN
bam-9579	194	7	of	of	ADP
bam-9579	194	8	chest	chest	NOUN
bam-9579	194	9	x	x	NOUN
bam-9579	194	10	-	-	NOUN
bam-9579	194	11	ray	ray	NOUN
bam-9579	194	12	and	and	CCONJ
bam-9579	194	13	chest	chest	NOUN
bam-9579	194	14	ct	ct	NUM
bam-9579	194	15	examination	examination	NOUN
bam-9579	194	16	in	in	ADP
bam-9579	194	17	ordinary	ordinary	ADJ
bam-9579	194	18	and	and	CCONJ
bam-9579	194	19	severe	severe	ADJ
bam-9579	194	20	/	/	SYM
bam-9579	194	21	critically	critically	ADV
bam-9579	194	22	ill	ill	ADJ
bam-9579	194	23	patients	patient	NOUN
bam-9579	194	24	.	.	PUNCT
bam-9579	195	1	there	there	PRON
bam-9579	195	2	was	be	VERB
bam-9579	195	3	no	no	DET
bam-9579	195	4	statistically	statistically	ADV
bam-9579	195	5	significant	significant	ADJ
bam-9579	195	6	difference	difference	NOUN
bam-9579	195	7	between	between	ADP
bam-9579	195	8	the	the	DET
bam-9579	195	9	groups	group	NOUN
bam-9579	195	10	.	.	PUNCT
bam-9579	196	1	the	the	DET
bam-9579	196	2	lung	lung	NOUN
bam-9579	196	3	ct	ct	NUM
bam-9579	196	4	signs	sign	NOUN
bam-9579	196	5	of	of	ADP
bam-9579	196	6	the	the	DET
bam-9579	196	7	diagnosed	diagnose	VERB
bam-9579	196	8	cases	case	NOUN
bam-9579	196	9	are	be	AUX
bam-9579	196	10	summarized	summarize	VERB
bam-9579	196	11	as	as	SCONJ
bam-9579	196	12	follows	follow	VERB
bam-9579	196	13	:	:	PUNCT
bam-9579	196	14	most	most	ADJ
bam-9579	196	15	patients	patient	NOUN
bam-9579	196	16	with	with	ADP
bam-9579	196	17	lung	lung	PROPN
bam-9579	196	18	ct	ct	PROPN
bam-9579	196	19	usually	usually	ADV
bam-9579	196	20	show	show	VERB
bam-9579	196	21	single	single	ADJ
bam-9579	196	22	or	or	CCONJ
bam-9579	196	23	multiple	multiple	ADJ
bam-9579	196	24	ground	ground	NOUN
bam-9579	196	25	glass	glass	NOUN
bam-9579	196	26	shadows	shadow	NOUN
bam-9579	196	27	,	,	PUNCT
bam-9579	196	28	and	and	CCONJ
bam-9579	196	29	consolidations	consolidation	NOUN
bam-9579	196	30	.	.	PUNCT
bam-9579	197	1	our	our	PRON
bam-9579	197	2	results	result	NOUN
bam-9579	197	3	showed	show	VERB
bam-9579	197	4	that	that	SCONJ
bam-9579	197	5	the	the	DET
bam-9579	197	6	most	most	ADV
bam-9579	197	7	prevalent	prevalent	ADJ
bam-9579	197	8	chest	chest	NOUN
bam-9579	197	9	ct	ct	NUM
bam-9579	197	10	feature	feature	NOUN
bam-9579	197	11	was	be	AUX
bam-9579	197	12	ground	ground	NOUN
bam-9579	197	13	-	-	PUNCT
bam-9579	197	14	glass	glass	NOUN
bam-9579	197	15	opacity	opacity	NOUN
bam-9579	197	16	(	(	PUNCT
bam-9579	197	17	43.0	43.0	NUM
bam-9579	197	18	%	%	NOUN
bam-9579	197	19	)	)	PUNCT
bam-9579	197	20	with	with	ADP
bam-9579	197	21	bilateral	bilateral	ADJ
bam-9579	197	22	involvement	involvement	NOUN
bam-9579	197	23	pattern	pattern	NOUN
bam-9579	197	24	(	(	PUNCT
bam-9579	197	25	78.7	78.7	NUM
bam-9579	197	26	%	%	NOUN
bam-9579	197	27	)	)	PUNCT
bam-9579	197	28	and	and	CCONJ
bam-9579	197	29	followed	follow	VERB
bam-9579	197	30	by	by	ADP
bam-9579	197	31	consolidation	consolidation	NOUN
bam-9579	197	32	and	and	CCONJ
bam-9579	197	33	peripheral	peripheral	ADJ
bam-9579	197	34	distribution	distribution	NOUN
bam-9579	197	35	.	.	PUNCT
bam-9579	198	1	severe	severe	ADJ
bam-9579	198	2	/	/	SYM
bam-9579	198	3	critically	critically	ADV
bam-9579	198	4	ill	ill	ADJ
bam-9579	198	5	patients	patient	NOUN
bam-9579	198	6	had	have	VERB
bam-9579	198	7	a	a	DET
bam-9579	198	8	significant	significant	ADJ
bam-9579	198	9	higher	high	ADJ
bam-9579	198	10	rate	rate	NOUN
bam-9579	198	11	of	of	ADP
bam-9579	198	12	abnormalities	abnormality	NOUN
bam-9579	198	13	,	,	PUNCT
bam-9579	198	14	including	include	VERB
bam-9579	198	15	ground	ground	NOUN
bam-9579	198	16	-	-	PUNCT
bam-9579	198	17	glass	glass	NOUN
bam-9579	198	18	opacity	opacity	NOUN
bam-9579	198	19	,	,	PUNCT
bam-9579	198	20	consolidation	consolidation	NOUN
bam-9579	198	21	,	,	PUNCT
bam-9579	198	22	crazy	crazy	ADJ
bam-9579	198	23	-	-	PUNCT
bam-9579	198	24	paving	pave	VERB
bam-9579	198	25	pattern	pattern	NOUN
bam-9579	198	26	(	(	PUNCT
bam-9579	198	27	p	p	X
bam-9579	198	28	<	<	X
bam-9579	198	29	0.001	0.001	NUM
bam-9579	198	30	)	)	PUNCT
bam-9579	198	31	.	.	PUNCT
bam-9579	199	1	only	only	ADV
bam-9579	199	2	airbronchogram	airbronchogram	NOUN
bam-9579	199	3	was	be	AUX
bam-9579	199	4	not	not	PART
bam-9579	199	5	significantly	significantly	ADV
bam-9579	199	6	differ	differ	VERB
bam-9579	199	7	among	among	ADP
bam-9579	199	8	two	two	NUM
bam-9579	199	9	table	table	NOUN
bam-9579	199	10	4	4	NUM
bam-9579	199	11	.	.	PUNCT
bam-9579	200	1	treatments	treatment	NOUN
bam-9579	200	2	of	of	ADP
bam-9579	200	3	patients	patient	NOUN
bam-9579	200	4	infected	infect	VERB
bam-9579	200	5	with	with	ADP
bam-9579	200	6	sars	sar	NOUN
bam-9579	200	7	-	-	PUNCT
bam-9579	200	8	cov-2	cov-2	NOUN
bam-9579	200	9	overall(n=239	overall(n=239	PROPN
bam-9579	200	10	)	)	PUNCT
bam-9579	200	11	(	(	PUNCT
bam-9579	200	12	n	n	CCONJ
bam-9579	200	13	,	,	PUNCT
bam-9579	200	14	%	%	INTJ
bam-9579	200	15	)	)	PUNCT
bam-9579	200	16	general	general	ADJ
bam-9579	200	17	group	group	NOUN
bam-9579	200	18	(	(	PUNCT
bam-9579	200	19	n=176	n=176	PROPN
bam-9579	200	20	)	)	PUNCT
bam-9579	200	21	(	(	PUNCT
bam-9579	200	22	n	n	CCONJ
bam-9579	200	23	,	,	PUNCT
bam-9579	200	24	%	%	INTJ
bam-9579	200	25	)	)	PUNCT
bam-9579	200	26	severe	severe	ADJ
bam-9579	200	27	and	and	CCONJ
bam-9579	200	28	critical	critical	ADJ
bam-9579	200	29	group	group	NOUN
bam-9579	200	30	(	(	PUNCT
bam-9579	200	31	n=63	n=63	PROPN
bam-9579	200	32	)	)	PUNCT
bam-9579	200	33	(	(	PUNCT
bam-9579	200	34	n	n	CCONJ
bam-9579	200	35	,	,	PUNCT
bam-9579	200	36	%	%	INTJ
bam-9579	200	37	)	)	PUNCT
bam-9579	200	38	p	p	NOUN
bam-9579	200	39	value	value	NOUN
bam-9579	200	40	antiviral	antiviral	NOUN
bam-9579	200	41	therapy	therapy	NOUN
bam-9579	200	42	oseltamivir	oseltamivir	PROPN
bam-9579	200	43	239	239	NUM
bam-9579	200	44	(	(	PUNCT
bam-9579	200	45	100	100	NUM
bam-9579	200	46	)	)	PUNCT
bam-9579	200	47	176	176	NUM
bam-9579	200	48	(	(	PUNCT
bam-9579	200	49	100	100	NUM
bam-9579	200	50	)	)	PUNCT
bam-9579	200	51	63	63	NUM
bam-9579	200	52	(	(	PUNCT
bam-9579	200	53	100	100	NUM
bam-9579	200	54	)	)	PUNCT
bam-9579	200	55	lopinavir	lopinavir	NOUN
bam-9579	200	56	44	44	NUM
bam-9579	200	57	(	(	PUNCT
bam-9579	200	58	18.4	18.4	NUM
bam-9579	200	59	)	)	PUNCT
bam-9579	200	60	12	12	NUM
bam-9579	200	61	(	(	PUNCT
bam-9579	200	62	6.8	6.8	NUM
bam-9579	200	63	)	)	PUNCT
bam-9579	200	64	32	32	NUM
bam-9579	200	65	(	(	PUNCT
bam-9579	200	66	50.7	50.7	NUM
bam-9579	200	67	)	)	PUNCT
bam-9579	200	68	<	<	X
bam-9579	200	69	0.001	0.001	NUM
bam-9579	200	70	no	no	DET
bam-9579	200	71	antiviral	antiviral	ADJ
bam-9579	200	72	drug	drug	NOUN
bam-9579	200	73	0	0	NUM
bam-9579	200	74	0	0	NUM
bam-9579	200	75	0	0	NUM
bam-9579	200	76	other	other	ADJ
bam-9579	200	77	treatments	treatment	NOUN
bam-9579	200	78	hydroxychloroquine	hydroxychloroquine	VERB
bam-9579	200	79	188	188	NUM
bam-9579	200	80	(	(	PUNCT
bam-9579	200	81	78.6	78.6	NUM
bam-9579	200	82	)	)	PUNCT
bam-9579	200	83	143	143	NUM
bam-9579	200	84	(	(	PUNCT
bam-9579	200	85	81.25	81.25	NUM
bam-9579	200	86	)	)	PUNCT
bam-9579	200	87	45	45	NUM
bam-9579	200	88	(	(	PUNCT
bam-9579	200	89	71.4	71.4	NUM
bam-9579	200	90	)	)	PUNCT
bam-9579	200	91	0.238	0.238	NUM
bam-9579	200	92	antibiotic	antibiotic	ADJ
bam-9579	200	93	*	*	SYM
bam-9579	200	94	148	148	NUM
bam-9579	200	95	(	(	PUNCT
bam-9579	200	96	62	62	NUM
bam-9579	200	97	)	)	SYM
bam-9579	200	98	105	105	NUM
bam-9579	200	99	(	(	PUNCT
bam-9579	200	100	59.6	59.6	NUM
bam-9579	200	101	)	)	PUNCT
bam-9579	200	102	33	33	NUM
bam-9579	200	103	(	(	PUNCT
bam-9579	200	104	52.4	52.4	NUM
bam-9579	200	105	)	)	PUNCT
bam-9579	200	106	0.346	0.346	NUM
bam-9579	200	107	glucocorticoid	glucocorticoid	NOUN
bam-9579	200	108	78	78	NUM
bam-9579	200	109	(	(	PUNCT
bam-9579	200	110	32.9	32.9	NUM
bam-9579	200	111	)	)	PUNCT
bam-9579	200	112	34	34	NUM
bam-9579	200	113	(	(	PUNCT
bam-9579	200	114	19.4	19.4	NUM
bam-9579	200	115	)	)	PUNCT
bam-9579	200	116	44	44	NUM
bam-9579	200	117	(	(	PUNCT
bam-9579	200	118	69.8	69.8	NUM
bam-9579	200	119	)	)	PUNCT
bam-9579	200	120	<	<	X
bam-9579	200	121	0.001	0.001	NUM
bam-9579	200	122	supportive	supportive	ADJ
bam-9579	200	123	therapy	therapy	NOUN
bam-9579	200	124	intranasal	intranasal	NOUN
bam-9579	200	125	oxygen	oxygen	NOUN
bam-9579	200	126	inhalation	inhalation	NOUN
bam-9579	200	127	121	121	NUM
bam-9579	200	128	(	(	PUNCT
bam-9579	200	129	50.6	50.6	NUM
bam-9579	200	130	)	)	PUNCT
bam-9579	200	131	61	61	NUM
bam-9579	200	132	(	(	PUNCT
bam-9579	200	133	34.5	34.5	NUM
bam-9579	200	134	)	)	PUNCT
bam-9579	200	135	60	60	NUM
bam-9579	200	136	(	(	PUNCT
bam-9579	200	137	95.8	95.8	NUM
bam-9579	200	138	)	)	PUNCT
bam-9579	200	139	<	<	X
bam-9579	200	140	0.001	0.001	NUM
bam-9579	200	141	high	high	ADJ
bam-9579	200	142	flow	flow	NOUN
bam-9579	200	143	oxygen	oxygen	NOUN
bam-9579	200	144	13	13	NUM
bam-9579	200	145	(	(	PUNCT
bam-9579	200	146	5.4	5.4	NUM
bam-9579	200	147	)	)	PUNCT
bam-9579	200	148	0	0	NUM
bam-9579	200	149	13	13	NUM
bam-9579	200	150	(	(	PUNCT
bam-9579	200	151	20.6	20.6	NUM
bam-9579	200	152	)	)	PUNCT
bam-9579	200	153	<	<	X
bam-9579	200	154	0.001	0.001	NUM
bam-9579	200	155	non	non	ADJ
bam-9579	200	156	-	-	ADJ
bam-9579	200	157	invasive	invasive	ADJ
bam-9579	200	158	and	and	CCONJ
bam-9579	200	159	invasive	invasive	ADJ
bam-9579	200	160	mechanical	mechanical	ADJ
bam-9579	200	161	ventilation	ventilation	NOUN
bam-9579	200	162	8	8	NUM
bam-9579	200	163	(	(	PUNCT
bam-9579	200	164	3.3	3.3	NUM
bam-9579	200	165	)	)	PUNCT
bam-9579	200	166	0	0	NUM
bam-9579	200	167	8	8	NUM
bam-9579	200	168	(	(	PUNCT
bam-9579	200	169	12.7	12.7	NUM
bam-9579	200	170	)	)	PUNCT
bam-9579	200	171	<	<	X
bam-9579	200	172	0.001	0.001	NUM
bam-9579	200	173	_	_	PUNCT
bam-9579	200	174	_	_	PUNCT
bam-9579	201	1	_	_	PUNCT
bam-9579	202	1	_	_	PUNCT
bam-9579	203	1	_	_	PUNCT
bam-9579	204	1	_	_	PUNCT
bam-9579	205	1	_	_	PUNCT
bam-9579	206	1	_	_	PUNCT
bam-9579	207	1	_	_	PUNCT
bam-9579	208	1	_	_	PUNCT
bam-9579	209	1	_	_	PUNCT
bam-9579	210	1	_	_	PUNCT
bam-9579	211	1	_	_	PUNCT
bam-9579	212	1	_	_	PUNCT
bam-9579	213	1	_	_	PUNCT
bam-9579	214	1	_	_	PUNCT
bam-9579	215	1	_	_	PUNCT
bam-9579	216	1	_	_	PUNCT
bam-9579	217	1	_	_	PUNCT
bam-9579	218	1	_	_	PUNCT
bam-9579	219	1	_	_	PUNCT
bam-9579	220	1	_	_	PUNCT
bam-9579	221	1	_	_	PUNCT
bam-9579	222	1	_	_	PUNCT
bam-9579	223	1	_	_	PUNCT
bam-9579	224	1	_	_	PUNCT
bam-9579	225	1	_	_	PUNCT
bam-9579	226	1	_	_	PUNCT
bam-9579	227	1	_	_	PUNCT
bam-9579	228	1	_	_	PUNCT
bam-9579	229	1	_	_	PUNCT
bam-9579	230	1	_	_	PUNCT
bam-9579	231	1	_	_	PUNCT
bam-9579	232	1	_	_	PUNCT
bam-9579	233	1	_	_	PUNCT
bam-9579	234	1	_	_	PUNCT
bam-9579	235	1	_	_	PUNCT
bam-9579	236	1	_	_	PUNCT
bam-9579	237	1	_	_	PUNCT
bam-9579	238	1	_	_	PUNCT
bam-9579	239	1	_	_	PUNCT
bam-9579	240	1	_	_	PUNCT
bam-9579	241	1	_	_	PUNCT
bam-9579	242	1	_	_	PUNCT
bam-9579	243	1	_	_	PUNCT
bam-9579	244	1	_	_	PUNCT
bam-9579	245	1	_	_	PUNCT
bam-9579	246	1	_	_	PUNCT
bam-9579	247	1	_	_	PUNCT
bam-9579	248	1	_	_	PUNCT
bam-9579	249	1	_	_	PUNCT
bam-9579	250	1	_	_	PUNCT
bam-9579	251	1	_	_	PUNCT
bam-9579	252	1	_	_	PUNCT
bam-9579	253	1	_	_	PUNCT
bam-9579	254	1	_	_	PUNCT
bam-9579	255	1	_	_	PUNCT
bam-9579	256	1	_	_	PUNCT
bam-9579	257	1	_	_	PUNCT
bam-9579	258	1	_	_	PUNCT
bam-9579	259	1	_	_	PUNCT
bam-9579	260	1	_	_	PUNCT
bam-9579	261	1	_	_	PUNCT
bam-9579	262	1	_	_	PUNCT
bam-9579	263	1	_	_	PUNCT
bam-9579	264	1	_	_	PUNCT
bam-9579	265	1	_	_	PUNCT
bam-9579	266	1	_	_	PUNCT
bam-9579	267	1	_	_	PUNCT
bam-9579	268	1	_	_	PUNCT
bam-9579	269	1	_	_	PUNCT
bam-9579	270	1	_	_	PUNCT
bam-9579	271	1	_	_	PUNCT
bam-9579	272	1	_	_	PUNCT
bam-9579	273	1	_	_	PUNCT
bam-9579	274	1	_	_	PUNCT
bam-9579	275	1	_	_	PUNCT
bam-9579	276	1	_	_	PUNCT
bam-9579	277	1	_	_	PUNCT
bam-9579	278	1	_	_	PUNCT
bam-9579	279	1	_	_	PUNCT
bam-9579	280	1	_	_	PUNCT
bam-9579	281	1	_	_	PUNCT
bam-9579	282	1	_	_	PUNCT
bam-9579	283	1	_	_	PUNCT
bam-9579	284	1	_	_	PUNCT
bam-9579	285	1	_	_	PUNCT
bam-9579	286	1	_	_	PUNCT
bam-9579	287	1	_	_	PUNCT
bam-9579	288	1	_	_	PUNCT
bam-9579	289	1	_	_	PUNCT
bam-9579	290	1	_	_	PUNCT
bam-9579	291	1	_	_	PUNCT
bam-9579	292	1	_	_	PUNCT
bam-9579	293	1	_	_	PUNCT
bam-9579	294	1	_	_	PUNCT
bam-9579	295	1	_	_	PUNCT
bam-9579	296	1	_	_	PUNCT
bam-9579	297	1	_	_	PUNCT
bam-9579	298	1	_	_	PUNCT
bam-9579	299	1	_	_	PUNCT
bam-9579	300	1	_	_	PUNCT
bam-9579	301	1	_	_	PUNCT
bam-9579	302	1	_	_	PUNCT
bam-9579	303	1	_	_	PUNCT
bam-9579	304	1	_	_	PUNCT
bam-9579	305	1	_	_	PUNCT
bam-9579	306	1	_	_	PUNCT
bam-9579	307	1	_	_	PUNCT
bam-9579	308	1	_	_	PUNCT
bam-9579	309	1	_	_	PUNCT
bam-9579	310	1	_	_	PUNCT
bam-9579	311	1	_	_	PUNCT
bam-9579	312	1	_	_	PUNCT
bam-9579	313	1	_	_	PUNCT
bam-9579	314	1	_	_	PUNCT
bam-9579	315	1	*	*	PUNCT
bam-9579	315	2	including	include	VERB
bam-9579	315	3	azithromycin	azithromycin	NOUN
bam-9579	315	4	or	or	CCONJ
bam-9579	315	5	levofloxacin	levofloxacin	NOUN
bam-9579	315	6	ordinary	ordinary	ADJ
bam-9579	315	7	and	and	CCONJ
bam-9579	315	8	severe	severe	ADJ
bam-9579	315	9	cases	case	NOUN
bam-9579	315	10	of	of	ADP
bam-9579	315	11	covid-19	covid-19	PROPN
bam-9579	315	12	in	in	ADP
bam-9579	315	13	iran	iran	PROPN
bam-9579	315	14	eur	eur	PROPN
bam-9579	315	15	j	j	PROPN
bam-9579	315	16	transl	transl	PROPN
bam-9579	315	17	myol	myol	ADV
bam-9579	315	18	31	31	NUM
bam-9579	315	19	(	(	PUNCT
bam-9579	315	20	3	3	NUM
bam-9579	315	21	):	):	PUNCT
bam-9579	315	22	9579	9579	NUM
bam-9579	315	23	,	,	PUNCT
bam-9579	315	24	2021	2021	NUM
bam-9579	315	25	doi	doi	NOUN
bam-9579	315	26	:	:	PUNCT
bam-9579	315	27	10.4081	10.4081	NUM
bam-9579	315	28	/	/	SYM
bam-9579	315	29	ejtm.2021.9579	ejtm.2021.9579	NUM
bam-9579	315	30	6	6	NUM
bam-9579	315	31	groups	group	NOUN
bam-9579	315	32	.	.	PUNCT
bam-9579	316	1	in	in	ADP
bam-9579	316	2	addition	addition	NOUN
bam-9579	316	3	,	,	PUNCT
bam-9579	316	4	the	the	DET
bam-9579	316	5	same	same	ADJ
bam-9579	316	6	results	result	NOUN
bam-9579	316	7	were	be	AUX
bam-9579	316	8	seen	see	VERB
bam-9579	316	9	in	in	ADP
bam-9579	316	10	chest	chest	NOUN
bam-9579	316	11	x	x	NOUN
bam-9579	316	12	-	-	NOUN
bam-9579	316	13	ray	ray	NOUN
bam-9579	316	14	(	(	PUNCT
bam-9579	316	15	table	table	NOUN
bam-9579	316	16	3	3	NUM
bam-9579	316	17	)	)	PUNCT
bam-9579	316	18	.	.	PUNCT
bam-9579	317	1	treatment	treatment	NOUN
bam-9579	317	2	and	and	CCONJ
bam-9579	317	3	prognosis	prognosis	NOUN
bam-9579	317	4	table	table	NOUN
bam-9579	317	5	4	4	NUM
bam-9579	317	6	shows	show	VERB
bam-9579	317	7	that	that	SCONJ
bam-9579	317	8	all	all	DET
bam-9579	317	9	patients	patient	NOUN
bam-9579	317	10	received	receive	VERB
bam-9579	317	11	one	one	NUM
bam-9579	317	12	or	or	CCONJ
bam-9579	317	13	more	more	ADJ
bam-9579	317	14	treatment	treatment	NOUN
bam-9579	317	15	,	,	PUNCT
bam-9579	317	16	including	include	VERB
bam-9579	317	17	239	239	NUM
bam-9579	317	18	cases	case	NOUN
bam-9579	317	19	of	of	ADP
bam-9579	317	20	oseltamivir	oseltamivir	NOUN
bam-9579	317	21	(	(	PUNCT
bam-9579	317	22	100	100	NUM
bam-9579	317	23	%	%	NOUN
bam-9579	317	24	)	)	PUNCT
bam-9579	317	25	and	and	CCONJ
bam-9579	317	26	44	44	NUM
bam-9579	317	27	cases	case	NOUN
bam-9579	317	28	of	of	ADP
bam-9579	317	29	lopinavir	lopinavir	NOUN
bam-9579	317	30	(	(	PUNCT
bam-9579	317	31	18.4	18.4	NUM
bam-9579	317	32	%	%	NOUN
bam-9579	317	33	)	)	PUNCT
bam-9579	317	34	.	.	PUNCT
bam-9579	318	1	patients	patient	NOUN
bam-9579	318	2	in	in	ADP
bam-9579	318	3	the	the	DET
bam-9579	318	4	severe	severe	ADJ
bam-9579	318	5	and	and	CCONJ
bam-9579	318	6	critically	critically	ADV
bam-9579	318	7	ill	ill	ADJ
bam-9579	318	8	groups	group	NOUN
bam-9579	318	9	received	receive	VERB
bam-9579	318	10	significantly	significantly	ADV
bam-9579	318	11	more	more	ADV
bam-9579	318	12	antiviral	antiviral	ADJ
bam-9579	318	13	drugs	drug	NOUN
bam-9579	318	14	than	than	ADP
bam-9579	318	15	the	the	DET
bam-9579	318	16	general	general	ADJ
bam-9579	318	17	group	group	NOUN
bam-9579	318	18	(	(	PUNCT
bam-9579	318	19	p	p	X
bam-9579	318	20	<	<	X
bam-9579	318	21	0.001	0.001	NUM
bam-9579	318	22	)	)	PUNCT
bam-9579	318	23	.	.	PUNCT
bam-9579	319	1	more	more	ADJ
bam-9579	319	2	than	than	ADP
bam-9579	319	3	50	50	NUM
bam-9579	319	4	%	%	NOUN
bam-9579	319	5	of	of	ADP
bam-9579	319	6	patients	patient	NOUN
bam-9579	319	7	in	in	ADP
bam-9579	319	8	both	both	DET
bam-9579	319	9	groups	group	NOUN
bam-9579	319	10	used	use	VERB
bam-9579	319	11	antibacterial	antibacterial	ADJ
bam-9579	319	12	drugs	drug	NOUN
bam-9579	319	13	,	,	PUNCT
bam-9579	319	14	mainly	mainly	ADV
bam-9579	319	15	including	include	VERB
bam-9579	319	16	azithromycin	azithromycin	NOUN
bam-9579	319	17	and	and	CCONJ
bam-9579	319	18	levofloxacin	levofloxacin	NOUN
bam-9579	319	19	.	.	PUNCT
bam-9579	320	1	glucocorticoids	glucocorticoid	NOUN
bam-9579	320	2	in	in	ADP
bam-9579	320	3	severe	severe	ADJ
bam-9579	320	4	and	and	CCONJ
bam-9579	320	5	critically	critically	ADV
bam-9579	320	6	ill	ill	ADJ
bam-9579	320	7	patients	patient	NOUN
bam-9579	320	8	[	[	X
bam-9579	320	9	44	44	NUM
bam-9579	320	10	cases	case	NOUN
bam-9579	320	11	(	(	PUNCT
bam-9579	320	12	69.8	69.8	NUM
bam-9579	320	13	%	%	NOUN
bam-9579	320	14	)	)	PUNCT
bam-9579	320	15	vs	vs	ADP
bam-9579	320	16	34	34	NUM
bam-9579	320	17	cases	case	NOUN
bam-9579	320	18	(	(	PUNCT
bam-9579	320	19	19.4	19.4	NUM
bam-9579	320	20	%	%	NOUN
bam-9579	320	21	)	)	PUNCT
bam-9579	320	22	,	,	PUNCT
bam-9579	320	23	p	p	X
bam-9579	320	24	<	<	X
bam-9579	320	25	0.001	0.001	NUM
bam-9579	320	26	]	]	PUNCT
bam-9579	320	27	.	.	PUNCT
bam-9579	321	1	the	the	DET
bam-9579	321	2	rate	rate	NOUN
bam-9579	321	3	of	of	ADP
bam-9579	321	4	nasal	nasal	ADJ
bam-9579	321	5	catheters	catheter	NOUN
bam-9579	321	6	and	and	CCONJ
bam-9579	321	7	high	high	ADJ
bam-9579	321	8	flow	flow	NOUN
bam-9579	321	9	oxygen	oxygen	NOUN
bam-9579	321	10	inhalation	inhalation	NOUN
bam-9579	321	11	is	be	AUX
bam-9579	321	12	also	also	ADV
bam-9579	321	13	higher	high	ADJ
bam-9579	321	14	(	(	PUNCT
bam-9579	321	15	p	p	X
bam-9579	321	16	<	<	X
bam-9579	321	17	0.001	0.001	NUM
bam-9579	321	18	,	,	PUNCT
bam-9579	321	19	0.026	0.026	NUM
bam-9579	321	20	)	)	PUNCT
bam-9579	321	21	.	.	PUNCT
bam-9579	322	1	in	in	ADP
bam-9579	322	2	this	this	DET
bam-9579	322	3	study	study	NOUN
bam-9579	322	4	,	,	PUNCT
bam-9579	322	5	five	five	NUM
bam-9579	322	6	critically	critically	ADV
bam-9579	322	7	ill	ill	ADJ
bam-9579	322	8	patients	patient	NOUN
bam-9579	322	9	died	die	VERB
bam-9579	322	10	of	of	ADP
bam-9579	322	11	acute	acute	ADJ
bam-9579	322	12	respiratory	respiratory	ADJ
bam-9579	322	13	distress	distress	NOUN
bam-9579	322	14	and	and	CCONJ
bam-9579	322	15	other	other	ADJ
bam-9579	322	16	patients	patient	NOUN
bam-9579	322	17	were	be	AUX
bam-9579	322	18	discharged	discharge	VERB
bam-9579	322	19	from	from	ADP
bam-9579	322	20	the	the	DET
bam-9579	322	21	hospital	hospital	NOUN
bam-9579	322	22	.	.	PUNCT
bam-9579	323	1	discussion	discussion	NOUN
bam-9579	323	2	the	the	DET
bam-9579	323	3	initial	initial	ADJ
bam-9579	323	4	reports	report	NOUN
bam-9579	323	5	on	on	ADP
bam-9579	323	6	the	the	DET
bam-9579	323	7	sars	sar	NOUN
bam-9579	323	8	-	-	PUNCT
bam-9579	323	9	cov-2	cov-2	PUNCT
bam-9579	323	10	and	and	CCONJ
bam-9579	323	11	covid-19	covid-19	PROPN
bam-9579	323	12	believed	believe	VERB
bam-9579	323	13	that	that	SCONJ
bam-9579	323	14	they	they	PRON
bam-9579	323	15	were	be	AUX
bam-9579	323	16	similar	similar	ADJ
bam-9579	323	17	to	to	ADP
bam-9579	323	18	the	the	DET
bam-9579	323	19	sars	sar	NOUN
bam-9579	323	20	and	and	CCONJ
bam-9579	323	21	mers	mer	NOUN
bam-9579	323	22	coronaviruses	coronaviruse	NOUN
bam-9579	323	23	that	that	PRON
bam-9579	323	24	occurred	occur	VERB
bam-9579	323	25	in	in	ADP
bam-9579	323	26	the	the	DET
bam-9579	323	27	early	early	ADJ
bam-9579	323	28	years	year	NOUN
bam-9579	323	29	.	.	PUNCT
bam-9579	324	1	most	most	ADJ
bam-9579	324	2	infected	infected	ADJ
bam-9579	324	3	patients	patient	NOUN
bam-9579	324	4	showed	show	VERB
bam-9579	324	5	fever	fever	NOUN
bam-9579	324	6	,	,	PUNCT
bam-9579	324	7	dry	dry	ADJ
bam-9579	324	8	cough	cough	NOUN
bam-9579	324	9	,	,	PUNCT
bam-9579	324	10	fatigue	fatigue	NOUN
bam-9579	324	11	,	,	PUNCT
bam-9579	324	12	and	and	CCONJ
bam-9579	324	13	dyspnea.3,9,10	dyspnea.3,9,10	VERB
bam-9579	324	14	this	this	DET
bam-9579	324	15	study	study	NOUN
bam-9579	324	16	also	also	ADV
bam-9579	324	17	confirmed	confirm	VERB
bam-9579	324	18	that	that	SCONJ
bam-9579	324	19	fever	fever	NOUN
bam-9579	324	20	and	and	CCONJ
bam-9579	324	21	dry	dry	ADJ
bam-9579	324	22	cough	cough	NOUN
bam-9579	324	23	accounted	account	VERB
bam-9579	324	24	for	for	ADP
bam-9579	324	25	84.8	84.8	NUM
bam-9579	324	26	%	%	NOUN
bam-9579	324	27	and	and	CCONJ
bam-9579	324	28	57.0	57.0	NUM
bam-9579	324	29	%	%	NOUN
bam-9579	324	30	of	of	ADP
bam-9579	324	31	the	the	DET
bam-9579	324	32	patients	patient	NOUN
bam-9579	324	33	'	'	PART
bam-9579	324	34	onset	onset	NOUN
bam-9579	324	35	symptoms	symptom	NOUN
bam-9579	324	36	,	,	PUNCT
bam-9579	324	37	respectively	respectively	ADV
bam-9579	324	38	.	.	PUNCT
bam-9579	325	1	the	the	DET
bam-9579	325	2	other	other	ADJ
bam-9579	325	3	onset	onset	NOUN
bam-9579	325	4	symptoms	symptom	NOUN
bam-9579	325	5	also	also	ADV
bam-9579	325	6	included	include	VERB
bam-9579	325	7	fatigue	fatigue	NOUN
bam-9579	325	8	,	,	PUNCT
bam-9579	325	9	muscle	muscle	NOUN
bam-9579	325	10	aches	ache	NOUN
bam-9579	325	11	,	,	PUNCT
bam-9579	325	12	difficult	difficult	ADJ
bam-9579	325	13	breathing	breathing	NOUN
bam-9579	325	14	,	,	PUNCT
bam-9579	325	15	dizziness	dizziness	NOUN
bam-9579	325	16	,	,	PUNCT
bam-9579	325	17	headache	headache	NOUN
bam-9579	325	18	,	,	PUNCT
bam-9579	325	19	and	and	CCONJ
bam-9579	325	20	diarrhea	diarrhea	NOUN
bam-9579	325	21	.	.	PUNCT
bam-9579	326	1	however	however	ADV
bam-9579	326	2	,	,	PUNCT
bam-9579	326	3	we	we	PRON
bam-9579	326	4	observed	observe	VERB
bam-9579	326	5	that	that	SCONJ
bam-9579	326	6	fewer	few	ADJ
bam-9579	326	7	patients	patient	NOUN
bam-9579	326	8	started	start	VERB
bam-9579	326	9	with	with	ADP
bam-9579	326	10	typical	typical	ADJ
bam-9579	326	11	upper	upper	ADJ
bam-9579	326	12	respiratory	respiratory	ADJ
bam-9579	326	13	symptoms	symptom	NOUN
bam-9579	326	14	,	,	PUNCT
bam-9579	326	15	such	such	ADJ
bam-9579	326	16	as	as	ADP
bam-9579	326	17	runny	runny	ADJ
bam-9579	326	18	nose	nose	NOUN
bam-9579	326	19	,	,	PUNCT
bam-9579	326	20	sneezing	sneeze	VERB
bam-9579	326	21	,	,	PUNCT
bam-9579	326	22	swollen	swollen	ADJ
bam-9579	326	23	throat	throat	NOUN
bam-9579	326	24	,	,	PUNCT
bam-9579	326	25	etc	etc	X
bam-9579	326	26	.	.	X
bam-9579	326	27	,	,	PUNCT
bam-9579	326	28	which	which	PRON
bam-9579	326	29	is	be	AUX
bam-9579	326	30	different	different	ADJ
bam-9579	326	31	from	from	ADP
bam-9579	326	32	the	the	DET
bam-9579	326	33	previously	previously	ADV
bam-9579	326	34	reported	report	VERB
bam-9579	326	35	symptoms	symptom	NOUN
bam-9579	326	36	related	relate	VERB
bam-9579	326	37	to	to	ADP
bam-9579	326	38	sars	sar	NOUN
bam-9579	326	39	and	and	CCONJ
bam-9579	326	40	mers.3	mers.3	PROPN
bam-9579	326	41	earlier	early	ADV
bam-9579	326	42	reports	report	NOUN
bam-9579	326	43	showed	show	VERB
bam-9579	326	44	that	that	SCONJ
bam-9579	326	45	the	the	DET
bam-9579	326	46	new	new	ADJ
bam-9579	326	47	coronavirus	coronavirus	NOUN
bam-9579	326	48	is	be	AUX
bam-9579	326	49	more	more	ADV
bam-9579	326	50	susceptible	susceptible	ADJ
bam-9579	326	51	to	to	ADP
bam-9579	326	52	men	man	NOUN
bam-9579	326	53	,	,	PUNCT
bam-9579	326	54	which	which	PRON
bam-9579	326	55	may	may	AUX
bam-9579	326	56	be	be	AUX
bam-9579	326	57	related	relate	VERB
bam-9579	326	58	to	to	ADP
bam-9579	326	59	the	the	DET
bam-9579	326	60	99	99	NUM
bam-9579	326	61	patients	patient	NOUN
bam-9579	326	62	included	include	VERB
bam-9579	326	63	are	be	AUX
bam-9579	326	64	mostly	mostly	ADV
bam-9579	326	65	male	male	ADJ
bam-9579	326	66	workers	worker	NOUN
bam-9579	326	67	in	in	ADP
bam-9579	327	1	wuhan	wuhan	PROPN
bam-9579	327	2	south	south	PROPN
bam-9579	327	3	china	china	PROPN
bam-9579	327	4	seafood	seafood	PROPN
bam-9579	327	5	market.11	market.11	NOUN
bam-9579	327	6	the	the	DET
bam-9579	327	7	ratio	ratio	NOUN
bam-9579	327	8	of	of	ADP
bam-9579	327	9	men	man	NOUN
bam-9579	327	10	to	to	ADP
bam-9579	327	11	women	woman	NOUN
bam-9579	327	12	in	in	ADP
bam-9579	327	13	this	this	DET
bam-9579	327	14	study	study	NOUN
bam-9579	327	15	is	be	AUX
bam-9579	327	16	1:0.81	1:0.81	NUM
bam-9579	327	17	,	,	PUNCT
bam-9579	327	18	but	but	CCONJ
bam-9579	327	19	there	there	PRON
bam-9579	327	20	is	be	VERB
bam-9579	327	21	no	no	DET
bam-9579	327	22	statistical	statistical	ADJ
bam-9579	327	23	difference	difference	NOUN
bam-9579	327	24	,	,	PUNCT
bam-9579	327	25	so	so	CCONJ
bam-9579	327	26	there	there	PRON
bam-9579	327	27	is	be	VERB
bam-9579	327	28	insufficient	insufficient	ADJ
bam-9579	327	29	evidence	evidence	NOUN
bam-9579	327	30	to	to	PART
bam-9579	327	31	prove	prove	VERB
bam-9579	327	32	that	that	SCONJ
bam-9579	327	33	men	man	NOUN
bam-9579	327	34	are	be	AUX
bam-9579	327	35	more	more	ADV
bam-9579	327	36	susceptible	susceptible	ADJ
bam-9579	327	37	to	to	ADP
bam-9579	327	38	covid-19	covid-19	PROPN
bam-9579	327	39	.	.	PUNCT
bam-9579	328	1	however	however	ADV
bam-9579	328	2	,	,	PUNCT
bam-9579	328	3	we	we	PRON
bam-9579	328	4	found	find	VERB
bam-9579	328	5	that	that	SCONJ
bam-9579	328	6	men	man	NOUN
bam-9579	328	7	account	account	VERB
bam-9579	328	8	for	for	ADP
bam-9579	328	9	a	a	DET
bam-9579	328	10	higher	high	ADJ
bam-9579	328	11	proportion	proportion	NOUN
bam-9579	328	12	of	of	ADP
bam-9579	328	13	severe	severe	ADJ
bam-9579	328	14	and	and	CCONJ
bam-9579	328	15	critically	critically	ADV
bam-9579	328	16	ill	ill	ADJ
bam-9579	328	17	patients	patient	NOUN
bam-9579	328	18	,	,	PUNCT
bam-9579	328	19	which	which	PRON
bam-9579	328	20	means	mean	VERB
bam-9579	328	21	that	that	SCONJ
bam-9579	328	22	men	man	NOUN
bam-9579	328	23	are	be	AUX
bam-9579	328	24	more	more	ADV
bam-9579	328	25	likely	likely	ADJ
bam-9579	328	26	to	to	PART
bam-9579	328	27	develop	develop	VERB
bam-9579	328	28	severe	severe	ADJ
bam-9579	328	29	and	and	CCONJ
bam-9579	328	30	critically	critically	ADJ
bam-9579	328	31	pneumonia	pneumonia	NOUN
bam-9579	328	32	.	.	PUNCT
bam-9579	329	1	this	this	DET
bam-9579	329	2	study	study	NOUN
bam-9579	329	3	also	also	ADV
bam-9579	329	4	found	find	VERB
bam-9579	329	5	that	that	SCONJ
bam-9579	329	6	severe	severe	ADJ
bam-9579	329	7	and	and	CCONJ
bam-9579	329	8	critically	critically	ADV
bam-9579	329	9	ill	ill	ADJ
bam-9579	329	10	patients	patient	NOUN
bam-9579	329	11	often	often	ADV
bam-9579	329	12	have	have	VERB
bam-9579	329	13	more	more	ADJ
bam-9579	329	14	comorbid	comorbid	NOUN
bam-9579	329	15	diseases	disease	NOUN
bam-9579	329	16	,	,	PUNCT
bam-9579	329	17	which	which	PRON
bam-9579	329	18	mainly	mainly	ADV
bam-9579	329	19	include	include	VERB
bam-9579	329	20	hypertension	hypertension	NOUN
bam-9579	329	21	and	and	CCONJ
bam-9579	329	22	cerebrovascular	cerebrovascular	ADJ
bam-9579	329	23	diseases	disease	NOUN
bam-9579	329	24	,	,	PUNCT
bam-9579	329	25	suggesting	suggest	VERB
bam-9579	329	26	that	that	SCONJ
bam-9579	329	27	these	these	DET
bam-9579	329	28	past	past	ADJ
bam-9579	329	29	medical	medical	ADJ
bam-9579	329	30	histories	history	NOUN
bam-9579	329	31	may	may	AUX
bam-9579	329	32	be	be	AUX
bam-9579	329	33	a	a	DET
bam-9579	329	34	risk	risk	NOUN
bam-9579	329	35	factor	factor	NOUN
bam-9579	329	36	for	for	ADP
bam-9579	329	37	severe	severe	ADJ
bam-9579	329	38	and	and	CCONJ
bam-9579	329	39	critically	critically	ADV
bam-9579	329	40	ill	ill	ADJ
bam-9579	329	41	patients	patient	NOUN
bam-9579	329	42	.	.	PUNCT
bam-9579	330	1	according	accord	VERB
bam-9579	330	2	to	to	ADP
bam-9579	330	3	the	the	DET
bam-9579	330	4	analysis	analysis	NOUN
bam-9579	330	5	of	of	ADP
bam-9579	330	6	the	the	DET
bam-9579	330	7	duration	duration	NOUN
bam-9579	330	8	of	of	ADP
bam-9579	330	9	time	time	NOUN
bam-9579	330	10	from	from	ADP
bam-9579	330	11	onset	onset	NOUN
bam-9579	330	12	to	to	ADP
bam-9579	330	13	admission	admission	NOUN
bam-9579	330	14	of	of	ADP
bam-9579	330	15	the	the	DET
bam-9579	330	16	two	two	NUM
bam-9579	330	17	groups	group	NOUN
bam-9579	330	18	of	of	ADP
bam-9579	330	19	patients	patient	NOUN
bam-9579	330	20	,	,	PUNCT
bam-9579	330	21	the	the	DET
bam-9579	330	22	time	time	NOUN
bam-9579	330	23	between	between	ADP
bam-9579	330	24	the	the	DET
bam-9579	330	25	onset	onset	NOUN
bam-9579	330	26	and	and	CCONJ
bam-9579	330	27	admission	admission	NOUN
bam-9579	330	28	to	to	ADP
bam-9579	330	29	hostital	hostital	ADJ
bam-9579	330	30	of	of	ADP
bam-9579	330	31	patients	patient	NOUN
bam-9579	330	32	in	in	ADP
bam-9579	330	33	the	the	DET
bam-9579	330	34	heavy	heavy	ADJ
bam-9579	330	35	and	and	CCONJ
bam-9579	330	36	critically	critically	ADV
bam-9579	330	37	ill	ill	ADJ
bam-9579	330	38	groups	group	NOUN
bam-9579	330	39	is	be	AUX
bam-9579	330	40	significantly	significantly	ADV
bam-9579	330	41	longer	long	ADJ
bam-9579	330	42	than	than	ADP
bam-9579	330	43	that	that	PRON
bam-9579	330	44	of	of	ADP
bam-9579	330	45	ordinary	ordinary	ADJ
bam-9579	330	46	patients	patient	NOUN
bam-9579	330	47	,	,	PUNCT
bam-9579	330	48	which	which	PRON
bam-9579	330	49	also	also	ADV
bam-9579	330	50	provides	provide	VERB
bam-9579	330	51	us	we	PRON
bam-9579	330	52	with	with	ADP
bam-9579	330	53	inspiration	inspiration	NOUN
bam-9579	330	54	for	for	ADP
bam-9579	330	55	disease	disease	NOUN
bam-9579	330	56	prevention	prevention	NOUN
bam-9579	330	57	and	and	CCONJ
bam-9579	330	58	control	control	PROPN
bam-9579	330	59	:	:	PUNCT
bam-9579	330	60	suspected	suspect	VERB
bam-9579	330	61	cases	case	NOUN
bam-9579	330	62	should	should	AUX
bam-9579	330	63	be	be	AUX
bam-9579	330	64	diagnosed	diagnose	VERB
bam-9579	330	65	and	and	CCONJ
bam-9579	330	66	detected	detect	VERB
bam-9579	330	67	early	early	ADV
bam-9579	330	68	,	,	PUNCT
bam-9579	330	69	early	early	ADJ
bam-9579	330	70	isolation	isolation	NOUN
bam-9579	330	71	,	,	PUNCT
bam-9579	330	72	early	early	ADJ
bam-9579	330	73	diagnosis	diagnosis	NOUN
bam-9579	330	74	,	,	PUNCT
bam-9579	330	75	early	early	ADJ
bam-9579	330	76	treatment	treatment	NOUN
bam-9579	330	77	,	,	PUNCT
bam-9579	330	78	to	to	PART
bam-9579	330	79	avoid	avoid	VERB
bam-9579	330	80	the	the	DET
bam-9579	330	81	conversion	conversion	NOUN
bam-9579	330	82	of	of	ADP
bam-9579	330	83	some	some	DET
bam-9579	330	84	ordinary	ordinary	ADJ
bam-9579	330	85	patients	patient	NOUN
bam-9579	330	86	to	to	PART
bam-9579	330	87	heavy	heavy	ADJ
bam-9579	330	88	and	and	CCONJ
bam-9579	330	89	critical	critical	ADJ
bam-9579	330	90	due	due	ADJ
bam-9579	330	91	to	to	ADP
bam-9579	330	92	delayed	delay	VERB
bam-9579	330	93	diagnosis	diagnosis	NOUN
bam-9579	330	94	and	and	CCONJ
bam-9579	330	95	treatment	treatment	NOUN
bam-9579	330	96	.	.	PUNCT
bam-9579	331	1	laboratory	laboratory	NOUN
bam-9579	331	2	analysis	analysis	NOUN
bam-9579	331	3	shows	show	VERB
bam-9579	331	4	that	that	SCONJ
bam-9579	331	5	many	many	ADJ
bam-9579	331	6	indicators	indicator	NOUN
bam-9579	331	7	are	be	AUX
bam-9579	331	8	significantly	significantly	ADV
bam-9579	331	9	different	different	ADJ
bam-9579	331	10	between	between	ADP
bam-9579	331	11	the	the	DET
bam-9579	331	12	patients	patient	NOUN
bam-9579	331	13	in	in	ADP
bam-9579	331	14	the	the	DET
bam-9579	331	15	severe	severe	ADJ
bam-9579	331	16	and	and	CCONJ
bam-9579	331	17	critical	critical	ADJ
bam-9579	331	18	group	group	NOUN
bam-9579	331	19	and	and	CCONJ
bam-9579	331	20	the	the	DET
bam-9579	331	21	normal	normal	ADJ
bam-9579	331	22	group	group	NOUN
bam-9579	331	23	.	.	PUNCT
bam-9579	332	1	we	we	PRON
bam-9579	332	2	observed	observe	VERB
bam-9579	332	3	that	that	SCONJ
bam-9579	332	4	the	the	DET
bam-9579	332	5	absolute	absolute	ADJ
bam-9579	332	6	value	value	NOUN
bam-9579	332	7	of	of	ADP
bam-9579	332	8	neu	neu	PROPN
bam-9579	332	9	,	,	PUNCT
bam-9579	332	10	neu%	neu%	PROPN
bam-9579	332	11	,	,	PUNCT
bam-9579	332	12	and	and	CCONJ
bam-9579	332	13	crp	crp	NOUN
bam-9579	332	14	were	be	AUX
bam-9579	332	15	more	more	ADV
bam-9579	332	16	significantly	significantly	ADV
bam-9579	332	17	increased	increase	VERB
bam-9579	332	18	in	in	ADP
bam-9579	332	19	patients	patient	NOUN
bam-9579	332	20	with	with	ADP
bam-9579	332	21	severe	severe	ADJ
bam-9579	332	22	and	and	CCONJ
bam-9579	332	23	critically	critically	ADV
bam-9579	332	24	ill	ill	ADJ
bam-9579	332	25	patients	patient	NOUN
bam-9579	332	26	;	;	PUNCT
bam-9579	332	27	and	and	CCONJ
bam-9579	332	28	the	the	DET
bam-9579	332	29	percentage	percentage	NOUN
bam-9579	332	30	and	and	CCONJ
bam-9579	332	31	absolute	absolute	ADJ
bam-9579	332	32	value	value	NOUN
bam-9579	332	33	of	of	ADP
bam-9579	332	34	lymphocytes	lymphocyte	NOUN
bam-9579	332	35	of	of	ADP
bam-9579	332	36	lym%	lym%	PROPN
bam-9579	332	37	were	be	AUX
bam-9579	332	38	also	also	ADV
bam-9579	332	39	more	more	ADV
bam-9579	332	40	significantly	significantly	ADV
bam-9579	332	41	decreased	decrease	VERB
bam-9579	332	42	than	than	ADP
bam-9579	332	43	those	those	PRON
bam-9579	332	44	of	of	ADP
bam-9579	332	45	ordinary	ordinary	ADJ
bam-9579	332	46	type	type	NOUN
bam-9579	332	47	.	.	PUNCT
bam-9579	333	1	changes	change	NOUN
bam-9579	333	2	in	in	ADP
bam-9579	333	3	these	these	DET
bam-9579	333	4	indicators	indicator	NOUN
bam-9579	333	5	indicate	indicate	VERB
bam-9579	333	6	that	that	SCONJ
bam-9579	333	7	the	the	DET
bam-9579	333	8	mechanism	mechanism	NOUN
bam-9579	333	9	of	of	ADP
bam-9579	333	10	covid-19	covid-19	PROPN
bam-9579	333	11	development	development	NOUN
bam-9579	333	12	may	may	AUX
bam-9579	333	13	be	be	AUX
bam-9579	333	14	similar	similar	ADJ
bam-9579	333	15	to	to	ADP
bam-9579	333	16	pneumonia	pneumonia	NOUN
bam-9579	333	17	caused	cause	VERB
bam-9579	333	18	by	by	ADP
bam-9579	333	19	sars	sar	NOUN
bam-9579	333	20	and	and	CCONJ
bam-9579	333	21	mers	mers	PROPN
bam-9579	333	22	coronavirus	coronavirus	PROPN
bam-9579	333	23	,	,	PUNCT
bam-9579	333	24	and	and	CCONJ
bam-9579	333	25	there	there	PRON
bam-9579	333	26	may	may	AUX
bam-9579	333	27	be	be	AUX
bam-9579	333	28	a	a	DET
bam-9579	333	29	process	process	NOUN
bam-9579	333	30	of	of	ADP
bam-9579	333	31	cellular	cellular	ADJ
bam-9579	333	32	immune	immune	ADJ
bam-9579	333	33	impairment.4	impairment.4	PROPN
bam-9579	333	34	sars	sars	PROPN
bam-9579	333	35	-	-	PUNCT
bam-9579	333	36	cov-2	cov-2	PART
bam-9579	333	37	infection	infection	NOUN
bam-9579	333	38	also	also	ADV
bam-9579	333	39	has	have	VERB
bam-9579	333	40	a	a	DET
bam-9579	333	41	certain	certain	ADJ
bam-9579	333	42	impact	impact	NOUN
bam-9579	333	43	on	on	ADP
bam-9579	333	44	the	the	DET
bam-9579	333	45	coagulation	coagulation	NOUN
bam-9579	333	46	system	system	NOUN
bam-9579	333	47	.	.	PUNCT
bam-9579	334	1	some	some	DET
bam-9579	334	2	patients	patient	NOUN
bam-9579	334	3	have	have	AUX
bam-9579	334	4	prolonged	prolong	VERB
bam-9579	334	5	pt	pt	PROPN
bam-9579	334	6	,	,	PUNCT
bam-9579	334	7	aptt	aptt	ADJ
bam-9579	334	8	,	,	PUNCT
bam-9579	334	9	and	and	CCONJ
bam-9579	334	10	severe	severe	ADJ
bam-9579	334	11	and	and	CCONJ
bam-9579	334	12	critically	critically	ADV
bam-9579	334	13	ill	ill	ADJ
bam-9579	334	14	patients	patient	NOUN
bam-9579	334	15	.	.	PUNCT
bam-9579	335	1	the	the	DET
bam-9579	335	2	d	d	ADJ
bam-9579	335	3	-	-	PUNCT
bam-9579	335	4	dimer	dimer	ADJ
bam-9579	335	5	increase	increase	NOUN
bam-9579	335	6	is	be	AUX
bam-9579	335	7	more	more	ADV
bam-9579	335	8	obvious	obvious	ADJ
bam-9579	335	9	than	than	ADP
bam-9579	335	10	the	the	DET
bam-9579	335	11	normal	normal	ADJ
bam-9579	335	12	type	type	NOUN
bam-9579	335	13	.	.	PUNCT
bam-9579	336	1	at	at	ADP
bam-9579	336	2	the	the	DET
bam-9579	336	3	same	same	ADJ
bam-9579	336	4	time	time	NOUN
bam-9579	336	5	,	,	PUNCT
bam-9579	336	6	we	we	PRON
bam-9579	336	7	also	also	ADV
bam-9579	336	8	observed	observe	VERB
bam-9579	336	9	that	that	SCONJ
bam-9579	336	10	lactate	lactate	NOUN
bam-9579	336	11	dehydrogenase	dehydrogenase	NOUN
bam-9579	336	12	(	(	PUNCT
bam-9579	336	13	ldh	ldh	PROPN
bam-9579	336	14	)	)	PUNCT
bam-9579	336	15	was	be	AUX
bam-9579	336	16	significantly	significantly	ADV
bam-9579	336	17	higher	high	ADJ
bam-9579	336	18	in	in	ADP
bam-9579	336	19	patients	patient	NOUN
bam-9579	336	20	with	with	ADP
bam-9579	336	21	severe	severe	ADJ
bam-9579	336	22	and	and	CCONJ
bam-9579	336	23	critically	critically	ADV
bam-9579	336	24	ill	ill	ADJ
bam-9579	336	25	patients	patient	NOUN
bam-9579	336	26	than	than	ADP
bam-9579	336	27	in	in	ADP
bam-9579	336	28	the	the	DET
bam-9579	336	29	normal	normal	ADJ
bam-9579	336	30	group	group	NOUN
bam-9579	336	31	,	,	PUNCT
bam-9579	336	32	which	which	PRON
bam-9579	336	33	indicates	indicate	VERB
bam-9579	336	34	that	that	SCONJ
bam-9579	336	35	the	the	DET
bam-9579	336	36	virus	virus	NOUN
bam-9579	336	37	may	may	AUX
bam-9579	336	38	directly	directly	ADV
bam-9579	336	39	or	or	CCONJ
bam-9579	336	40	indirectly	indirectly	ADV
bam-9579	336	41	damage	damage	VERB
bam-9579	336	42	cardiomyocytes	cardiomyocyte	NOUN
bam-9579	336	43	through	through	ADP
bam-9579	336	44	cytokine	cytokine	ADJ
bam-9579	336	45	storms	storm	NOUN
bam-9579	336	46	.	.	PUNCT
bam-9579	337	1	the	the	DET
bam-9579	337	2	reduction	reduction	NOUN
bam-9579	337	3	of	of	ADP
bam-9579	337	4	alb	alb	PROPN
bam-9579	337	5	levels	level	NOUN
bam-9579	337	6	is	be	AUX
bam-9579	337	7	particularly	particularly	ADV
bam-9579	337	8	obvious	obvious	ADJ
bam-9579	337	9	in	in	ADP
bam-9579	337	10	severe	severe	ADJ
bam-9579	337	11	and	and	CCONJ
bam-9579	337	12	critically	critically	ADV
bam-9579	337	13	ill	ill	ADJ
bam-9579	337	14	patients	patient	NOUN
bam-9579	337	15	.	.	PUNCT
bam-9579	338	1	it	it	PRON
bam-9579	338	2	is	be	AUX
bam-9579	338	3	speculated	speculate	VERB
bam-9579	338	4	that	that	SCONJ
bam-9579	338	5	it	it	PRON
bam-9579	338	6	may	may	AUX
bam-9579	338	7	be	be	AUX
bam-9579	338	8	related	relate	VERB
bam-9579	338	9	to	to	ADP
bam-9579	338	10	the	the	DET
bam-9579	338	11	liver	liver	NOUN
bam-9579	338	12	albumin	albumin	ADJ
bam-9579	338	13	synthesis	synthesis	NOUN
bam-9579	338	14	disorder	disorder	NOUN
bam-9579	338	15	caused	cause	VERB
bam-9579	338	16	by	by	ADP
bam-9579	338	17	the	the	DET
bam-9579	338	18	direct	direct	ADJ
bam-9579	338	19	damage	damage	NOUN
bam-9579	338	20	of	of	ADP
bam-9579	338	21	the	the	DET
bam-9579	338	22	virus	virus	NOUN
bam-9579	338	23	to	to	PART
bam-9579	338	24	liver	liver	NOUN
bam-9579	338	25	cells	cell	NOUN
bam-9579	338	26	.	.	PUNCT
bam-9579	339	1	in	in	ADP
bam-9579	339	2	addition	addition	NOUN
bam-9579	339	3	,	,	PUNCT
bam-9579	339	4	increased	increase	VERB
bam-9579	339	5	body	body	NOUN
bam-9579	339	6	consumption	consumption	NOUN
bam-9579	339	7	due	due	ADP
bam-9579	339	8	to	to	ADP
bam-9579	339	9	inflammation	inflammation	NOUN
bam-9579	339	10	,	,	PUNCT
bam-9579	339	11	fever	fever	NOUN
bam-9579	339	12	,	,	PUNCT
bam-9579	339	13	etc	etc	X
bam-9579	339	14	.	.	X
bam-9579	339	15	can	can	AUX
bam-9579	339	16	also	also	ADV
bam-9579	339	17	lead	lead	VERB
bam-9579	339	18	to	to	ADP
bam-9579	339	19	low	low	ADJ
bam-9579	339	20	alb	alb	PROPN
bam-9579	339	21	.	.	PUNCT
bam-9579	340	1	although	although	SCONJ
bam-9579	340	2	the	the	DET
bam-9579	340	3	vast	vast	ADJ
bam-9579	340	4	majority	majority	NOUN
bam-9579	340	5	of	of	ADP
bam-9579	340	6	patients	patient	NOUN
bam-9579	340	7	did	do	AUX
bam-9579	340	8	not	not	PART
bam-9579	340	9	have	have	VERB
bam-9579	340	10	obvious	obvious	ADJ
bam-9579	340	11	renal	renal	ADJ
bam-9579	340	12	impairment	impairment	NOUN
bam-9579	340	13	and	and	CCONJ
bam-9579	340	14	their	their	PRON
bam-9579	340	15	bun	bun	NOUN
bam-9579	340	16	values	value	NOUN
bam-9579	340	17	were	be	AUX
bam-9579	340	18	within	within	ADP
bam-9579	340	19	the	the	DET
bam-9579	340	20	normal	normal	ADJ
bam-9579	340	21	range	range	NOUN
bam-9579	340	22	,	,	PUNCT
bam-9579	340	23	the	the	DET
bam-9579	340	24	bun	bun	PROPN
bam-9579	340	25	levels	level	NOUN
bam-9579	340	26	of	of	ADP
bam-9579	340	27	patients	patient	NOUN
bam-9579	340	28	in	in	ADP
bam-9579	340	29	the	the	DET
bam-9579	340	30	severe	severe	ADJ
bam-9579	340	31	and	and	CCONJ
bam-9579	340	32	critical	critical	ADJ
bam-9579	340	33	group	group	NOUN
bam-9579	340	34	were	be	AUX
bam-9579	340	35	still	still	ADV
bam-9579	340	36	generally	generally	ADV
bam-9579	340	37	higher	high	ADJ
bam-9579	340	38	than	than	ADP
bam-9579	340	39	those	those	PRON
bam-9579	340	40	in	in	ADP
bam-9579	340	41	the	the	DET
bam-9579	340	42	normal	normal	ADJ
bam-9579	340	43	group	group	NOUN
bam-9579	340	44	,	,	PUNCT
bam-9579	340	45	which	which	PRON
bam-9579	340	46	may	may	AUX
bam-9579	340	47	be	be	AUX
bam-9579	340	48	more	more	ADV
bam-9579	340	49	severe	severe	ADJ
bam-9579	340	50	than	than	ADP
bam-9579	340	51	the	the	DET
bam-9579	340	52	former	former	ADJ
bam-9579	340	53	.	.	PROPN
bam-9579	340	54	fever	fever	NOUN
bam-9579	340	55	caused	cause	VERB
bam-9579	340	56	by	by	ADP
bam-9579	340	57	high	high	ADJ
bam-9579	340	58	metabolism	metabolism	NOUN
bam-9579	340	59	.	.	PUNCT
bam-9579	341	1	in	in	ADP
bam-9579	341	2	conclusion	conclusion	NOUN
bam-9579	341	3	,	,	PUNCT
bam-9579	341	4	sars	sar	NOUN
bam-9579	341	5	-	-	PUNCT
bam-9579	341	6	cov-2	cov-2	PART
bam-9579	341	7	infection	infection	NOUN
bam-9579	341	8	has	have	VERB
bam-9579	341	9	adverse	adverse	ADJ
bam-9579	341	10	effects	effect	NOUN
bam-9579	341	11	on	on	ADP
bam-9579	341	12	multiple	multiple	ADJ
bam-9579	341	13	organs	organ	NOUN
bam-9579	341	14	and	and	CCONJ
bam-9579	341	15	systems	system	NOUN
bam-9579	341	16	,	,	PUNCT
bam-9579	341	17	including	include	VERB
bam-9579	341	18	the	the	DET
bam-9579	341	19	coagulation	coagulation	NOUN
bam-9579	341	20	system	system	NOUN
bam-9579	341	21	,	,	PUNCT
bam-9579	341	22	heart	heart	NOUN
bam-9579	341	23	,	,	PUNCT
bam-9579	341	24	liver	liver	NOUN
bam-9579	341	25	,	,	PUNCT
bam-9579	341	26	and	and	CCONJ
bam-9579	341	27	kidneys	kidney	NOUN
bam-9579	341	28	,	,	PUNCT
bam-9579	341	29	and	and	CCONJ
bam-9579	341	30	the	the	DET
bam-9579	341	31	specific	specific	ADJ
bam-9579	341	32	damage	damage	NOUN
bam-9579	341	33	mechanism	mechanism	NOUN
bam-9579	341	34	requires	require	VERB
bam-9579	341	35	further	further	ADJ
bam-9579	341	36	pathophysiology	pathophysiology	NOUN
bam-9579	341	37	for	for	ADP
bam-9579	341	38	the	the	DET
bam-9579	341	39	pathogenicity	pathogenicity	NOUN
bam-9579	341	40	of	of	ADP
bam-9579	341	41	the	the	DET
bam-9579	341	42	virus	virus	NOUN
bam-9579	341	43	the	the	DET
bam-9579	341	44	study	study	NOUN
bam-9579	341	45	.	.	PUNCT
bam-9579	342	1	anti	anti	ADJ
bam-9579	342	2	-	-	ADJ
bam-9579	342	3	viral	viral	ADJ
bam-9579	342	4	drugs	drug	NOUN
bam-9579	342	5	is	be	AUX
bam-9579	342	6	particularly	particularly	ADV
bam-9579	342	7	important	important	ADJ
bam-9579	342	8	in	in	ADP
bam-9579	342	9	the	the	DET
bam-9579	342	10	treatment	treatment	NOUN
bam-9579	342	11	of	of	ADP
bam-9579	342	12	coronavirus	coronavirus	NOUN
bam-9579	342	13	,	,	PUNCT
bam-9579	342	14	but	but	CCONJ
bam-9579	342	15	there	there	PRON
bam-9579	342	16	is	be	VERB
bam-9579	342	17	still	still	ADV
bam-9579	342	18	no	no	DET
bam-9579	342	19	specific	specific	ADJ
bam-9579	342	20	drug	drug	NOUN
bam-9579	342	21	for	for	ADP
bam-9579	342	22	coronavirus	coronavirus	NOUN
bam-9579	342	23	infection.12	infection.12	NOUN
bam-9579	342	24	in	in	ADP
bam-9579	342	25	this	this	DET
bam-9579	342	26	study	study	NOUN
bam-9579	342	27	,	,	PUNCT
bam-9579	342	28	all	all	DET
bam-9579	342	29	patients	patient	NOUN
bam-9579	342	30	received	receive	VERB
bam-9579	342	31	oseltamivir	oseltamivir	PROPN
bam-9579	342	32	antiviral	antiviral	ADJ
bam-9579	342	33	therapy	therapy	NOUN
bam-9579	342	34	.	.	PUNCT
bam-9579	343	1	we	we	PRON
bam-9579	343	2	showed	show	VERB
bam-9579	343	3	that	that	DET
bam-9579	343	4	combination	combination	NOUN
bam-9579	343	5	of	of	ADP
bam-9579	343	6	oseltamivir	oseltamivir	PROPN
bam-9579	343	7	and	and	CCONJ
bam-9579	343	8	glucocorticosteroid	glucocorticosteroid	VERB
bam-9579	343	9	such	such	ADJ
bam-9579	343	10	as	as	ADP
bam-9579	343	11	dexamethasone	dexamethasone	NOUN
bam-9579	343	12	was	be	AUX
bam-9579	343	13	very	very	ADV
bam-9579	343	14	effective	effective	ADJ
bam-9579	343	15	in	in	ADP
bam-9579	343	16	severe	severe	ADJ
bam-9579	343	17	patients	patient	NOUN
bam-9579	343	18	.	.	PUNCT
bam-9579	344	1	however	however	ADV
bam-9579	344	2	,	,	PUNCT
bam-9579	344	3	statistuical	statistuical	ADJ
bam-9579	344	4	analysis	analysis	NOUN
bam-9579	344	5	failed	fail	VERB
bam-9579	344	6	to	to	PART
bam-9579	344	7	show	show	VERB
bam-9579	344	8	the	the	DET
bam-9579	344	9	effectiveness	effectiveness	NOUN
bam-9579	344	10	of	of	ADP
bam-9579	344	11	this	this	DET
bam-9579	344	12	treatment	treatment	NOUN
bam-9579	344	13	in	in	ADP
bam-9579	344	14	criticaly	criticaly	NOUN
bam-9579	344	15	ill	ill	ADJ
bam-9579	344	16	patients	patient	NOUN
bam-9579	344	17	.	.	PUNCT
bam-9579	345	1	in	in	ADP
bam-9579	345	2	view	view	NOUN
bam-9579	345	3	of	of	ADP
bam-9579	345	4	previous	previous	ADJ
bam-9579	345	5	reports	report	NOUN
bam-9579	345	6	that	that	SCONJ
bam-9579	345	7	sars	sar	NOUN
bam-9579	345	8	-	-	PUNCT
bam-9579	345	9	cov	cov	PROPN
bam-9579	345	10	,	,	PUNCT
bam-9579	345	11	mers	mer	NOUN
bam-9579	345	12	-	-	PUNCT
bam-9579	345	13	cov	cov	NOUN
bam-9579	345	14	,	,	PUNCT
bam-9579	345	15	and	and	CCONJ
bam-9579	345	16	sars	sar	NOUN
bam-9579	345	17	-	-	PUNCT
bam-9579	345	18	cov-2	cov-2	PART
bam-9579	345	19	infections	infection	NOUN
bam-9579	345	20	can	can	AUX
bam-9579	345	21	induce	induce	VERB
bam-9579	345	22	cytokine	cytokine	ADJ
bam-9579	345	23	storms,3	storms,3	NOUN
bam-9579	345	24	glucocorticoids	glucocorticoid	NOUN
bam-9579	345	25	are	be	AUX
bam-9579	345	26	often	often	ADV
bam-9579	345	27	used	use	VERB
bam-9579	345	28	to	to	PART
bam-9579	345	29	treat	treat	VERB
bam-9579	345	30	severely	severely	ADV
bam-9579	345	31	ill	ill	ADJ
bam-9579	345	32	patients	patient	NOUN
bam-9579	345	33	and	and	CCONJ
bam-9579	345	34	can	can	AUX
bam-9579	345	35	benefit	benefit	VERB
bam-9579	345	36	by	by	ADP
bam-9579	345	37	reducing	reduce	VERB
bam-9579	345	38	lung	lung	NOUN
bam-9579	345	39	damage	damage	NOUN
bam-9579	345	40	caused	cause	VERB
bam-9579	345	41	by	by	ADP
bam-9579	345	42	inflammation	inflammation	NOUN
bam-9579	345	43	.	.	PUNCT
bam-9579	346	1	however	however	ADV
bam-9579	346	2	,	,	PUNCT
bam-9579	346	3	there	there	PRON
bam-9579	346	4	are	be	VERB
bam-9579	346	5	also	also	ADV
bam-9579	346	6	studies	study	NOUN
bam-9579	346	7	that	that	SCONJ
bam-9579	346	8	the	the	DET
bam-9579	346	9	application	application	NOUN
bam-9579	346	10	of	of	ADP
bam-9579	346	11	glucocorticoids	glucocorticoid	NOUN
bam-9579	346	12	does	do	AUX
bam-9579	346	13	not	not	PART
bam-9579	346	14	significantly	significantly	ADV
bam-9579	346	15	improve	improve	VERB
bam-9579	346	16	the	the	DET
bam-9579	346	17	prognosis.13	prognosis.13	NOUN
bam-9579	346	18	in	in	ADP
bam-9579	346	19	conclusion	conclusion	NOUN
bam-9579	346	20	,	,	PUNCT
bam-9579	346	21	taken	take	VERB
bam-9579	346	22	together	together	ADV
bam-9579	346	23	,	,	PUNCT
bam-9579	346	24	our	our	PRON
bam-9579	346	25	data	datum	NOUN
bam-9579	346	26	reported	report	VERB
bam-9579	346	27	that	that	SCONJ
bam-9579	346	28	five	five	NUM
bam-9579	346	29	critically	critically	ADV
bam-9579	346	30	ill	ill	ADJ
bam-9579	346	31	patients	patient	NOUN
bam-9579	346	32	died	die	VERB
bam-9579	346	33	of	of	ADP
bam-9579	346	34	acute	acute	ADJ
bam-9579	346	35	respiratory	respiratory	ADJ
bam-9579	346	36	distress	distress	NOUN
bam-9579	346	37	and	and	CCONJ
bam-9579	346	38	other	other	ADJ
bam-9579	346	39	patients	patient	NOUN
bam-9579	346	40	were	be	AUX
bam-9579	346	41	discharged	discharge	VERB
bam-9579	346	42	from	from	ADP
bam-9579	346	43	the	the	DET
bam-9579	346	44	hospital	hospital	NOUN
bam-9579	346	45	.	.	PUNCT
bam-9579	347	1	elderly	elderly	ADJ
bam-9579	347	2	patients	patient	NOUN
bam-9579	347	3	with	with	ADP
bam-9579	347	4	multiple	multiple	ADJ
bam-9579	347	5	cardiovascular	cardiovascular	ADJ
bam-9579	347	6	and	and	CCONJ
bam-9579	347	7	cerebrovascular	cerebrovascular	ADJ
bam-9579	347	8	diseases	disease	NOUN
bam-9579	347	9	are	be	AUX
bam-9579	347	10	more	more	ADV
bam-9579	347	11	prone	prone	ADJ
bam-9579	347	12	to	to	ADP
bam-9579	347	13	severe	severe	ADJ
bam-9579	347	14	and	and	CCONJ
bam-9579	347	15	critical	critical	ADJ
bam-9579	347	16	covid-19	covid-19	PROPN
bam-9579	347	17	,	,	PUNCT
bam-9579	347	18	and	and	CCONJ
bam-9579	347	19	often	often	ADV
bam-9579	347	20	have	have	VERB
bam-9579	347	21	abnormalities	abnormality	NOUN
bam-9579	347	22	in	in	ADP
bam-9579	347	23	multiple	multiple	ADJ
bam-9579	347	24	organs	organ	NOUN
bam-9579	347	25	or	or	CCONJ
bam-9579	347	26	systems.totally	systems.totally	PRON
bam-9579	347	27	,	,	PUNCT
bam-9579	347	28	we	we	PRON
bam-9579	347	29	ordinary	ordinary	ADJ
bam-9579	347	30	and	and	CCONJ
bam-9579	347	31	severe	severe	ADJ
bam-9579	347	32	cases	case	NOUN
bam-9579	347	33	of	of	ADP
bam-9579	347	34	covid-19	covid-19	PROPN
bam-9579	347	35	in	in	ADP
bam-9579	347	36	iran	iran	PROPN
bam-9579	348	1	eur	eur	PROPN
bam-9579	348	2	j	j	PROPN
bam-9579	348	3	transl	transl	PROPN
bam-9579	348	4	myol	myol	ADV
bam-9579	348	5	31	31	NUM
bam-9579	348	6	(	(	PUNCT
bam-9579	348	7	3	3	NUM
bam-9579	348	8	):	):	PUNCT
bam-9579	348	9	9579	9579	NUM
bam-9579	348	10	,	,	PUNCT
bam-9579	348	11	2021	2021	NUM
bam-9579	348	12	doi	doi	NOUN
bam-9579	348	13	:	:	PUNCT
bam-9579	348	14	10.4081	10.4081	NUM
bam-9579	348	15	/	/	SYM
bam-9579	348	16	ejtm.2021.9579	ejtm.2021.9579	X
bam-9579	348	17	7	7	NUM
bam-9579	348	18	showed	show	VERB
bam-9579	348	19	that	that	DET
bam-9579	348	20	combination	combination	NOUN
bam-9579	348	21	of	of	ADP
bam-9579	348	22	oseltamivir	oseltamivir	PROPN
bam-9579	348	23	and	and	CCONJ
bam-9579	348	24	glucocorticosteroid	glucocorticosteroid	VERB
bam-9579	348	25	such	such	ADJ
bam-9579	348	26	as	as	ADP
bam-9579	348	27	dexamethasone	dexamethasone	NOUN
bam-9579	348	28	was	be	AUX
bam-9579	348	29	very	very	ADV
bam-9579	348	30	effective	effective	ADJ
bam-9579	348	31	in	in	ADP
bam-9579	348	32	severe	severe	ADJ
bam-9579	348	33	patients	patient	NOUN
bam-9579	348	34	.	.	PUNCT
bam-9579	349	1	clinicians	clinician	NOUN
bam-9579	349	2	should	should	AUX
bam-9579	349	3	make	make	VERB
bam-9579	349	4	timely	timely	ADJ
bam-9579	349	5	decisions	decision	NOUN
bam-9579	349	6	based	base	VERB
bam-9579	349	7	on	on	ADP
bam-9579	349	8	clinical	clinical	ADJ
bam-9579	349	9	symptoms	symptom	NOUN
bam-9579	349	10	,	,	PUNCT
bam-9579	349	11	signs	sign	NOUN
bam-9579	349	12	and	and	CCONJ
bam-9579	349	13	laboratory	laboratory	NOUN
bam-9579	349	14	examination	examination	NOUN
bam-9579	349	15	results	result	NOUN
bam-9579	349	16	judge	judge	VERB
bam-9579	349	17	and	and	CCONJ
bam-9579	349	18	adjust	adjust	VERB
bam-9579	349	19	the	the	DET
bam-9579	349	20	treatment	treatment	NOUN
bam-9579	349	21	plan	plan	NOUN
bam-9579	349	22	.	.	PUNCT
bam-9579	350	1	list	list	NOUN
bam-9579	350	2	of	of	ADP
bam-9579	350	3	acronyms	acronym	NOUN
bam-9579	350	4	alb	alb	VERB
bam-9579	350	5	–	–	PUNCT
bam-9579	350	6	albumin	albumin	ADJ
bam-9579	350	7	alt	alt	PROPN
bam-9579	350	8	alanine	alanine	PROPN
bam-9579	350	9	aminotransferase	aminotransferase	PROPN
bam-9579	350	10	ast	ast	PROPN
bam-9579	350	11	aspartate	aspartate	PROPN
bam-9579	350	12	aminotransferase	aminotransferase	PROPN
bam-9579	350	13	bun	bun	PROPN
bam-9579	350	14	urea	urea	PROPN
bam-9579	350	15	nitrogen	nitrogen	PROPN
bam-9579	350	16	ck	ck	PROPN
bam-9579	350	17	creatine	creatine	PROPN
bam-9579	350	18	kinase	kinase	PROPN
bam-9579	350	19	ck	ck	PROPN
bam-9579	350	20	-	-	PUNCT
bam-9579	350	21	mb	mb	ADP
bam-9579	350	22	creatine	creatine	PROPN
bam-9579	350	23	kinase	kinase	PROPN
bam-9579	350	24	isoform	isoform	PROPN
bam-9579	350	25	enzymes	enzyme	NOUN
bam-9579	350	26	covid-19	covid-19	PROPN
bam-9579	350	27	new	new	ADJ
bam-9579	350	28	coronavirus	coronavirus	NOUN
bam-9579	350	29	infection	infection	NOUN
bam-9579	350	30	cr	cr	PROPN
bam-9579	350	31	creatinine	creatinine	PROPN
bam-9579	350	32	,	,	PUNCT
bam-9579	350	33	crp	crp	PROPN
bam-9579	350	34	c	c	NOUN
bam-9579	350	35	-	-	ADJ
bam-9579	350	36	reactive	reactive	ADJ
bam-9579	350	37	protein	protein	NOUN
bam-9579	350	38	fio2	fio2	NOUN
bam-9579	350	39	fraction	fraction	NOUN
bam-9579	350	40	of	of	ADP
bam-9579	350	41	inspiration	inspiration	NOUN
bam-9579	350	42	oxygen	oxygen	NOUN
bam-9579	350	43	icu	icu	PROPN
bam-9579	350	44	–	–	PUNCT
bam-9579	350	45	intensive	intensive	ADJ
bam-9579	350	46	care	care	NOUN
bam-9579	350	47	unit	unit	NOUN
bam-9579	350	48	ldh	ldh	PROPN
bam-9579	350	49	lactate	lactate	PROPN
bam-9579	350	50	dehydrogenase	dehydrogenase	PROPN
bam-9579	350	51	lym	lym	PROPN
bam-9579	350	52	lymphocyte	lymphocyte	PROPN
bam-9579	350	53	neu	neu	PROPN
bam-9579	350	54	–	–	PUNCT
bam-9579	350	55	neutrophils	neutrophil	VERB
bam-9579	350	56	pao2	pao2	VERB
bam-9579	350	57	partial	partial	ADJ
bam-9579	350	58	pressure	pressure	NOUN
bam-9579	350	59	of	of	ADP
bam-9579	350	60	oxygen	oxygen	NOUN
bam-9579	350	61	plt	plt	NOUN
bam-9579	350	62	platelets	platelet	NOUN
bam-9579	350	63	pt	pt	X
bam-9579	350	64	prothrombin	prothrombin	NOUN
bam-9579	350	65	time	time	NOUN
bam-9579	350	66	rt	rt	NOUN
bam-9579	350	67	-	-	PUNCT
bam-9579	350	68	pc	pc	NOUN
bam-9579	350	69	real	real	ADJ
bam-9579	350	70	-	-	PUNCT
bam-9579	350	71	time	time	NOUN
bam-9579	350	72	fluorescence	fluorescence	NOUN
bam-9579	350	73	quantitative	quantitative	ADJ
bam-9579	350	74	polymerase	polymerase	NOUN
bam-9579	350	75	chain	chain	NOUN
bam-9579	350	76	reaction	reaction	NOUN
bam-9579	350	77	sars	sar	NOUN
bam-9579	350	78	-	-	PUNCT
bam-9579	350	79	cov-2	cov-2	NOUN
bam-9579	350	80	severe	severe	ADJ
bam-9579	350	81	acute	acute	ADJ
bam-9579	350	82	respiratory	respiratory	ADJ
bam-9579	350	83	syndrome	syndrome	NOUN
bam-9579	350	84	coronavirus	coronavirus	NOUN
bam-9579	350	85	2	2	NUM
bam-9579	350	86	tb	tb	ADP
bam-9579	350	87	total	total	ADJ
bam-9579	350	88	bilirubin	bilirubin	NOUN
bam-9579	350	89	authors	author	NOUN
bam-9579	350	90	contributions	contribution	NOUN
bam-9579	350	91	suz	suz	PROPN
bam-9579	350	92	,	,	PUNCT
bam-9579	350	93	siz	siz	PROPN
bam-9579	350	94	,	,	PUNCT
bam-9579	350	95	sd	sd	PROPN
bam-9579	350	96	,	,	PUNCT
bam-9579	350	97	ha	ha	INTJ
bam-9579	350	98	,	,	PUNCT
bam-9579	350	99	sjhs	sjhs	PROPN
bam-9579	350	100	,	,	PUNCT
bam-9579	350	101	mmi	mmi	PROPN
bam-9579	350	102	,	,	PUNCT
bam-9579	350	103	mm	mm	PROPN
bam-9579	350	104	,	,	PUNCT
bam-9579	350	105	ssm	ssm	PROPN
bam-9579	350	106	,	,	PUNCT
bam-9579	350	107	and	and	CCONJ
bam-9579	350	108	mz	mz	PROPN
bam-9579	350	109	contributed	contribute	VERB
bam-9579	350	110	to	to	ADP
bam-9579	350	111	the	the	DET
bam-9579	350	112	research	research	NOUN
bam-9579	350	113	concept	concept	NOUN
bam-9579	350	114	and	and	CCONJ
bam-9579	350	115	study	study	NOUN
bam-9579	350	116	design	design	NOUN
bam-9579	350	117	,	,	PUNCT
bam-9579	350	118	literature	literature	NOUN
bam-9579	350	119	review	review	PROPN
bam-9579	350	120	,	,	PUNCT
bam-9579	350	121	data	data	NOUN
bam-9579	350	122	collection	collection	NOUN
bam-9579	350	123	,	,	PUNCT
bam-9579	350	124	statistical	statistical	ADJ
bam-9579	350	125	analyses	analysis	NOUN
bam-9579	350	126	,	,	PUNCT
bam-9579	350	127	data	datum	NOUN
bam-9579	350	128	interpretation	interpretation	NOUN
bam-9579	350	129	,	,	PUNCT
bam-9579	350	130	manuscript	manuscript	NOUN
bam-9579	350	131	writing	writing	NOUN
bam-9579	350	132	and	and	CCONJ
bam-9579	350	133	review	review	VERB
bam-9579	350	134	.	.	PUNCT
bam-9579	351	1	acknowledgments	acknowledgment	NOUN
bam-9579	351	2	none	none	NOUN
bam-9579	351	3	funding	fund	VERB
bam-9579	351	4	none	none	NOUN
bam-9579	351	5	conflict	conflict	NOUN
bam-9579	351	6	of	of	ADP
bam-9579	351	7	interest	interest	NOUN
bam-9579	351	8	the	the	DET
bam-9579	351	9	authors	author	NOUN
bam-9579	351	10	declare	declare	VERB
bam-9579	351	11	no	no	DET
bam-9579	351	12	conflicts	conflict	NOUN
bam-9579	351	13	of	of	ADP
bam-9579	351	14	interest	interest	NOUN
bam-9579	351	15	.	.	PUNCT
bam-9579	352	1	ethical	ethical	ADJ
bam-9579	352	2	publication	publication	NOUN
bam-9579	352	3	statement	statement	NOUN
bam-9579	352	4	we	we	PRON
bam-9579	352	5	confirm	confirm	VERB
bam-9579	352	6	that	that	SCONJ
bam-9579	352	7	we	we	PRON
bam-9579	352	8	have	have	AUX
bam-9579	352	9	read	read	VERB
bam-9579	352	10	the	the	DET
bam-9579	352	11	journal	journal	NOUN
bam-9579	352	12	’s	’s	PART
bam-9579	352	13	position	position	NOUN
bam-9579	352	14	on	on	ADP
bam-9579	352	15	issues	issue	NOUN
bam-9579	352	16	involved	involve	VERB
bam-9579	352	17	in	in	ADP
bam-9579	352	18	ethical	ethical	ADJ
bam-9579	352	19	publication	publication	NOUN
bam-9579	352	20	and	and	CCONJ
bam-9579	352	21	affirm	affirm	NOUN
bam-9579	352	22	that	that	SCONJ
bam-9579	352	23	this	this	DET
bam-9579	352	24	report	report	NOUN
bam-9579	352	25	is	be	AUX
bam-9579	352	26	consistent	consistent	ADJ
bam-9579	352	27	with	with	ADP
bam-9579	352	28	those	those	DET
bam-9579	352	29	guidelines	guideline	NOUN
bam-9579	352	30	.	.	PUNCT
bam-9579	353	1	corresponding	correspond	VERB
bam-9579	353	2	author	author	NOUN
bam-9579	353	3	sarah	sarah	PROPN
bam-9579	353	4	dahmardeh	dahmardeh	PROPN
bam-9579	353	5	,	,	PUNCT
bam-9579	353	6	pasteur	pasteur	PROPN
bam-9579	353	7	institute	institute	PROPN
bam-9579	353	8	of	of	ADP
bam-9579	353	9	iran	iran	PROPN
bam-9579	353	10	,	,	PUNCT
bam-9579	353	11	tehran	tehran	PROPN
bam-9579	353	12	,	,	PUNCT
bam-9579	353	13	iran	iran	PROPN
bam-9579	353	14	.	.	PUNCT
bam-9579	354	1	orcid	orcid	NOUN
bam-9579	355	1	i	i	PRON
bam-9579	355	2	d	d	NOUN
bam-9579	355	3	:	:	PUNCT
bam-9579	355	4	0000	0000	NUM
bam-9579	355	5	-	-	PUNCT
bam-9579	355	6	0002	0002	NUM
bam-9579	355	7	-	-	PUNCT
bam-9579	355	8	0015	0015	NUM
bam-9579	355	9	-	-	PUNCT
bam-9579	355	10	2819	2819	NUM
bam-9579	355	11	sarah	sarah	PROPN
bam-9579	355	12	dahmardeh	dahmardeh	PROPN
bam-9579	355	13	:	:	PUNCT
bam-9579	356	1	sarahdahmardeh@gmail.com	sarahdahmardeh@gmail.com	X
bam-9579	357	1	e	e	X
bam-9579	357	2	-	-	NOUN
bam-9579	357	3	mails	mail	NOUN
bam-9579	357	4	and	and	CCONJ
bam-9579	357	5	orcid	orcid	NOUN
bam-9579	357	6	i	i	INTJ
bam-9579	357	7	d	d	PROPN
bam-9579	357	8	of	of	ADP
bam-9579	357	9	co	co	NOUN
bam-9579	357	10	-	-	NOUN
bam-9579	357	11	authors	author	NOUN
bam-9579	357	12	susan	susan	PROPN
bam-9579	357	13	azizmohammadi	azizmohammadi	PROPN
bam-9579	357	14	:	:	PUNCT
bam-9579	357	15	dr.azizmohamadi@gmail.com	dr.azizmohamadi@gmail.com	PROPN
bam-9579	357	16	orcid	orcid	PROPN
bam-9579	357	17	id:0000	id:0000	PROPN
bam-9579	357	18	-	-	PUNCT
bam-9579	357	19	0001	0001	NUM
bam-9579	357	20	-	-	PUNCT
bam-9579	357	21	7364	7364	NUM
bam-9579	357	22	-	-	SYM
bam-9579	357	23	1253	1253	NUM
bam-9579	357	24	sima	sima	NOUN
bam-9579	357	25	azizmohammad	azizmohammad	NOUN
bam-9579	357	26	:	:	PUNCT
bam-9579	358	1	simaazizmohammadi@yahoo.com	simaazizmohammadi@yahoo.com	X
bam-9579	358	2	orcid	orcid	PROPN
bam-9579	358	3	id:0000	id:0000	NUM
bam-9579	358	4	-	-	PUNCT
bam-9579	358	5	0003	0003	NUM
bam-9579	358	6	-	-	PUNCT
bam-9579	358	7	0560	0560	NUM
bam-9579	358	8	-	-	PUNCT
bam-9579	358	9	0497	0497	NUM
bam-9579	358	10	hossein	hossein	PROPN
bam-9579	358	11	azargashb	azargashb	PROPN
bam-9579	358	12	:	:	PUNCT
bam-9579	358	13	h_azargashb@yahoo.com	h_azargashb@yahoo.com	X
bam-9579	359	1	orcid	orcid	NOUN
bam-9579	360	1	i	i	INTJ
bam-9579	360	2	d	d	NOUN
bam-9579	360	3	:	:	PUNCT
bam-9579	360	4	0000	0000	NUM
bam-9579	360	5	-	-	PUNCT
bam-9579	360	6	0003	0003	NUM
bam-9579	360	7	-	-	PUNCT
bam-9579	360	8	1371	1371	NUM
bam-9579	360	9	-	-	SYM
bam-9579	360	10	1971	1971	NUM
bam-9579	360	11	seyyed	seyye	VERB
bam-9579	360	12	javad	javad	PROPN
bam-9579	360	13	hosseini	hosseini	PROPN
bam-9579	360	14	shokouh	shokouh	PROPN
bam-9579	360	15	:	:	PUNCT
bam-9579	360	16	sj.hoseini@ajaums.ac.ir	sj.hoseini@ajaums.ac.ir	PROPN
bam-9579	360	17	orcid	orcid	NOUN
bam-9579	360	18	i	i	NOUN
bam-9579	360	19	d	d	NOUN
bam-9579	360	20	:	:	PUNCT
bam-9579	360	21	0000	0000	NUM
bam-9579	360	22	-	-	PUNCT
bam-9579	360	23	0002	0002	NUM
bam-9579	360	24	-	-	PUNCT
bam-9579	360	25	13292	13292	NUM
bam-9579	360	26	-	-	PUNCT
bam-9579	360	27	1736	1736	NUM
bam-9579	360	28	mojgan	mojgan	ADJ
bam-9579	360	29	mohajeri	mohajeri	ADJ
bam-9579	360	30	-	-	PUNCT
bam-9579	360	31	iravani	iravani	NOUN
bam-9579	360	32	:	:	PUNCT
bam-9579	360	33	mojganmoon23001@gmail.com	mojganmoon23001@gmail.com	X
bam-9579	361	1	orcid	orcid	PROPN
bam-9579	362	1	i	i	PRON
bam-9579	362	2	d	d	NOUN
bam-9579	362	3	:	:	PUNCT
bam-9579	362	4	0000	0000	NUM
bam-9579	362	5	-	-	PUNCT
bam-9579	362	6	0001	0001	NUM
bam-9579	362	7	-	-	PUNCT
bam-9579	362	8	8279	8279	NUM
bam-9579	362	9	-	-	SYM
bam-9579	362	10	6273	6273	NUM
bam-9579	362	11	maziar	maziar	NOUN
bam-9579	362	12	mobasher	mobasher	NOUN
bam-9579	362	13	:	:	PUNCT
bam-9579	362	14	mobashermaziar.icm@gmail.com	mobashermaziar.icm@gmail.com	X
bam-9579	363	1	orcid	orcid	PROPN
bam-9579	364	1	i	i	PRON
bam-9579	364	2	d	d	NOUN
bam-9579	364	3	:	:	PUNCT
bam-9579	364	4	0000	0000	NUM
bam-9579	364	5	-	-	PUNCT
bam-9579	364	6	0001	0001	NUM
bam-9579	364	7	-	-	PUNCT
bam-9579	364	8	6677	6677	NUM
bam-9579	364	9	-	-	PUNCT
bam-9579	364	10	8235	8235	NUM
bam-9579	364	11	saeed	saeed	NOUN
bam-9579	364	12	soleiman	soleiman	NOUN
bam-9579	364	13	-	-	PUNCT
bam-9579	364	14	meigooni	meigooni	NOUN
bam-9579	364	15	:	:	PUNCT
bam-9579	365	1	dr.saeed.meigooni@gmail.com	dr.saeed.meigooni@gmail.com	PROPN
bam-9579	365	2	orcid	orcid	PROPN
bam-9579	366	1	i	i	PRON
bam-9579	366	2	d	d	NOUN
bam-9579	366	3	:	:	PUNCT
bam-9579	366	4	0000	0000	NUM
bam-9579	366	5	-	-	PUNCT
bam-9579	366	6	0001	0001	NUM
bam-9579	366	7	-	-	PUNCT
bam-9579	366	8	5641	5641	NUM
bam-9579	366	9	-	-	PUNCT
bam-9579	366	10	7380	7380	NUM
bam-9579	366	11	mahdi	mahdi	PROPN
bam-9579	366	12	zabihi	zabihi	PROPN
bam-9579	366	13	:	:	PUNCT
bam-9579	366	14	zabihi.nurse@gmail.com	zabihi.nurse@gmail.com	X
bam-9579	366	15	orcid	orcid	NOUN
bam-9579	367	1	i	i	NOUN
bam-9579	367	2	d	d	NOUN
bam-9579	367	3	:	:	PUNCT
bam-9579	367	4	0000	0000	NUM
bam-9579	367	5	-	-	PUNCT
bam-9579	367	6	0003	0003	NUM
bam-9579	367	7	-	-	SYM
bam-9579	367	8	1743	1743	NUM
bam-9579	367	9	-	-	SYM
bam-9579	367	10	8546	8546	NUM
bam-9579	367	11	references	reference	NOUN
bam-9579	367	12	1	1	NUM
bam-9579	367	13	.	.	PUNCT
bam-9579	367	14	bogoch	bogoch	PROPN
bam-9579	367	15	ii	ii	PROPN
bam-9579	367	16	,	,	PUNCT
bam-9579	367	17	watts	watt	VERB
bam-9579	367	18	a	a	PRON
bam-9579	367	19	,	,	PUNCT
bam-9579	367	20	thomas	thomas	PROPN
bam-9579	367	21	-	-	PUNCT
bam-9579	367	22	bachli	bachli	PROPN
bam-9579	367	23	a	a	PRON
bam-9579	367	24	,	,	PUNCT
bam-9579	367	25	huber	huber	PROPN
bam-9579	367	26	c	c	PROPN
bam-9579	367	27	,	,	PUNCT
bam-9579	367	28	kraemer	kraemer	PROPN
bam-9579	367	29	mug	mug	PROPN
bam-9579	367	30	,	,	PUNCT
bam-9579	367	31	khan	khan	PROPN
bam-9579	367	32	k.	k.	PROPN
bam-9579	367	33	potential	potential	PROPN
bam-9579	367	34	for	for	ADP
bam-9579	367	35	global	global	ADJ
bam-9579	367	36	spread	spread	NOUN
bam-9579	367	37	of	of	ADP
bam-9579	367	38	a	a	DET
bam-9579	367	39	novel	novel	ADJ
bam-9579	367	40	coronavirus	coronavirus	NOUN
bam-9579	367	41	from	from	ADP
bam-9579	367	42	china	china	PROPN
bam-9579	367	43	.	.	PUNCT
bam-9579	368	1	j	j	PROPN
bam-9579	368	2	travel	travel	PROPN
bam-9579	368	3	med	me	VERB
bam-9579	368	4	.	.	PUNCT
bam-9579	369	1	2020	2020	NUM
bam-9579	369	2	mar	mar	PROPN
bam-9579	369	3	13;27(2):taaa011	13;27(2):taaa011	NUM
bam-9579	369	4	.	.	PUNCT
bam-9579	370	1	doi	doi	NOUN
bam-9579	370	2	:	:	PUNCT
bam-9579	370	3	10.1093	10.1093	NUM
bam-9579	370	4	/	/	SYM
bam-9579	370	5	jtm/	jtm/	PROPN
bam-9579	370	6	taaa011	taaa011	PROPN
bam-9579	370	7	.	.	PROPN
bam-9579	370	8	2	2	NUM
bam-9579	370	9	.	.	X
bam-9579	370	10	national	national	PROPN
bam-9579	370	11	health	health	PROPN
bam-9579	370	12	commission	commission	PROPN
bam-9579	370	13	of	of	ADP
bam-9579	370	14	the	the	DET
bam-9579	370	15	people	people	NOUN
bam-9579	370	16	's	's	PART
bam-9579	370	17	republic	republic	NOUN
bam-9579	370	18	of	of	ADP
bam-9579	370	19	china	china	PROPN
bam-9579	370	20	.	.	PUNCT
bam-9579	371	1	the	the	DET
bam-9579	371	2	latest	late	ADJ
bam-9579	371	3	situation	situation	NOUN
bam-9579	371	4	of	of	ADP
bam-9579	371	5	the	the	DET
bam-9579	371	6	new	new	ADJ
bam-9579	371	7	coronavirus	coronavirus	NOUN
bam-9579	371	8	pneumonia	pneumonia	NOUN
bam-9579	371	9	epidemic	epidemic	NOUN
bam-9579	371	10	situation	situation	NOUN
bam-9579	371	11	as	as	ADP
bam-9579	371	12	of	of	ADP
bam-9579	371	13	24:00	24:00	NUM
bam-9579	371	14	on	on	ADP
bam-9579	371	15	february	february	PROPN
bam-9579	371	16	18	18	NUM
bam-9579	371	17	.	.	PUNCT
bam-9579	372	1	[	[	X
bam-9579	372	2	eb	eb	PROPN
bam-9579	372	3	/	/	SYM
bam-9579	372	4	ol].[2020	ol].[2020	PROPN
bam-9579	372	5	-	-	PUNCT
bam-9579	372	6	02	02	NUM
bam-9579	372	7	-	-	PUNCT
bam-9579	372	8	19	19	NUM
bam-9579	372	9	]	]	SYM
bam-9579	372	10	3	3	NUM
bam-9579	372	11	.	.	PUNCT
bam-9579	372	12	shang	shang	PROPN
bam-9579	372	13	y	y	PROPN
bam-9579	372	14	,	,	PUNCT
bam-9579	372	15	pan	pan	PROPN
bam-9579	372	16	c	c	PROPN
bam-9579	372	17	,	,	PUNCT
bam-9579	372	18	yang	yang	PROPN
bam-9579	372	19	x	x	PROPN
bam-9579	372	20	,	,	PUNCT
bam-9579	372	21	zhong	zhong	PROPN
bam-9579	372	22	m	m	PROPN
bam-9579	372	23	,	,	PUNCT
bam-9579	372	24	shang	shang	PROPN
bam-9579	372	25	x	x	PROPN
bam-9579	372	26	,	,	PUNCT
bam-9579	372	27	wu	wu	PROPN
bam-9579	372	28	z	z	PROPN
bam-9579	372	29	,	,	PUNCT
bam-9579	372	30	yu	yu	PROPN
bam-9579	372	31	z	z	PROPN
bam-9579	372	32	,	,	PUNCT
bam-9579	372	33	zhang	zhang	PROPN
bam-9579	372	34	w	w	PROPN
bam-9579	372	35	,	,	PUNCT
bam-9579	372	36	zhong	zhong	PROPN
bam-9579	372	37	q	q	X
bam-9579	372	38	,	,	PUNCT
bam-9579	372	39	zheng	zheng	PROPN
bam-9579	372	40	x	x	AUX
bam-9579	372	41	,	,	PUNCT
bam-9579	372	42	sang	sing	VERB
bam-9579	372	43	l	l	NOUN
bam-9579	372	44	,	,	PUNCT
bam-9579	372	45	jiang	jiang	PROPN
bam-9579	372	46	l	l	PROPN
bam-9579	372	47	,	,	PUNCT
bam-9579	373	1	zhang	zhang	PROPN
bam-9579	373	2	j	j	PROPN
bam-9579	373	3	,	,	PUNCT
bam-9579	373	4	xiong	xiong	PROPN
bam-9579	373	5	w	w	PROPN
bam-9579	373	6	,	,	PUNCT
bam-9579	373	7	liu	liu	PROPN
bam-9579	373	8	j	j	PROPN
bam-9579	373	9	,	,	PUNCT
bam-9579	373	10	chen	chen	PROPN
bam-9579	373	11	d.	d.	PROPN
bam-9579	373	12	management	management	PROPN
bam-9579	373	13	of	of	ADP
bam-9579	373	14	critically	critically	ADV
bam-9579	373	15	ill	ill	ADJ
bam-9579	373	16	patients	patient	NOUN
bam-9579	373	17	with	with	ADP
bam-9579	373	18	covid19	covid19	NOUN
bam-9579	373	19	in	in	ADP
bam-9579	373	20	icu	icu	PROPN
bam-9579	373	21	:	:	PUNCT
bam-9579	373	22	statement	statement	NOUN
bam-9579	373	23	from	from	ADP
bam-9579	373	24	front	front	ADJ
bam-9579	373	25	-	-	PUNCT
bam-9579	373	26	line	line	NOUN
bam-9579	373	27	intensive	intensive	ADJ
bam-9579	373	28	care	care	NOUN
bam-9579	373	29	experts	expert	NOUN
bam-9579	373	30	in	in	ADP
bam-9579	373	31	wuhan	wuhan	PROPN
bam-9579	373	32	,	,	PUNCT
bam-9579	373	33	china	china	PROPN
bam-9579	373	34	.	.	PUNCT
bam-9579	374	1	ann	ann	PROPN
bam-9579	374	2	intensive	intensive	ADJ
bam-9579	374	3	care	care	NOUN
bam-9579	374	4	.	.	PUNCT
bam-9579	375	1	2020	2020	NUM
bam-9579	375	2	jun	jun	PROPN
bam-9579	375	3	6;10(1):73	6;10(1):73	NUM
bam-9579	375	4	.	.	PUNCT
bam-9579	376	1	doi	doi	NOUN
bam-9579	376	2	:	:	PUNCT
bam-9579	376	3	10.1186	10.1186	NUM
bam-9579	376	4	/	/	SYM
bam-9579	376	5	s13613	s13613	PROPN
bam-9579	376	6	-	-	PUNCT
bam-9579	376	7	020	020	NUM
bam-9579	376	8	-	-	PUNCT
bam-9579	376	9	00689	00689	NUM
bam-9579	376	10	-	-	SYM
bam-9579	376	11	1	1	NUM
bam-9579	376	12	.	.	NOUN
bam-9579	376	13	4	4	NUM
bam-9579	376	14	.	.	X
bam-9579	377	1	huang	huang	PROPN
bam-9579	377	2	c	c	PROPN
bam-9579	377	3	,	,	PUNCT
bam-9579	377	4	wang	wang	PROPN
bam-9579	377	5	y	y	PROPN
bam-9579	377	6	,	,	PUNCT
bam-9579	377	7	li	li	PROPN
bam-9579	377	8	x	x	PROPN
bam-9579	377	9	,	,	PUNCT
bam-9579	377	10	ren	ren	PROPN
bam-9579	377	11	l	l	PROPN
bam-9579	377	12	,	,	PUNCT
bam-9579	377	13	zhao	zhao	PROPN
bam-9579	377	14	j	j	PROPN
bam-9579	377	15	,	,	PUNCT
bam-9579	377	16	hu	hu	PROPN
bam-9579	377	17	y	y	PROPN
bam-9579	377	18	,	,	PUNCT
bam-9579	377	19	zhang	zhang	PROPN
bam-9579	377	20	l	l	PROPN
bam-9579	377	21	,	,	PUNCT
bam-9579	377	22	fan	fan	PROPN
bam-9579	377	23	g	g	PROPN
bam-9579	377	24	,	,	PUNCT
bam-9579	377	25	xu	xu	PROPN
bam-9579	377	26	j	j	PROPN
bam-9579	377	27	,	,	PUNCT
bam-9579	377	28	gu	gu	PROPN
bam-9579	377	29	x	x	PROPN
bam-9579	377	30	,	,	PUNCT
bam-9579	377	31	cheng	cheng	PROPN
bam-9579	377	32	z	z	PROPN
bam-9579	377	33	,	,	PUNCT
bam-9579	377	34	yu	yu	PROPN
bam-9579	377	35	t	t	PROPN
bam-9579	377	36	,	,	PUNCT
bam-9579	377	37	xia	xia	PROPN
bam-9579	377	38	j	j	PROPN
bam-9579	377	39	,	,	PUNCT
bam-9579	377	40	wei	wei	PROPN
bam-9579	377	41	y	y	PROPN
bam-9579	377	42	,	,	PUNCT
bam-9579	377	43	wu	wu	PROPN
bam-9579	377	44	w	w	PROPN
bam-9579	377	45	,	,	PUNCT
bam-9579	377	46	xie	xie	PROPN
bam-9579	377	47	x	x	PROPN
bam-9579	377	48	,	,	PUNCT
bam-9579	377	49	yin	yin	PROPN
bam-9579	377	50	w	w	PROPN
bam-9579	377	51	,	,	PUNCT
bam-9579	377	52	li	li	PROPN
bam-9579	377	53	h	h	PROPN
bam-9579	377	54	,	,	PUNCT
bam-9579	377	55	liu	liu	PROPN
bam-9579	377	56	m	m	PROPN
bam-9579	377	57	,	,	PUNCT
bam-9579	377	58	xiao	xiao	PROPN
bam-9579	377	59	y	y	PROPN
bam-9579	377	60	,	,	PUNCT
bam-9579	377	61	gao	gao	PROPN
bam-9579	377	62	h	h	PROPN
bam-9579	377	63	,	,	PUNCT
bam-9579	377	64	guo	guo	PROPN
bam-9579	377	65	l	l	PROPN
bam-9579	377	66	,	,	PUNCT
bam-9579	377	67	xie	xie	PROPN
bam-9579	377	68	j	j	PROPN
bam-9579	377	69	,	,	PUNCT
bam-9579	377	70	wang	wang	PROPN
bam-9579	377	71	g	g	PROPN
bam-9579	377	72	,	,	PUNCT
bam-9579	377	73	jiang	jiang	PROPN
bam-9579	377	74	r	r	PROPN
bam-9579	377	75	,	,	PUNCT
bam-9579	377	76	gao	gao	PROPN
bam-9579	377	77	z	z	PROPN
bam-9579	377	78	,	,	PUNCT
bam-9579	377	79	jin	jin	PROPN
bam-9579	377	80	q	q	PROPN
bam-9579	377	81	,	,	PUNCT
bam-9579	377	82	wang	wang	PROPN
bam-9579	377	83	j	j	PROPN
bam-9579	377	84	,	,	PUNCT
bam-9579	377	85	cao	cao	PROPN
bam-9579	377	86	b.	b.	PROPN
bam-9579	377	87	clinical	clinical	PROPN
bam-9579	377	88	features	feature	NOUN
bam-9579	377	89	of	of	ADP
bam-9579	377	90	patients	patient	NOUN
bam-9579	377	91	infected	infect	VERB
bam-9579	377	92	with	with	ADP
bam-9579	377	93	2019	2019	NUM
bam-9579	377	94	novel	novel	ADJ
bam-9579	377	95	coronavirus	coronavirus	NOUN
bam-9579	377	96	in	in	ADP
bam-9579	377	97	wuhan	wuhan	PROPN
bam-9579	377	98	,	,	PUNCT
bam-9579	377	99	china	china	PROPN
bam-9579	377	100	.	.	PUNCT
bam-9579	378	1	lancet	lancet	PROPN
bam-9579	378	2	.	.	PUNCT
bam-9579	379	1	2020	2020	NUM
bam-9579	379	2	feb	feb	PROPN
bam-9579	379	3	15;395(10223):497	15;395(10223):497	NUM
bam-9579	379	4	-	-	SYM
bam-9579	379	5	506	506	NUM
bam-9579	379	6	.	.	PUNCT
bam-9579	380	1	doi	doi	NOUN
bam-9579	380	2	:	:	PUNCT
bam-9579	380	3	10.1016	10.1016	NUM
bam-9579	380	4	/	/	SYM
bam-9579	380	5	s0140	s0140	PROPN
bam-9579	380	6	-	-	PUNCT
bam-9579	380	7	6736(20)30183	6736(20)30183	NUM
bam-9579	380	8	-	-	PUNCT
bam-9579	380	9	5	5	NUM
bam-9579	380	10	.	.	PUNCT
bam-9579	381	1	epub	epub	NOUN
bam-9579	381	2	2020	2020	NUM
bam-9579	381	3	jan	jan	PROPN
bam-9579	381	4	24	24	NUM
bam-9579	381	5	.	.	PUNCT
bam-9579	381	6	erratum	erratum	PROPN
bam-9579	381	7	in	in	ADP
bam-9579	381	8	:	:	PUNCT
bam-9579	381	9	lancet	lancet	PROPN
bam-9579	381	10	.	.	PUNCT
bam-9579	382	1	2020	2020	NUM
bam-9579	382	2	jan	jan	PROPN
bam-9579	382	3	30	30	NUM
bam-9579	382	4	.	.	PUNCT
bam-9579	383	1	5	5	NUM
bam-9579	383	2	.	.	X
bam-9579	384	1	wang	wang	PROPN
bam-9579	384	2	d	d	PROPN
bam-9579	384	3	,	,	PUNCT
bam-9579	384	4	hu	hu	PROPN
bam-9579	384	5	b	b	PROPN
bam-9579	384	6	,	,	PUNCT
bam-9579	384	7	hu	hu	PROPN
bam-9579	384	8	c	c	PROPN
bam-9579	384	9	,	,	PUNCT
bam-9579	384	10	zhu	zhu	PROPN
bam-9579	384	11	f	f	X
bam-9579	384	12	,	,	PUNCT
bam-9579	384	13	liu	liu	PROPN
bam-9579	384	14	x	x	PROPN
bam-9579	384	15	,	,	PUNCT
bam-9579	384	16	zhang	zhang	PROPN
bam-9579	384	17	j	j	PROPN
bam-9579	384	18	,	,	PUNCT
bam-9579	384	19	wang	wang	PROPN
bam-9579	384	20	b	b	PROPN
bam-9579	384	21	,	,	PUNCT
bam-9579	384	22	xiang	xiang	PROPN
bam-9579	384	23	h	h	PROPN
bam-9579	384	24	,	,	PUNCT
bam-9579	384	25	cheng	cheng	PROPN
bam-9579	384	26	z	z	PROPN
bam-9579	384	27	,	,	PUNCT
bam-9579	384	28	xiong	xiong	PROPN
bam-9579	384	29	y	y	PROPN
bam-9579	384	30	,	,	PUNCT
bam-9579	384	31	zhao	zhao	PROPN
bam-9579	384	32	y	y	PROPN
bam-9579	384	33	,	,	PUNCT
bam-9579	384	34	li	li	PROPN
bam-9579	384	35	y	y	PROPN
bam-9579	384	36	,	,	PUNCT
bam-9579	384	37	wang	wang	PROPN
bam-9579	384	38	x	x	PROPN
bam-9579	384	39	,	,	PUNCT
bam-9579	384	40	peng	peng	PROPN
bam-9579	384	41	z.	z.	PROPN
bam-9579	384	42	clinical	clinical	PROPN
bam-9579	384	43	characteristics	characteristic	NOUN
bam-9579	384	44	of	of	ADP
bam-9579	384	45	138	138	NUM
bam-9579	384	46	hospitalized	hospitalize	VERB
bam-9579	384	47	patients	patient	NOUN
bam-9579	384	48	with	with	ADP
bam-9579	384	49	2019	2019	NUM
bam-9579	384	50	novel	novel	ADJ
bam-9579	384	51	coronavirus	coronavirus	NOUN
bam-9579	384	52	-	-	PUNCT
bam-9579	384	53	infected	infect	VERB
bam-9579	384	54	pneumonia	pneumonia	NOUN
bam-9579	384	55	in	in	ADP
bam-9579	384	56	wuhan	wuhan	PROPN
bam-9579	384	57	,	,	PUNCT
bam-9579	384	58	china	china	PROPN
bam-9579	384	59	.	.	PUNCT
bam-9579	385	1	jama	jama	PROPN
bam-9579	385	2	.	.	PUNCT
bam-9579	386	1	2020	2020	NUM
bam-9579	386	2	mar	mar	PROPN
bam-9579	386	3	17;323(11):1061	17;323(11):1061	NUM
bam-9579	386	4	-	-	SYM
bam-9579	386	5	1069	1069	NUM
bam-9579	386	6	.	.	PUNCT
bam-9579	387	1	doi	doi	NOUN
bam-9579	387	2	:	:	PUNCT
bam-9579	387	3	10.1001	10.1001	NUM
bam-9579	387	4	/	/	SYM
bam-9579	387	5	jama.2020.1585	jama.2020.1585	PROPN
bam-9579	387	6	.	.	PUNCT
bam-9579	388	1	erratum	erratum	PROPN
bam-9579	388	2	in	in	ADP
bam-9579	388	3	:	:	PUNCT
bam-9579	388	4	jama	jama	PROPN
bam-9579	388	5	.	.	PUNCT
bam-9579	389	1	2021	2021	NUM
bam-9579	389	2	mar	mar	PROPN
bam-9579	389	3	16;325(11):1113	16;325(11):1113	PROPN
bam-9579	389	4	.	.	PUNCT
bam-9579	390	1	6	6	NUM
bam-9579	390	2	.	.	X
bam-9579	390	3	chan	chan	PROPN
bam-9579	390	4	jf	jf	PROPN
bam-9579	390	5	,	,	PUNCT
bam-9579	390	6	yuan	yuan	PROPN
bam-9579	390	7	s	s	PROPN
bam-9579	390	8	,	,	PUNCT
bam-9579	390	9	kok	kok	PROPN
bam-9579	390	10	kh	kh	PROPN
bam-9579	390	11	,	,	PUNCT
bam-9579	390	12	to	to	ADP
bam-9579	390	13	kk	kk	PROPN
bam-9579	390	14	,	,	PUNCT
bam-9579	390	15	chu	chu	PROPN
bam-9579	390	16	h	h	PROPN
bam-9579	390	17	,	,	PUNCT
bam-9579	390	18	yang	yang	PROPN
bam-9579	390	19	j	j	PROPN
bam-9579	390	20	,	,	PUNCT
bam-9579	390	21	xing	xing	PROPN
bam-9579	390	22	f	f	PROPN
bam-9579	390	23	,	,	PUNCT
bam-9579	390	24	liu	liu	PROPN
bam-9579	390	25	j	j	PROPN
bam-9579	390	26	,	,	PUNCT
bam-9579	390	27	yip	yip	PROPN
bam-9579	390	28	cc	cc	PROPN
bam-9579	390	29	,	,	PUNCT
bam-9579	390	30	poon	poon	NOUN
bam-9579	390	31	rw	rw	NOUN
bam-9579	390	32	,	,	PUNCT
bam-9579	390	33	tsoi	tsoi	PROPN
bam-9579	390	34	hw	hw	PROPN
bam-9579	390	35	,	,	PUNCT
bam-9579	390	36	lo	lo	PROPN
bam-9579	390	37	sk	sk	PROPN
bam-9579	390	38	,	,	PUNCT
bam-9579	390	39	chan	chan	PROPN
bam-9579	390	40	kh	kh	PROPN
bam-9579	390	41	,	,	PUNCT
bam-9579	390	42	poon	poon	NOUN
bam-9579	390	43	vk	vk	PROPN
bam-9579	390	44	,	,	PUNCT
bam-9579	390	45	chan	chan	PROPN
bam-9579	390	46	wm	wm	PROPN
bam-9579	390	47	,	,	PUNCT
bam-9579	390	48	ip	ip	PROPN
bam-9579	391	1	jd	jd	PROPN
bam-9579	391	2	,	,	PUNCT
bam-9579	391	3	cai	cai	PROPN
bam-9579	391	4	jp	jp	PROPN
bam-9579	391	5	,	,	PUNCT
bam-9579	391	6	cheng	cheng	PROPN
bam-9579	391	7	vc	vc	PROPN
bam-9579	391	8	,	,	PUNCT
bam-9579	391	9	chen	chen	PROPN
bam-9579	391	10	h	h	PROPN
bam-9579	391	11	,	,	PUNCT
bam-9579	391	12	hui	hui	PROPN
bam-9579	391	13	ck	ck	PROPN
bam-9579	391	14	,	,	PUNCT
bam-9579	391	15	yuen	yuen	PROPN
bam-9579	391	16	ky	ky	PROPN
bam-9579	391	17	.	.	PUNCT
bam-9579	392	1	a	a	DET
bam-9579	392	2	familial	familial	ADJ
bam-9579	392	3	cluster	cluster	NOUN
bam-9579	392	4	of	of	ADP
bam-9579	392	5	pneumonia	pneumonia	NOUN
bam-9579	392	6	associated	associate	VERB
bam-9579	392	7	with	with	ADP
bam-9579	392	8	the	the	DET
bam-9579	392	9	2019	2019	NUM
bam-9579	392	10	novel	novel	ADJ
bam-9579	392	11	coronavirus	coronavirus	NOUN
bam-9579	392	12	indicating	indicate	VERB
bam-9579	392	13	person	person	NOUN
bam-9579	392	14	-	-	PUNCT
bam-9579	392	15	to	to	ADP
bam-9579	392	16	-	-	PUNCT
bam-9579	392	17	person	person	NOUN
bam-9579	392	18	transmission	transmission	NOUN
bam-9579	392	19	:	:	PUNCT
bam-9579	392	20	a	a	DET
bam-9579	392	21	study	study	NOUN
bam-9579	392	22	of	of	ADP
bam-9579	392	23	a	a	DET
bam-9579	392	24	family	family	NOUN
bam-9579	392	25	cluster	cluster	NOUN
bam-9579	392	26	.	.	PUNCT
bam-9579	393	1	lancet	lancet	PROPN
bam-9579	393	2	.	.	PUNCT
bam-9579	394	1	mailto:sarahdahmardeh@gmail.com	mailto:sarahdahmardeh@gmail.com	X
bam-9579	395	1	mailto:dr.azizmohamadi@gmail.com	mailto:dr.azizmohamadi@gmail.com	PROPN
bam-9579	395	2	mailto:simaazizmohammadi@yahoo.com	mailto:simaazizmohammadi@yahoo.com	PROPN
bam-9579	396	1	mailto:h_azargashb@yahoo.com	mailto:h_azargashb@yahoo.com	X
bam-9579	396	2	mailto:sj.hoseini@ajaums.ac.ir	mailto:sj.hoseini@ajaums.ac.ir	PROPN
bam-9579	396	3	mailto:mojganmoon23001@gmail.com	mailto:mojganmoon23001@gmail.com	PROPN
bam-9579	396	4	mailto:mobashermaziar.icm@gmail.com	mailto:mobashermaziar.icm@gmail.com	PROPN
bam-9579	396	5	mailto:dr.saeed.meigooni@gmail.com	mailto:dr.saeed.meigooni@gmail.com	PROPN
bam-9579	396	6	mailto:zabihi.nurse@gmail.com	mailto:zabihi.nurse@gmail.com	PROPN
bam-9579	396	7	https://orcid.org/0000-0003-1743-8546	https://orcid.org/0000-0003-1743-8546	PROPN
bam-9579	396	8	ordinary	ordinary	ADJ
bam-9579	396	9	and	and	CCONJ
bam-9579	396	10	severe	severe	ADJ
bam-9579	396	11	cases	case	NOUN
bam-9579	396	12	of	of	ADP
bam-9579	396	13	covid-19	covid-19	PROPN
bam-9579	396	14	in	in	ADP
bam-9579	396	15	iran	iran	PROPN
bam-9579	396	16	eur	eur	PROPN
bam-9579	396	17	j	j	PROPN
bam-9579	396	18	transl	transl	PROPN
bam-9579	396	19	myol	myol	ADV
bam-9579	396	20	31	31	NUM
bam-9579	396	21	(	(	PUNCT
bam-9579	396	22	3	3	NUM
bam-9579	396	23	):	):	PUNCT
bam-9579	396	24	9579	9579	NUM
bam-9579	396	25	,	,	PUNCT
bam-9579	396	26	2021	2021	NUM
bam-9579	396	27	doi	doi	NOUN
bam-9579	396	28	:	:	PUNCT
bam-9579	396	29	10.4081	10.4081	NUM
bam-9579	396	30	/	/	SYM
bam-9579	396	31	ejtm.2021.9579	ejtm.2021.9579	NUM
bam-9579	396	32	8	8	NUM
bam-9579	396	33	2020	2020	NUM
bam-9579	396	34	feb	feb	NOUN
bam-9579	396	35	15;395(10223):514	15;395(10223):514	NUM
bam-9579	396	36	-	-	SYM
bam-9579	396	37	523	523	NUM
bam-9579	396	38	.	.	PUNCT
bam-9579	397	1	doi	doi	NOUN
bam-9579	397	2	:	:	PUNCT
bam-9579	397	3	10.1016/	10.1016/	NUM
bam-9579	397	4	s0140	s0140	PROPN
bam-9579	397	5	-	-	PUNCT
bam-9579	397	6	6736(20)30154	6736(20)30154	NOUN
bam-9579	397	7	-	-	SYM
bam-9579	397	8	9	9	NUM
bam-9579	397	9	.	.	PUNCT
bam-9579	398	1	epub	epub	PROPN
bam-9579	398	2	2020	2020	NUM
bam-9579	398	3	jan	jan	PROPN
bam-9579	398	4	24	24	NUM
bam-9579	398	5	.	.	PUNCT
bam-9579	398	6	7	7	X
bam-9579	398	7	.	.	X
bam-9579	399	1	ren	ren	PROPN
bam-9579	399	2	ll	ll	AUX
bam-9579	399	3	,	,	PUNCT
bam-9579	399	4	wang	wang	PROPN
bam-9579	399	5	ym	ym	PROPN
bam-9579	399	6	,	,	PUNCT
bam-9579	399	7	wu	wu	PROPN
bam-9579	399	8	zq	zq	PROPN
bam-9579	399	9	,	,	PUNCT
bam-9579	399	10	xiang	xiang	PROPN
bam-9579	399	11	zc	zc	PROPN
bam-9579	399	12	,	,	PUNCT
bam-9579	399	13	guo	guo	PROPN
bam-9579	399	14	l	l	PROPN
bam-9579	399	15	,	,	PUNCT
bam-9579	399	16	xu	xu	PROPN
bam-9579	399	17	t	t	PROPN
bam-9579	399	18	,	,	PUNCT
bam-9579	399	19	jiang	jiang	PROPN
bam-9579	399	20	yz	yz	PROPN
bam-9579	399	21	,	,	PUNCT
bam-9579	399	22	xiong	xiong	PROPN
bam-9579	399	23	y	y	PROPN
bam-9579	399	24	,	,	PUNCT
bam-9579	399	25	li	li	PROPN
bam-9579	399	26	yj	yj	PROPN
bam-9579	399	27	,	,	PUNCT
bam-9579	399	28	li	li	PROPN
bam-9579	399	29	xw	xw	PROPN
bam-9579	399	30	,	,	PUNCT
bam-9579	399	31	li	li	PROPN
bam-9579	399	32	h	h	PROPN
bam-9579	399	33	,	,	PUNCT
bam-9579	399	34	fan	fan	PROPN
bam-9579	399	35	gh	gh	PROPN
bam-9579	399	36	,	,	PUNCT
bam-9579	399	37	gu	gu	NOUN
bam-9579	399	38	xy	xy	PROPN
bam-9579	399	39	,	,	PUNCT
bam-9579	399	40	xiao	xiao	PROPN
bam-9579	399	41	y	y	PROPN
bam-9579	399	42	,	,	PUNCT
bam-9579	399	43	gao	gao	PROPN
bam-9579	399	44	h	h	PROPN
bam-9579	399	45	,	,	PUNCT
bam-9579	399	46	xu	xu	PROPN
bam-9579	400	1	jy	jy	PROPN
bam-9579	400	2	,	,	PUNCT
bam-9579	400	3	yang	yang	PROPN
bam-9579	400	4	f	f	PROPN
bam-9579	400	5	,	,	PUNCT
bam-9579	400	6	wang	wang	PROPN
bam-9579	400	7	xm	xm	PROPN
bam-9579	400	8	,	,	PUNCT
bam-9579	400	9	wu	wu	PROPN
bam-9579	400	10	c	c	PROPN
bam-9579	400	11	,	,	PUNCT
bam-9579	400	12	chen	chen	PROPN
bam-9579	400	13	l	l	PROPN
bam-9579	400	14	,	,	PUNCT
bam-9579	400	15	liu	liu	PROPN
bam-9579	400	16	yw	yw	PROPN
bam-9579	400	17	,	,	PUNCT
bam-9579	400	18	liu	liu	PROPN
bam-9579	400	19	b	b	PROPN
bam-9579	400	20	,	,	PUNCT
bam-9579	400	21	yang	yang	PROPN
bam-9579	400	22	j	j	PROPN
bam-9579	400	23	,	,	PUNCT
bam-9579	400	24	wang	wang	PROPN
bam-9579	400	25	xr	xr	PROPN
bam-9579	400	26	,	,	PUNCT
bam-9579	400	27	dong	dong	PROPN
bam-9579	400	28	j	j	PROPN
bam-9579	400	29	,	,	PUNCT
bam-9579	400	30	li	li	PROPN
bam-9579	400	31	l	l	PROPN
bam-9579	400	32	,	,	PUNCT
bam-9579	400	33	huang	huang	PROPN
bam-9579	400	34	cl	cl	PROPN
bam-9579	400	35	,	,	PUNCT
bam-9579	400	36	zhao	zhao	PROPN
bam-9579	400	37	jp	jp	PROPN
bam-9579	400	38	,	,	PUNCT
bam-9579	400	39	hu	hu	PROPN
bam-9579	401	1	y	y	PROPN
bam-9579	401	2	,	,	PUNCT
bam-9579	401	3	cheng	cheng	PROPN
bam-9579	401	4	zs	zs	PROPN
bam-9579	401	5	,	,	PUNCT
bam-9579	401	6	liu	liu	PROPN
bam-9579	401	7	ll	ll	PROPN
bam-9579	401	8	,	,	PUNCT
bam-9579	401	9	qian	qian	PROPN
bam-9579	401	10	zh	zh	PROPN
bam-9579	401	11	,	,	PUNCT
bam-9579	401	12	qin	qin	PROPN
bam-9579	401	13	c	c	X
bam-9579	401	14	,	,	PUNCT
bam-9579	401	15	jin	jin	PROPN
bam-9579	401	16	q	q	PROPN
bam-9579	401	17	,	,	PUNCT
bam-9579	402	1	cao	cao	PROPN
bam-9579	402	2	b	b	PROPN
bam-9579	402	3	,	,	PUNCT
bam-9579	402	4	wang	wang	PROPN
bam-9579	402	5	jw	jw	PROPN
bam-9579	402	6	.	.	PROPN
bam-9579	402	7	identification	identification	NOUN
bam-9579	402	8	of	of	ADP
bam-9579	402	9	a	a	DET
bam-9579	402	10	novel	novel	ADJ
bam-9579	402	11	coronavirus	coronavirus	NOUN
bam-9579	402	12	causing	cause	VERB
bam-9579	402	13	severe	severe	ADJ
bam-9579	402	14	pneumonia	pneumonia	NOUN
bam-9579	402	15	in	in	ADP
bam-9579	402	16	human	human	NOUN
bam-9579	402	17	:	:	PUNCT
bam-9579	402	18	a	a	DET
bam-9579	402	19	descriptive	descriptive	ADJ
bam-9579	402	20	study	study	NOUN
bam-9579	402	21	.	.	PUNCT
bam-9579	403	1	chin	chin	PROPN
bam-9579	403	2	med	med	PROPN
bam-9579	403	3	j	j	PROPN
bam-9579	403	4	(	(	PUNCT
bam-9579	403	5	engl	engl	PROPN
bam-9579	403	6	)	)	PUNCT
bam-9579	403	7	.	.	PUNCT
bam-9579	404	1	2020	2020	NUM
bam-9579	404	2	may	may	AUX
bam-9579	404	3	5;133(9):1015	5;133(9):1015	PROPN
bam-9579	404	4	-	-	PUNCT
bam-9579	404	5	1024	1024	NUM
bam-9579	404	6	.	.	PUNCT
bam-9579	405	1	doi	doi	NOUN
bam-9579	405	2	:	:	PUNCT
bam-9579	405	3	10.1097	10.1097	NUM
bam-9579	405	4	/	/	SYM
bam-9579	405	5	cm9.0000000000000722	cm9.0000000000000722	NOUN
bam-9579	405	6	.	.	NOUN
bam-9579	405	7	8	8	NUM
bam-9579	405	8	.	.	PUNCT
bam-9579	406	1	chen	chen	PROPN
bam-9579	406	2	y	y	PROPN
bam-9579	406	3	,	,	PUNCT
bam-9579	406	4	liu	liu	PROPN
bam-9579	406	5	q	q	PROPN
bam-9579	406	6	,	,	PUNCT
bam-9579	406	7	guo	guo	PROPN
bam-9579	406	8	d.	d.	NOUN
bam-9579	406	9	emerging	emerge	VERB
bam-9579	406	10	coronaviruses	coronaviruse	NOUN
bam-9579	406	11	:	:	PUNCT
bam-9579	406	12	genome	genome	NOUN
bam-9579	406	13	structure	structure	NOUN
bam-9579	406	14	,	,	PUNCT
bam-9579	406	15	replication	replication	NOUN
bam-9579	406	16	,	,	PUNCT
bam-9579	406	17	and	and	CCONJ
bam-9579	406	18	pathogenesis	pathogenesis	NOUN
bam-9579	406	19	.	.	PUNCT
bam-9579	407	1	j	j	PROPN
bam-9579	407	2	med	med	PROPN
bam-9579	407	3	virol	virol	NOUN
bam-9579	407	4	.	.	PUNCT
bam-9579	408	1	2020	2020	NUM
bam-9579	408	2	apr;92(4):418	apr;92(4):418	NOUN
bam-9579	408	3	-	-	PUNCT
bam-9579	408	4	423	423	NUM
bam-9579	408	5	.	.	PUNCT
bam-9579	409	1	doi	doi	NOUN
bam-9579	409	2	:	:	PUNCT
bam-9579	409	3	10.1002	10.1002	NUM
bam-9579	409	4	/	/	SYM
bam-9579	409	5	jmv.25681	jmv.25681	PROPN
bam-9579	409	6	.	.	PUNCT
bam-9579	410	1	epub	epub	PROPN
bam-9579	410	2	2020	2020	NUM
bam-9579	410	3	feb	feb	PROPN
bam-9579	410	4	7	7	NUM
bam-9579	410	5	.	.	PUNCT
bam-9579	410	6	erratum	erratum	PROPN
bam-9579	410	7	in	in	ADP
bam-9579	410	8	:	:	PUNCT
bam-9579	410	9	j	j	PROPN
bam-9579	410	10	med	med	PROPN
bam-9579	410	11	virol	virol	NOUN
bam-9579	410	12	.	.	PUNCT
bam-9579	411	1	2020	2020	NUM
bam-9579	411	2	oct;92(10):2249	oct;92(10):2249	PROPN
bam-9579	411	3	.	.	PROPN
bam-9579	412	1	9	9	NUM
bam-9579	412	2	.	.	X
bam-9579	412	3	lee	lee	PROPN
bam-9579	412	4	n	n	PROPN
bam-9579	412	5	,	,	PUNCT
bam-9579	412	6	hui	hui	PROPN
bam-9579	413	1	d	d	PROPN
bam-9579	413	2	,	,	PUNCT
bam-9579	413	3	wu	wu	PROPN
bam-9579	413	4	a	a	X
bam-9579	413	5	,	,	PUNCT
bam-9579	413	6	chan	chan	PROPN
bam-9579	413	7	p	p	PROPN
bam-9579	413	8	,	,	PUNCT
bam-9579	413	9	cameron	cameron	PROPN
bam-9579	413	10	p	p	PROPN
bam-9579	413	11	,	,	PUNCT
bam-9579	413	12	joynt	joynt	PROPN
bam-9579	413	13	gm	gm	PROPN
bam-9579	413	14	,	,	PUNCT
bam-9579	413	15	ahuja	ahuja	PROPN
bam-9579	413	16	a	a	PROPN
bam-9579	413	17	,	,	PUNCT
bam-9579	413	18	yung	yung	PROPN
bam-9579	413	19	my	my	PRON
bam-9579	413	20	,	,	PUNCT
bam-9579	413	21	leung	leung	PROPN
bam-9579	413	22	cb	cb	PROPN
bam-9579	413	23	,	,	PUNCT
bam-9579	413	24	to	to	ADP
bam-9579	413	25	kf	kf	PROPN
bam-9579	413	26	,	,	PUNCT
bam-9579	413	27	lui	lui	X
bam-9579	413	28	sf	sf	PROPN
bam-9579	413	29	,	,	PUNCT
bam-9579	413	30	szeto	szeto	PROPN
bam-9579	413	31	cc	cc	PROPN
bam-9579	413	32	,	,	PUNCT
bam-9579	413	33	chung	chung	PROPN
bam-9579	413	34	s	s	PART
bam-9579	413	35	,	,	PUNCT
bam-9579	413	36	sung	sung	PROPN
bam-9579	413	37	jj	jj	PROPN
bam-9579	413	38	.	.	PUNCT
bam-9579	414	1	a	a	DET
bam-9579	414	2	major	major	ADJ
bam-9579	414	3	outbreak	outbreak	NOUN
bam-9579	414	4	of	of	ADP
bam-9579	414	5	severe	severe	ADJ
bam-9579	414	6	acute	acute	ADJ
bam-9579	414	7	respiratory	respiratory	ADJ
bam-9579	414	8	syndrome	syndrome	NOUN
bam-9579	414	9	in	in	ADP
bam-9579	414	10	hong	hong	PROPN
bam-9579	414	11	kong	kong	PROPN
bam-9579	414	12	.	.	PUNCT
bam-9579	415	1	n	n	PROPN
bam-9579	415	2	engl	engl	PROPN
bam-9579	415	3	j	j	PROPN
bam-9579	415	4	med	med	PROPN
bam-9579	415	5	.	.	PUNCT
bam-9579	416	1	2003	2003	NUM
bam-9579	416	2	may	may	AUX
bam-9579	416	3	15;348(20):198694	15;348(20):198694	NUM
bam-9579	416	4	.	.	PUNCT
bam-9579	417	1	doi	doi	NOUN
bam-9579	417	2	:	:	PUNCT
bam-9579	417	3	10.1056	10.1056	NUM
bam-9579	417	4	/	/	SYM
bam-9579	417	5	nejmoa030685	nejmoa030685	PROPN
bam-9579	417	6	.	.	PUNCT
bam-9579	418	1	epub	epub	PROPN
bam-9579	418	2	2003	2003	NUM
bam-9579	418	3	apr	apr	NOUN
bam-9579	418	4	7	7	NUM
bam-9579	418	5	.	.	NOUN
bam-9579	418	6	10	10	NUM
bam-9579	418	7	.	.	PUNCT
bam-9579	419	1	assiri	assiri	PROPN
bam-9579	419	2	a	a	PROPN
bam-9579	419	3	,	,	PUNCT
bam-9579	419	4	al	al	PROPN
bam-9579	419	5	-	-	PUNCT
bam-9579	419	6	tawfiq	tawfiq	PROPN
bam-9579	419	7	ja	ja	PROPN
bam-9579	419	8	,	,	PUNCT
bam-9579	419	9	al	al	PROPN
bam-9579	419	10	-	-	PUNCT
bam-9579	419	11	rabeeah	rabeeah	PROPN
bam-9579	419	12	aa	aa	PROPN
bam-9579	419	13	,	,	PUNCT
bam-9579	419	14	alrabiah	alrabiah	PROPN
bam-9579	419	15	fa	fa	PROPN
bam-9579	419	16	,	,	PUNCT
bam-9579	419	17	al	al	PROPN
bam-9579	419	18	-	-	PUNCT
bam-9579	419	19	hajjar	hajjar	PROPN
bam-9579	419	20	s	s	PROPN
bam-9579	419	21	,	,	PUNCT
bam-9579	419	22	al	al	PROPN
bam-9579	419	23	-	-	PUNCT
bam-9579	419	24	barrak	barrak	PROPN
bam-9579	419	25	a	a	PRON
bam-9579	419	26	,	,	PUNCT
bam-9579	419	27	flemban	flemban	ADJ
bam-9579	419	28	h	h	NOUN
bam-9579	419	29	,	,	PUNCT
bam-9579	419	30	al	al	PROPN
bam-9579	419	31	-	-	PUNCT
bam-9579	419	32	nassir	nassir	PROPN
bam-9579	419	33	wn	wn	PROPN
bam-9579	419	34	,	,	PUNCT
bam-9579	419	35	balkhy	balkhy	VERB
bam-9579	419	36	hh	hh	PROPN
bam-9579	419	37	,	,	PUNCT
bam-9579	419	38	al	al	PROPN
bam-9579	419	39	-	-	PUNCT
bam-9579	419	40	hakeem	hakeem	PROPN
bam-9579	419	41	rf	rf	NOUN
bam-9579	419	42	,	,	PUNCT
bam-9579	419	43	makhdoom	makhdoom	NOUN
bam-9579	419	44	hq	hq	NOUN
bam-9579	419	45	,	,	PUNCT
bam-9579	419	46	zumla	zumla	NOUN
bam-9579	419	47	ai	ai	VERB
bam-9579	419	48	,	,	PUNCT
bam-9579	419	49	memish	memish	PROPN
bam-9579	419	50	za	za	PROPN
bam-9579	419	51	.	.	PROPN
bam-9579	420	1	epidemiological	epidemiological	ADJ
bam-9579	420	2	,	,	PUNCT
bam-9579	420	3	demographic	demographic	ADJ
bam-9579	420	4	,	,	PUNCT
bam-9579	420	5	and	and	CCONJ
bam-9579	420	6	clinical	clinical	ADJ
bam-9579	420	7	characteristics	characteristic	NOUN
bam-9579	420	8	of	of	ADP
bam-9579	420	9	47	47	NUM
bam-9579	420	10	cases	case	NOUN
bam-9579	420	11	of	of	ADP
bam-9579	420	12	middle	middle	PROPN
bam-9579	420	13	east	east	PROPN
bam-9579	420	14	respiratory	respiratory	ADJ
bam-9579	420	15	syndrome	syndrome	NOUN
bam-9579	420	16	coronavirus	coronavirus	NOUN
bam-9579	420	17	disease	disease	NOUN
bam-9579	420	18	from	from	ADP
bam-9579	420	19	saudi	saudi	PROPN
bam-9579	420	20	arabia	arabia	PROPN
bam-9579	420	21	:	:	PUNCT
bam-9579	420	22	a	a	DET
bam-9579	420	23	descriptive	descriptive	ADJ
bam-9579	420	24	study	study	NOUN
bam-9579	420	25	.	.	PUNCT
bam-9579	421	1	lancet	lancet	PROPN
bam-9579	421	2	infect	infect	PROPN
bam-9579	421	3	dis	dis	PROPN
bam-9579	421	4	.	.	PUNCT
bam-9579	421	5	2013	2013	NUM
bam-9579	421	6	sep;13(9):752	sep;13(9):752	PROPN
bam-9579	421	7	-	-	SYM
bam-9579	421	8	61	61	NUM
bam-9579	421	9	.	.	PUNCT
bam-9579	422	1	doi	doi	NOUN
bam-9579	422	2	:	:	PUNCT
bam-9579	422	3	10.1016	10.1016	NUM
bam-9579	422	4	/	/	SYM
bam-9579	422	5	s14733099(13)70204	s14733099(13)70204	NOUN
bam-9579	422	6	-	-	PUNCT
bam-9579	422	7	4	4	NUM
bam-9579	422	8	.	.	PUNCT
bam-9579	423	1	epub	epub	PROPN
bam-9579	423	2	2013	2013	NUM
bam-9579	423	3	jul	jul	PROPN
bam-9579	423	4	26	26	NUM
bam-9579	423	5	.	.	PUNCT
bam-9579	424	1	11	11	NUM
bam-9579	424	2	.	.	PUNCT
bam-9579	425	1	chen	chen	PROPN
bam-9579	425	2	n	n	CCONJ
bam-9579	425	3	,	,	PUNCT
bam-9579	425	4	zhou	zhou	PROPN
bam-9579	425	5	m	m	PROPN
bam-9579	425	6	,	,	PUNCT
bam-9579	425	7	dong	dong	PROPN
bam-9579	425	8	x	x	PROPN
bam-9579	425	9	,	,	PUNCT
bam-9579	425	10	qu	qu	PROPN
bam-9579	425	11	j	j	PROPN
bam-9579	425	12	,	,	PUNCT
bam-9579	425	13	gong	gong	PROPN
bam-9579	425	14	f	f	PROPN
bam-9579	425	15	,	,	PUNCT
bam-9579	425	16	han	han	PROPN
bam-9579	425	17	y	y	PROPN
bam-9579	425	18	,	,	PUNCT
bam-9579	425	19	qiu	qiu	PROPN
bam-9579	425	20	y	y	PROPN
bam-9579	425	21	,	,	PUNCT
bam-9579	425	22	wang	wang	PROPN
bam-9579	425	23	j	j	PROPN
bam-9579	425	24	,	,	PUNCT
bam-9579	425	25	liu	liu	PROPN
bam-9579	425	26	y	y	PROPN
bam-9579	425	27	,	,	PUNCT
bam-9579	425	28	wei	wei	PROPN
bam-9579	425	29	y	y	PROPN
bam-9579	425	30	,	,	PUNCT
bam-9579	425	31	xia	xia	PROPN
bam-9579	425	32	j	j	PROPN
bam-9579	425	33	,	,	PUNCT
bam-9579	425	34	yu	yu	PROPN
bam-9579	425	35	t	t	PROPN
bam-9579	425	36	,	,	PUNCT
bam-9579	425	37	zhang	zhang	PROPN
bam-9579	425	38	x	x	PROPN
bam-9579	425	39	,	,	PUNCT
bam-9579	425	40	zhang	zhang	PROPN
bam-9579	425	41	l.	l.	PROPN
bam-9579	425	42	epidemiological	epidemiological	ADJ
bam-9579	425	43	and	and	CCONJ
bam-9579	425	44	clinical	clinical	ADJ
bam-9579	425	45	characteristics	characteristic	NOUN
bam-9579	425	46	of	of	ADP
bam-9579	425	47	99	99	NUM
bam-9579	425	48	cases	case	NOUN
bam-9579	425	49	of	of	ADP
bam-9579	425	50	2019	2019	NUM
bam-9579	425	51	novel	novel	ADJ
bam-9579	425	52	coronavirus	coronavirus	NOUN
bam-9579	425	53	pneumonia	pneumonia	NOUN
bam-9579	425	54	in	in	ADP
bam-9579	425	55	wuhan	wuhan	PROPN
bam-9579	425	56	,	,	PUNCT
bam-9579	425	57	china	china	PROPN
bam-9579	425	58	:	:	PUNCT
bam-9579	425	59	a	a	DET
bam-9579	425	60	descriptive	descriptive	ADJ
bam-9579	425	61	study	study	NOUN
bam-9579	425	62	.	.	PUNCT
bam-9579	426	1	lancet	lancet	PROPN
bam-9579	426	2	.	.	PUNCT
bam-9579	427	1	2020	2020	NUM
bam-9579	427	2	feb	feb	X
bam-9579	427	3	15;395(10223):507	15;395(10223):507	NUM
bam-9579	427	4	-	-	SYM
bam-9579	427	5	513	513	NUM
bam-9579	427	6	.	.	PUNCT
bam-9579	428	1	doi	doi	NOUN
bam-9579	428	2	:	:	PUNCT
bam-9579	428	3	10.1016	10.1016	NUM
bam-9579	428	4	/	/	SYM
bam-9579	428	5	s01406736(20)30211	s01406736(20)30211	PROPN
bam-9579	428	6	-	-	SYM
bam-9579	428	7	7	7	NUM
bam-9579	428	8	.	.	PUNCT
bam-9579	429	1	epub	epub	PROPN
bam-9579	429	2	2020	2020	NUM
bam-9579	429	3	jan	jan	PROPN
bam-9579	429	4	30	30	NUM
bam-9579	429	5	.	.	PUNCT
bam-9579	429	6	12	12	NUM
bam-9579	429	7	.	.	X
bam-9579	430	1	de	de	PROPN
bam-9579	430	2	wit	wit	PROPN
bam-9579	430	3	e	e	PROPN
bam-9579	430	4	,	,	PUNCT
bam-9579	430	5	van	van	PROPN
bam-9579	430	6	doremalen	doremalen	PROPN
bam-9579	430	7	n	n	CCONJ
bam-9579	430	8	,	,	PUNCT
bam-9579	430	9	falzarano	falzarano	ADJ
bam-9579	430	10	d	d	NOUN
bam-9579	430	11	,	,	PUNCT
bam-9579	430	12	munster	munster	PROPN
bam-9579	430	13	vj	vj	PROPN
bam-9579	430	14	.	.	PROPN
bam-9579	430	15	sars	sars	PROPN
bam-9579	430	16	and	and	CCONJ
bam-9579	430	17	mers	mer	NOUN
bam-9579	430	18	:	:	PUNCT
bam-9579	430	19	recent	recent	ADJ
bam-9579	430	20	insights	insight	NOUN
bam-9579	430	21	into	into	ADP
bam-9579	430	22	emerging	emerge	VERB
bam-9579	430	23	coronaviruses	coronaviruse	NOUN
bam-9579	430	24	.	.	PUNCT
bam-9579	431	1	nat	nat	PROPN
bam-9579	431	2	rev	rev	VERB
bam-9579	431	3	microbiol	microbiol	PROPN
bam-9579	431	4	.	.	PUNCT
bam-9579	432	1	2016	2016	NUM
bam-9579	432	2	aug;14(8):523	aug;14(8):523	NOUN
bam-9579	432	3	-	-	SYM
bam-9579	432	4	34	34	NUM
bam-9579	432	5	.	.	PUNCT
bam-9579	433	1	doi	doi	NOUN
bam-9579	433	2	:	:	PUNCT
bam-9579	433	3	10.1038	10.1038	NUM
bam-9579	433	4	/	/	SYM
bam-9579	433	5	nrmicro.2016.81	nrmicro.2016.81	NOUN
bam-9579	433	6	.	.	PUNCT
bam-9579	434	1	epub	epub	PROPN
bam-9579	434	2	2016	2016	NUM
bam-9579	434	3	jun	jun	PROPN
bam-9579	434	4	27	27	NUM
bam-9579	434	5	.	.	PUNCT
bam-9579	435	1	submission	submission	NOUN
bam-9579	435	2	:	:	PUNCT
bam-9579	435	3	december	december	PROPN
bam-9579	435	4	31	31	NUM
bam-9579	435	5	,	,	PUNCT
bam-9579	435	6	2020	2020	NUM
bam-9579	435	7	revision	revision	NOUN
bam-9579	435	8	received	receive	VERB
bam-9579	435	9	:	:	PUNCT
bam-9579	435	10	april	april	PROPN
bam-9579	435	11	28	28	NUM
bam-9579	435	12	,	,	PUNCT
bam-9579	435	13	2021	2021	NUM
bam-9579	435	14	accepted	accept	VERB
bam-9579	435	15	for	for	ADP
bam-9579	435	16	publication	publication	NOUN
bam-9579	435	17	:	:	PUNCT
bam-9579	435	18	april	april	PROPN
bam-9579	435	19	29	29	NUM
bam-9579	435	20	,	,	PUNCT
bam-9579	435	21	2021	2021	NUM